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CHAPTERl 
PREVALENCE AND PROGNOSIS OF ELECTROCARDIOGRAPIDC 
FINDINGS IN THE ELDERLY: A REVIEW 
Introductiou 
In most developed countries the proportion of elderly people in the population is 
expected to increase in the next decades. Cardiovascular disease is a leading cause 
of death and disability in the elderly and it is predicted that the absolute incidence 
rates of cardiac disease in older adults will increase significantly in the years to 
come. 
Since the invention of electrocardiography in 1902 by Willem Einthoven, the 
electrocardiogram (ECG) has gained an important position in clinical cardiolog/. In 
the last decade, computer programs for ECG interpretation with good pelformance 
have become available2, improving the applicability of ECGs in medical practice 
and in epidemiologic research. The EeG offers an inexpensive. noninvasive instru-
ment to determine the presence of coronmy hemt disease as well as other cardiae 
abnormalities, such as ventricular hypertrophy and atrial fibrillation, known to be 
associated with the risk of future cardiovascular events. Especially in the elderly, in 
whom medical histories may be troubled by concomitant diseases and are not 
always as reliable as one would desire, the ECG could serve as a useful diagnostic 
and prognostic instrument. 
Since the 1950s, large epidemiologic studies among young and middle-aged men 
and women have provided important information on the prevalence and prognosis of 
ECG abnormalities. Relatively few studies have been pelfonned in the elderly. A 
comparison of individual studies is hampered because of differences in diagnostic 
criteria applied in the individual studies, although comparability has improved since 
the introduction in 1960 of the Minnesota Code as a standardized coding system for 
the ECG3 . Recently, several studies reported that ECG indicators of autonomic 
balance, such as heart rate variability and QTc interval duration, may be strong pre-
dictors of cardiac and all-cause mortality, both in middle-aged and in older subjects. 
1 
Chapter 1 
In this chapter, the prevalence and prognosis of ECG abnormalities in the elderly 
will be reviewed. The ECG abnormalities included are Minnesota Code items, myo-
cardial infarction, left ventricular hypertrophy, repolarization disturbances, con-
duction defects, and atrial fibrillation. Finally, new developments concerning ECG 
parameters of autonomic balance will be discusscd. 
Methods 
A thorough literature search using computerized literature databases and lateral 
literature references was performed. In addition, several recent reviews, concerning 
electrocardiography in epidemiology4 and ECG findings in the elderly" 6, were 
sClUtinized. 
The review of literature on the prevalence of ECG abnormalities was limited to 
studies that apply the Minnesota Code. In selecting studies reporting prevalence of 
MimlCsota Code abnormalities, we only included studies that were performed in the 
general population aged 60 years or older, or studies in the general adult population 
that presented data in age strata. Studies limited to hospitalized patients or to men 
only were excluded. In total, seven studies could be found in which prevalence of 
Minnesota Code items in the elderly population at large was reported'-l3. In 
addition, we computed the prevalence of Minnesota Code items among men and 
women aged 60 years or older in the Rotterdam Study, a population-based study 
among men and women aged 55 years or older, living in the Rotterdam district of 
Ommoord l4 . 
Prevalence of ECG abnormalities according to the Minnesota Code 
Selected characteristics of the eight population· based cross-sectional studies are 
shown in Table 1. Tables 2, 3, and 4 summarize the major findings from these 
studies. 
Q-QS pattems 
The overall prevalence of Q-QS abnormalities, suggestive of myocardial infarction, 
in the elderly population varies between 4.5% and 15.7% . The prevalence ratio of 
2 
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minor and major infarct patterns is consistent, approximately 0.40, across all studies 
apart from the Rotterdam Study. Prevalence of Q-QS patterns, in particular minor 
Q-QS abnormalities, in the Rotterdam Study is higher than in the other studies. In 
all studies, Q-QS pattcrns m'e more frequent in men than in women, with prevalence 
clearly increasing with age in both sexes. 
QRS ({xis deviation 
Ostrander et a1.9• 15 reported a prevalence of left axis deviation of 18% in men and 
women 60 years or over, whereas in other studies considerably lower prevalences 
are found. An increase in the prevalence of axis deviation with advancing age in 
both sexes is demonstrated in all studies, and men are more frequently affected than 
women. 
Ventricular hypertrophy 
Major differences exist in the reported prevalence of left ventricular hypertrophy 
(LVH), which varies from 8.8% to 16.9%. Also, the presence of LVH with ST-T 
abnormalities varies considerably, from 4.2% to 8.0%. In six of the eight studies, 
women appear to be more often affected by L VH than men. Only Ostor et a1. 8 and 
Casiglia et a1.13 reported a higher prevalence of LVH in men. Right ventricular 
hypertrophy is rarely found and more refined criteria to detect minor abnormalities 
of the right ventricle have been proposed'. 
ST-T abnormalities 
Also the prevalence of ST-T wave abnormalities varies widely across studies. The 
prevalence of ST-segment items varies from 5.4% to 19.3% in men, and from 6.7% 
to 24.0% in women. Similarly, the prevalence of T-wave abnormalities varies from 
5.5% to 33.1 % in men and from 6.8% to 33.6% in women. The prevalence of ST-T 
abnormalities rapidly increases with age and no clear gender differences are present. 
3 
Table 1. Summary of major characteristics of eight population-based studies in the elderly Q 
" '" First author (reference) " " Ostrander Kennedy Kitchin Campbell Ostor Furberg Casiglia Rotterdam 
--(9) (10) (11) (7) (8) (12) (13) Study 
Subjects (n) 663 400 487 2254 4118 5150 2254 5089 
Men, % 46 48 44 39 49 43 36 40 
Response rate (%) >70 NR NR 60 72 NR 73 70 
Age range (y) ,,60 ,,65 62-90 2:65 ,,60 ,,65 ,,65 60-106 
Mean age (y) 70 74 NR 71 68 73 NR 72 
Men 70 74 NR 71 68 74 NR 70 
Women 71 75 NR 71 67 73 NR 73 
NR= not reported 
Table 2. Prevalence of electrocardiographic evidence of myocardial infarction (Q-QS abnormalities) in eight population-
based studies in the elderly 
""-
First author (reference) 
Ostrander KeJUledy Kitchin Campbell Ostor Furberg Casiglia Rotterdam 
(9) (10) (11) (7) (8) (12) (13) Study 
Q-Qs abnonnalities, 
Code 1.1-1.3 6.8 9.5 7.7 6.3 4.5 NR NR 15.7 
Men 9.1 7.9 10.0 6.3 20.0 
Women 4.7 7.4 4.0 2.7 12.9 
Major Q-QS abnonnalities 
Code 1.1-J.2 5.0 NR 5.4 4.7 3.1 5.2 2.3 8.7 
Men 6.8 5.6 7.8 4.3 7.3 3.6 11.6 
Women 3.6 5.2 2.4 2.0 3.6 1.4 6.8 
Minor Q-QS abnonnalities 
Code 1.3 1.8 NR 2.3 1.6 1.4 NR NR 7.0 
Men 2.3 2.3 2.2 2.0 8.3 
Women 1.4 2.2 1.2 0.8 6.1 
NR= not reported 
Table 3. Prevalence of axis deviation, ventricular hypertrophy, and ST -segment and T -wave abnormalities in eight 
population based studies in the elderly 
First author (reference) 
Ostrander Kennedy Kitchin Campbell Ostor Furberg Casiglia Rotterdam 
(9) (10) (11) (7) (8) (12) (13) Study 
LAD, Code 2.1 18.4 6.5 8.5 NR 7.9 NR 13.1 8.9 
Men 21.0 10.2 10.2 15.9 10.9 
Women 16.2 7.1 5.6 11.4 7.5 
RAD, Code 2.2 0.2 NR 0.8 NR 0.7 NR NR 0.1 
Men 0.3 1.9 0.8 0.1 ~ 
Women 0.0 0.0 0.5 0.1 
'" ~ L VB. Code 3.1-3.3 10.1 14.0 9.7* 8.8 16.9 NR 10.0 11.9 ~ 
Men 8.2 3.7 6.7 20.6 11.7 12.4 ~ 
" Women 11.5 7.1 10.2 13.1 8.9 11.6  
LVH with ST-T NR 6.3 NR 4.6 NR 42 NR 8.0 " s.. v. Men 2.9 4.3 7.4 
"" Women 5.6 4.1 8.4 <3
RVH. Code 3.2 NR 0.0 2.5 0.7 NR NR NR 0.0 ":§ 
Men 3.3 1.4 0.1 i:; 
Women 1.9 0.3 0.0 0;' 
ST segment items. Code 4.1-4.4 10.9 NR 10.1 6.2 10.6 NR NR 20.3 ~ 
Men 7.9 13.0 5.4 11.6 19.3 t'l (J 
Women 13.4 24.0 6.7 9.7 20.9 Cl 
T-wave items, Code 5.1-5.4 32.1 10.5** 27.0 15.3 24.4 6.3 23.6* 30.9 ~ 
Men 33.1 23.0 19.2 26.3 5.5 18.1 27.0 ;;., 
Women 31.3 30.0 12.9 22.6 6.8 27.0 33.6 ~. 
" NR= notreported: *Only code 3.1: ** ST-T combined Code 4.1 or 4.3 and Code 5.1 or 5.3 ;::" 
s;, 
" 
" 
-"-
" 
.., 
q-
Q 
Table 4. Prevalence of atrioventricular and ventricular conduction defects, extrasystoles, and atrial fibrillation in eight 
-6 
population-based studies in the elderly 
" 
.., 
-
First author (reference) 
Ostrander Kennedy Kitchin Campbell Ostor Fmuerg Casiglia Rotterdam 
(9) (10) (11) (7) (8) (12) (13) Studl 
A V conduction defects, NR 23 3.3 1.1 6.9 NR NR 6.8 
Code 6.1-6.3 3.7 1.5 8.7 8.0 
Men 3.0 0.8 5.2 6.0 
Women 
First degree A V block, Code 6.3 6.2 2.0 NR 0.9 6.8 5.3 3.9 6.8 
Men 6.9 1.5 8.7 8.1 5.0 8.0 
Women 5.6 0.6 5.0 3.2 3.2 6.0 
LBBB. Code 7.1 1.7 2.5 0.6 1.4 1.6 1.7 3.9 2.9 
Men 0.7 1.4 1.6 1.9 1.6 3.9 2.7 
0\ Women 2.5 0.0 1.2 1.3 1.8 3.9 3.0 
RBBB. Code 7.2 2.0 3.5 2.3 1.8 2.3 4.3 7.4' 4.1 
Men 3.0 2.3 2.8 3.6 6.8 10.8 6.5 
Women 1.1 2.2 1.2 1.1 2.4 5.4 2.4 
Incomplete RBBB. Code 7.3 2.1 2.8 1.5 1.4 1.7 NR NR 2.8 
Men 3.3 1.4 1.6 1.8 3.5 
Women 1.1 1.5 1.3 1.5 2.4 
Intraventricular block. Code 7.4 NR NR NR 0.5 0.8 2.7 NR 0.8 
Men 0.8 1.2 4.7 1.2 
Women 0.3 0.3 1.2 0.5 
Extrasystole, Code 8.1 5.6 4.5 NR 3.1 3.1 NR NR 3.7 
Men 8.9 3.6 3.6 4.8 
Women 2.8 2.5 2.5 3.0 
Atrial fibrillation. Code 8.3 2.4 3.0 2.5 1.4 1.4 3.2 4.0 3.6 
Men 2.6 2.3 1.3 1.3 4.0 3.8 4.0 
Women 2.2 2.6 1.5 1.5 2.6 4.1 3.3 
NR= not reported; * Code 7.2 and 7.3 combined 
Prevalence and prognosis of ECGfindings in the elderly 
Conduction defects 
First degree A V block is by far the most conmlOn atrioventricular conduction defect, 
ranging from 0.9% to 6.8% in older subjects.A right bundle branch block occurs 
more frequently than a left bundle branch block (range 1.8% to 4.3% and 0.6% to 
3.9%, respectively). Right bundle branch block and intraventricular block appear to 
be more frequent in men than in women. Such a difference does not exist for left 
bundle branch block. 
Arrhythmias 
The prevalence of cardiac arrhythmias increases with age. Atrial fibrillation, with a 
reported prevalence of 1.4% to 4.0%, is the most common cardiac arrhythmia. 
Comments 
Reported prevalences of most ECG abnormalities according to the Minnesota Code 
showed considerable variation between individual studies. Although all studies 
reviewed were performed in non-hospitalized and unseleeted populations, these 
studies differ with regard to the number of participants, age and gender distribution, 
and response rate. Apart from regional differences in the occurrence of cardio-
vascular diseases, different selection criteria may explain at least part of the varia-
tion in prevalence of ECG abnormalities. In addition, the period in which the studies 
,vere performed, varying from the sixties to the nineties, may be a source of varia-
tion. Although coding took place according to the Minnesota Code, differences in 
coding procedures, by one or morc observers, by hand or computer, may also ac-
count for part of the variation. Intcr- and intraobserver variability in Minnesota Co-
ding may be considerablelO• 16. 17. The Rotterdam Study is the only study using an 
extensively validated computer program for ECG codingl'. 19. 
Several ECG abnormalities according to the Minnesota Code, e.g., Q-QS patterns, 
left axis deviation, left bundle branch block, high amplitude R-waves, ST-T 
abnormalities, and atrial fibrillation are established risk indicators of future 
d· I 8 13 20·23 D' . d . f h d car lQVaSCU ar events" . mgnosls an prognosls 0 t esc an other ECG 
abnormalities will be discussed in more detail ill the next paragraphs. 
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Diagnosis and prognosis of specific ECG abnormalities 
Myocardial infarction 
Myocardial infarction may occur with or without symptoms'4 and with or without 
lasting ECG abnormalities25, '6, Especially in the elderly, patients with myocardial 
infarction often present themselves with atypical symptoms and signs 14, 
The proportion of myocardial infarctions that occur without typical symptoms, 
silent myocardial infarctions, ranges from 20% to 68% (Table 5). This proportion 
appears to be higher in women than in men. The prevalence of silent myocardial 
infarction (on average 4.6% in men and 3.5% in women in the Rotterdam Study) 
increases with ageI4 , 
The prognosis of silent MI with regard to the occurrence of new coronary events, 
such as recurrent myocardial infarction, ventricular fibrillation, and sudden cardiac 
death, is similar to that of symptomatic myocardial infarction27~31. In the elderly, the 
absolute risk of new coronary events is usually high. For example, Aronow et al. 28 
reported that during four years of follow~up new coronary events occurred in 65% 
of men and women with recognized myocardial infarction and in 56% of men and 
women with silent myocardial infarction. As the detection of silent myocardial 
infarction is completely dependent of the ECG, these findings may have important 
implications for the use of ECGs for cardiovascular screening of elderly patients in 
medical practice. 
Non-Q-wave Inyocardial infarction, defined as symptomatic myocardial infarction 
without matching ECG abnormalities, but confirmed by raised cardiac enzyme 
Table 5. Proportion of proven electrocardiographic myocardial infarc-
tion that occurs without symptoms (silent) in the elderly. 
First author (reference) 
Rodstein (37) 
Aronow (38) 
Furberg (12) 
Nadebnann (27) 
De Bruyne (14) 
Prevalence 
(% (number of silent events! total number 
of myocardial infarctions)) 
8 
31%(t6/52) 
68% (781 115) 
20% (t 471744) 
34% (25/72) 
36% (127/353) 
Prevalence and prognosis of ECG findings in the elderly 
levels or autopsy, may occur in 38% to 62% of all myocardial infarctions, depen-
ding on the Minnesota Code criteria used, and is more frequent in myocardial in-
farctions that occurred farther in the past26 , In the Bronx Aging Study27, among men 
and women aged 75 to 85 years, 62% of the reported myocardial infarctions are 
non-Q-wave myocardial infarctions, In the Rotterdam Study, the prevalence of non-
Q-wave myocardial infarction is 4.4% in men and 1.8% in women, Overall, 26% of 
all myocardial infarctions were non-Q-wave infarctions, The prognostic 
implications of non-Q-wave myocardial infarctions arc similar those of electro-
d' I'd' I' f ' 32-36 car lOgrap He myocar 13 In arctlOlls . 
Lejl ventricular hypertrophy 
Diagnosis of left ventricular hypertrophy measured by ECG has a poor sensitivity 
and predictive value in detecting echocardiographically determined left ventricular 
hypertrophy, In a report of Aronow et a1. 39, the sensitivity of five different ECG 
criteria for left ventricular hypertrophy varies from 12% to 29%, the specificity 
ranges from 93% to 96%, and the positive predictive value ranges from 62% to 
72%, In the Framingham Heart Study the sensitivity of ECG criteria of left ventri-
cular hypertrophy (using R in a VL, S in V3 and QRS duration) for echocardio-
graphic left ventricular hypertrophy is 39% in men and 51 % in women, at a speci-
ficity level of 95%40, An even poorer sensitivity has been reported when diabetes, a 
common comorbidity, is present", Prevalence estimates of left ventricular hyper-
trophy by ECG arc strongly influenced by the ECG criteria used, 
Prognosis of left ventricular hypertrophy in the elderly is reported to be similar to 
that of silent myocardial infarction42, Subjects with left ventricular hypertrophy arc 
at increased risk for coronary events, atherothrombotic brain infarctions, congestive 
heart failure, peripheral artcIY disease, ventricular arrhythmias, and total mortality32, 
42-46, Also, serial changes in electrocardiographic left ventricular hypertrophy have 
prognostic implications, Serial increase of left ventricular hypertrophy has a poorer 
prognosis and serial decrease of left ventricular hypertrophy has a better prognosis 
for cardiovascular disease32, 47, Recent studies indicate that treatment of left 
ventricular hypertrophy can reduce the incidence of coronary heart disease 48. 
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Repo/arization disturbances 
In previous studies, ST-T changes, either isolated or in combination with other 
ischemic or hypertrophic changes, have been associated with coronary heart disease 
and sudden cardiac death in middle-aged populations'" 49-59, as well as in elderly 
populations" 21, 60-65, In middle-aged populations, the association of ST -T abnorma-
lities has often been reported to be more pronounced in men than in women, but this 
difference seems to be absent in the elderly, Although ST-T abnormalities often are 
transient, they are independently associated with future coronary heart disease, The 
risk associated with ST-T abnormalities is more pronounced in combination with 
other ECG abnormalities, such as pathologic Q-waves, left ventricular hypertrophy 
or intraventricular conduction defects. Repolarization disturbances on the ECG arc 
multifactorial and may be associated with increasing age, myocardial ischemia, hy-
pertension, ventricular hypertrophy, ventricular conduction defects, use of digitalis, 
autonomic dysfunction, and other pathophysiologic processes, 
Conduction dejects 
Atrioventricular conduction time increases with age, due to changes both in the 
atrioventricular nodal and the His-Purkinje systcm66. In addition, atrioventricular 
block is associated with coronary ischemia, vagotonia and digitalis use67 . In contrast 
to younger populations, in which the presence of atrioventricular block is usually 
considered a benign condition, not associated 'with an increased risk for coronary 
h d ' 68 69, Id I ' ,- f' 'I bl k ' I eart lsease ' ,1l1 0 er popu atIons an aSSOcIatIOn 0 atnoventncu ar oc S WIt 1 
coronary heart disease has been reported in several studies 70-72, Other shldies in el-
derly patients report no association of atrioventricular block with coronary events73 , 
Left bundle branch block is uncommon in the absence of cardiovascular disease74 
and is associated with future coronary heart disease65,75 and all-cause mortality22,73 
in elderly men and women, Right bundle branch block occurs more frequently than 
left bundle branch block, Only in 20% of subjects with right bundle branch block, 
clinical and necropsy findings of coronary heart disease are present'6, ContradictOlY 
results have been published on the risk associated with right bundle branch block in 
the elderly, An association with mortality was observed in a study by Caird et al.22 
and an association with coronary events was present in the Framingham Study77, 
10 
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while no associations were found in several other studies62• 73, 78, 79, 
Intraventricular conduction defects, defined as a prolonged QRS duration (20,11 
seconds) in the absence of left or right bundle branch block, has been reported to 
increase the incidence of total mortality" and cardiac events?3 in the elderly, In the 
Framingham Heart Study, elderly men and women with intraventricular conduction 
defect were at increased risk for coronary heart disease, although this was not 
statistically significant65 , 
Arrhythmias 
The prevalence of atrial fibrillation increases with age'O and is higher in those with 
overt cardiovascular disease12 , 81, 82, Many studies have reported that chronic atrial 
fibrillation is independently associated with thromboembolic stroke83.86 , Recently, 
an association of atrial fibrillation with dementia was rcported87 . In addition, atrial 
fibrillation was a risk factor for ali-cause mortality in the Coronary Drug Project" 
and for cardiovascular mortality in the Framingham Heart StudySO, 
Premature ventricular complexes on the resting ECG were a risk factor for total 
mortality in the Coronary Drug Project" and for cardiovascular mortality in the 
Busselton Study62, In the elderly an increased risk of cardiovascular events asso-
ciated with frequent ventricular premature beats on ambulatory ECGs has been re-
d I , 88·90 H '" I d' , d porte severa tltnes . owever, no aSSOcIatIOn WIt 1 car laC outcome was loun 
between ventricular premature beats on the resting ECG in elderly in the Baltimore 
Longitudinal Study9I, Using I -minute rhythm strips, no association was found in 
subjects without clinical heart disease, but a strong association was present in elder-
ly subjects with a history of clinical heart disease", The latter finding suggests that 
ventricular premature complexes are markers of underlying ischemic heart disease, 
ECG indicators of autonomic fUllction 
Prolonged QTc interval and decreased heart rate variability (HRV) have been put 
forward as indicators of autonomic balance93 . 94, With increasing age, sympathetic 
activity increases relative to vagal activity95, Autonomic balance, in particular QTc 
interval and heart rate variability, is influenced by various physiological and patho-
II 
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physiological conditions, such as respiration96 , diabetic neuropathy97-!OO, left ventri-
cular function!OI, and coronary heart diseaseI02-105• Both risk indicators have been 
associated with a poor prognosis in patients after myocardial infarctionl06-112, 
Recently, some studies on the prognostic value of prolonged QTc interval were per-
formed iu the general population, producing controversial results. In the Dutch Civil 
Servants Study!l3, men and women with prolonged heart-rate adjusted QT intervals 
had a twofold risk for death from coronary heart disease. Also in the Zutphen Stu-
dy"4 among middle-aged and elderly men, increased risks for cardiac mortality 
were reported. However, no association was found between QTc interval and car-
diac outcome in the Framingham Stud/IS and the Bronx Aging Study7l. 
Results from population-based studies concerning the risk associated with decreased 
HRV are more consistent. In lniddle-aged men and women, decreased HRV was 
associated with a poorer cardiac prognosis in three studicS lI6-118 , An increased risk 
for all-cause mortality associated with decreased HRV was found in elderly men 
and women in the Framingham Study"9 and in elderly men in the Zutphen Study!20. 
However, no association of decreased HRV with both cardiac and all-cause mor-
tality was found in the Bronx Aging Study7l. 
Comments 
Reports from literature show that the BCG contains a wealth of both etiologic and 
prognostic information. However, many studies use thcir own definitions of ECG 
diagnoses and thus results from different studies show wide variation and call1lot 
easily be compared. In addition, characteristics of subjects included in individual 
studies differ. Measurement techniques of intervals and amplitudes need to be stan-
dardized, to allow results from epidemiological studies to be applicable in medical 
practice. Since computer programs with good performance have become available2, 
they offer an efficient, inexpensive, and, in particular, a standardized way to inter-
pret BCGs. 
Conclusions 
The prevalence of abnormal BCG findings is relatively high in the elderly, increases 
12 
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with age and is higher in men than in women. Most BCG findings that are often 
markers of coronary heart disease or other disease processes, are associated with fu-
ture coronary heart disease. However, diagnostic criteria show wide variation 
among studies, and standardization is urgently needed. Computer programs for BCG 
analysis may offer a solution The significance of conventional and new BCG risk 
indicators in elderly men and women needs to be confirmed and the predictive value 
of BCG findings in addition to established cardiovascular risk indicators necds to be 
determined. Although in younger subjects without heart disease the BCG is not con-
sidcred a useful tool for screening purposes!2!, the BCG may well be valuable to 
identify elderly subjects at risk for future coronary heart disease, because both pre-
valence of BCG abnormalities and incidence of cardiac disease arc higher at older 
age. 
This thesis addresses several diagnostic (chapter 2) and prognostic (chapter 3) as-
pects of the BCG in non hospitalized subjects. In chapter 2.1 diagnostic BCG inter-
pretation in population-based research by computer and by trained research physi-
cians is evaluated, using experienced cardiologists as a reference. In addition, three 
sccnarios for BCG interpretation in large population-based studies are studied. 
Reproducibility of computerized BCG measurements and coding is described in 
chaptcr 2.2. Prevalence of BCG abnormalities is directly based on diagnostic criteria 
for BCG abnormalities. In elderly mcn and women, we studied the prevalence of 
different types of myocardial infarction and of prolonged heart-rate adjusted QT 
intervals, and the influencc of diagnostic criteria for these BCG abnormalities on 
their estimated prevalence. In chapter 3, the prognostic value of several "new" BCG 
abnormalities, notably prolonged QTc (chapter 3.1), QTc dispersion (chapter 3.2), T 
axis deviation (chapter 3.3) and heart rate variability (chapter 3.4), is described. Cli-
nical relevance of electrocardiographic dsk indicators largely depends on the added 
value of BCG abnormalities to the cardiovascular risk profile, in indicating subjects 
at increased absolute risk for future heart disease. In chapter 3.5 we studied the pre-
dictive value of conventional and "new" ECG abnormalities for cardiac mortality, 
when used in addition to the cardiovascular risk profile, commonly available in ge-
neral practice. Finally, in chapter 4 the implications of the studies presented in this 
thesis are discussed and recommendations for future research are provided. 
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CHAPTER 2.1 
DIAGNOSTIC INTERPRETATION OF ELECTROCARDIOGRAMS 
IN POPULATION· BASED RESEARCH: COMPUTER PROGRAM, 
RESEARCH PHYSICIANS, OR CARDIOLOGISTS? 
Abstract 
We assessed the pelfonnance of diagnostic ECG interpretation by the computer 
program MEANS and by research physicians, compared to cardiologists, in a 
population·based study. To establish a strategy for ECG intelpretation in health surveys, 
we also studied the diagnostic capacity of three scenrnios: use of the computer program 
alone (A), computer program and cardiologist (B), and computer program, research 
physician and crn'diologist (C). A stratified random srnnple of 381 ECGs was drawn 
from ECGs collected in the Rotterdam Study (n=3057), which were interpreted both by 
a trained research physician using a form for snuctured clinical evaluation mid MEANS. 
All ECGs were intelpreted independently by two crn'diologists; if they disagreed 
(n=175) the ECG was judged by a third cardiologist. 
Five ECG diagnoses were considered: anterior and inferior myocardial infarction (MI), 
left and right bundle branch block (LBBB and REBB) and left ventricular hypertrophy 
(LVH). Overall, sensitivities and specificities of MEANS and the research physicians 
were high. The sensitivity of MEANS ranged from 73.8% to 92.9% and of the research 
physician ranged from 71.8% to 96.9%. The specificity of MEANS rrnlged from 97.5% 
to 99.8% mid of the research physician from 96.3% to 99.6%. To diagnose LVH, LBBB 
and RBBB, use of the computer program alone gives satisfactory results. Preferably, all 
positive fmdings of anterior and inferior Ml by the progrrnn, should be verified by a 
crn·diologist. We conclude that diagnostic ECG interpretation by computer can be very 
helpful in population·based research, being at least as good as ECG interpretation by a 
trained research physician, but much more efficient and therefore less expensive. 
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Introduction 
The use of electrocardiograms (ECGs) in population-based studies may lead to enor-
mous numbers of ECGs to be interpreted. Traditionally, ECG interpretation is perfor-
med by cardiologists. To reduce the workload for cardiologists, trained research physi-
cians or computer programs for ECG intelpretation can be used, with or without super-
vision by an experienced cardiologist. Computer programs have two major advantages 
compared to human readers: the intra- and interobserver variability in ECG intelpre-
tation and coding is reduced and it saves time spent by physicians, and therefore costs. 
Tn health surveys most experience with the use of ECG computer programs has been 
gathered with the Minnesota Code or related coding schemesl-3. These schemes, 
however, only purport to describe ECG wave forms and not to deliver a diagnosis. If, 
somehow, diagnoses are appended to the descriptions, they have a rather poor 
sensitivity and specificity, notably for myocardial infarction (MI) and left venuicular 
hypertrophy (L VH)'. 
An alternative for descriptive ECG codes such as the Minnesota Code, diagnostic ECG 
interpretation can be used in health surveys. The performance of diagnostic ECG inter-
pretation by computer programs or cardiologists' has been'siudied some years ago in the 
study Cornman Standards for Quantitative Electrocardiography (CSE), sponsored by the 
European Community, with promising results 4.7. However, the CSE project was based 
on hospitalized patients only. As severity of disease in hospitalized patients will differ 
from that in the population at large, the CSE results cailllot be _extrapolated to the 
general population. Little is known about the value of diagnostic ECG intelpretation by 
computer programs or research physicians in health surveys. 
The primmy objective of the present study was to assess the performance of diagnostic 
ECG intelpretation by our ECG computer program MEANS (Modulm' ECG Analysis 
System),·9 and by research physicians, compm-ed to cardiologists, in population-based 
research. Our second objective was to establish a strategy for ECG intelpretation in 
health surveys. We anticipated that combining ECG intelpretations [rom computer 
program, research physician and cm'diologist would inlprove sensitivity and specificity 
of ECG diagnoses and effectively decrease the workload for human readers. We 
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compared three different scenmios: one in which the ECGs were interpreted by the 
computer program alone, a second in which the ECGs were initially interpreted by the 
computer program and positive findings were checked by a cardiologist, and a third in 
which all ECGs were interpreted independently by a research physician and by the 
computer program, and only those on which they disagreed were interpreted by a 
cardiologist. 
Methods 
Data Collection 
The ECGs used in this study were collected during the baseline examination of the Rot-
terdam Study, a population-based cohort study aimed at assessing the occunence and 
dsk factors of clu"Onic diseases in the elderly. Objectives and methods of the Rotterdam 
Study are described in detail elsewherc lO• Briefly, in the Rotterdam Study all men and 
women aged 55 yem's or older, living in the Rotterdam district Onunoord, were invited 
to pm1icipate. Of 7,983 pmticipants (response rate 78%) baseline data, were collected 
[rom 1990 to 1993, including an ECG, information on histOl}, of cardiovascular disease, 
and established cardiovasculm' risk factors. 
The [n'st 3,436 ECGs collected in the Rotterdam Study were evaluated by resem'ch 
physicians, using an extensive form for structured clinical ECG evaluation. All research 
physicians had finished their theoretical and clinical medical training, resulting in a 
diploma of "medical doctor", without specialization. Training for ECG intelpretation by 
an expedenced cardiologist (DACM Kmijssen) consisted of two phases. First, in ten 
plenary sessions, special lectures about ECG interpretation were given and the use of 
the evaluation fmm was practiced. Second, in a teaching period, ECGs were double-
coded by the research physician and the experienced cardiologist. Discrepancies 
between their interpretations were discussed in detail and a consensus was reached. 
After this training pedod the research physicimls worked independently. 
Of the first 3,436 ECGs, 3,057 were stored digitally and interpreted by the ECG 
computer program MEANS. The MEANS program uses complex decision trees for 
diagnostic classification. Signal analysis mId diagnostic classification of the MEANS 
program have been extensively evaluated by the developers themselves8,9,II and in the 
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CSE study'·7, in which cardiologists and clinical evidence were the rcference. 
TIle ECGs used in the present study were sampled from the set of 3,057 ECGs. 
Palient selection and ECG intelpretalion 
For two reasons, we emiched the sample of ECGs with abnonnal ECGs and ECGs on 
which the MEANS program and the research physician disagreed. First, because of low 
disease prevalence in the general population, we wanted to incrcase the number of ECG 
abnormalities to improve the precision of sensitivity estimates. For the purpose of selec-
tion we considered an ECG abnormality to be present if the MEANS program and the 
research physician agreed on the abnonnality. Second, as we wanted to compare the 
MEANS program with human readers, we hypothesized that those cases in which the 
ECG interpretation of the MEANS program and the research physician differed would 
be most informative. Thus, we included a relatively large proportion of such ECGs in 
our sample. 
We distinguished five main ECG diagnoses: antelior myocardial infarction (AMI), 
inferior myocardial infarction (IMI), left ventlicular hypertrophy (L VH), left bundle 
branch block (LBBB) and right bundle branch block (RBBB). The MEANS program 
grades the diagnoses AMI, 1M! and LVH using one of foul' levels of certainty: 'no', 
'possible', 'probable' or 'definite'. For LBBB and RBBB the MEANS program provi-
des a dichotomous classification, indicating 'no' or 'definite'. The research physicians 
used a dichotomous classification for all categolies. 
For a pruticular ECG diagnosis we defined a disagreement between the MEANS pro-
gram and the research physician as 'lninor' if the corresponding levels of certainty were 
adjacent (e.g., 'no' and 'possible'); if not, the disagreement was considered 'major' 
(e.g., 'no' or 'possible' and 'definite'). For each of the five main ECG diagnoses separa-
tely, the 3057 ECGs were categolized in four groups according to agreement or disa-
gr'eement on ECG classification between computer and research physician: (A) agr'ee-
ment on presence of an abnormality, (B) agreement on absence of an abnormality, (C) 
'major' disagreement, and (D) 'minor' disagreement. For instance, a particular BeG 
could be classified in group A for AMI, group B for !MI, LBBB and RBBB and group 
CforLVH. 
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We selected a stratified random sample of 400 ECGs from these four groups: (A) 50 
ECGs with agreement on the presence of an abnormality, (B) 100 ECGs with agreement 
on the absence of an ECG abnormality, (C) 200 ECGs with 'major disagreement', and 
(D) 50 ECGs with 'minor disagreement'. Within these strata the five main ECG 
categories were represented propOliionally: 50% AMI or IMT, 20% LVH, and 30% 
LBBB or RBBB. As ECG abnormalities are not mutually exclusive, there was some 
overlap in the ECGs sampled. The final data set consisted of 381 ECGs. 
Referellce EGG illtelpretation 
A reference ECG interpretation was obtained by having two experienced cardiologists 
(JWD and MG) intCipret the set of 381 ECGs, using a standardized fOlm. The 
cardiologists graded ECG diagnoses using four levels of certainty. Each cardiologist 
was blinded for the ECG interpretation of the research physician, the MEANS program 
and the other cardiologist. The ECG intelpretations of the cardiologists were compared 
similarly as described above for the compmison between the MEANS progrmn and the 
research physician. When both cardiologists fully agreed on the ECG intelpretation 
(n=206), tillS intelpretation was taken as the reference. In case the two cardiologists had 
a 'minor' (n=76) or 'major' (n=99) disagreement, the ECG was interpreted by a third 
cardiologist (GvH) with large experience in reading ECGs, who was also blinded for 
prior ECG interpretations. TIllS interpretation was then taken as a reference. There was 
'major' disagreement between the third cardiologist and both other cardiologists in 20 of 
the 175 cases. No attempt was made to verify ECG readings of AMI, !MI, and LVH to 
clinical evidence. 
Data Analysis 
In all analyses the cardiologists' interpretation served as the reference. For each of the 
five main ECG diagnoses two-by-two tables were computed, both for the MEANS 
program and the research physician against the reference. This required the levels of 
celiainty of the MEANS pragranl for AMI, IMI and L VH, and of all diagnoses by the 
cm'diologists to be dichotomized. As a standard plDcedure the threshold was put be-
tween 'possible' and 'probable', i.e. 'no' and 'possible' were taken as 'no abnormality' 
and 'probable' and 'definite' were taken as 'presence of abnormality', Two alternative 
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procedures for classification of AMI, IMI and LVH by the MEANS program resulted 
from shifting the threshold one level of certainty up or down. These alternative 
procedures did not apply to the classification of LBBB and RBBB by the MEANS 
program arId to all ECG diagnoses by the research physician, as only two levels of 
celiainty had been used for these classifications. 
To assess diagnostic pelformance, sensitivity and specificity were computed. Because 
of the eurichment, a stratified arlalysis had to be pelformed. For sensitivity the preva-
lence of disease in each stratum was taken as a weight, whereas for specificity the pre-
valence of non-diseased subjects in each stratum was taken as a weightl2. Confidence 
intervals of the sensitivity and specificity were computed using the delta-method to esti-
mate the standard etTor of a rate ratio, in which both numerator and denominator are 
estimates!3, 
Strategies/or ECG inte/pretation 
To establish a strategy for ECG interpretation in population-based research we envisa-
ged three scenarios which are logistically feasible, anticipating that combining ECG in-
terpretations from computer program and research physician with that of a cardiologist 
in selected cases, may improve sensitivity and specificity of a certain ECG diagnosis. 
We then studied the trade-off between workload on the one hand, and diagnostic pelfor-
mance on the other hand. For each scenario workload (expressed as percentage of all 
ECGs to be interpreted by research physicians or cardiologists), prevalence estimates of 
ECG diagnoses, and proporiions of ECGs eOlTectly classified as abnonnal or normal, 
were computed. The propoliion correctly classified as abnormal or normal represent the 
positive and negative predictive values of the ECG intclprctation, respectively, again 
with the cardiologists' interpretation as a reference. 
In the first scenar'io, the MEANS program alone was uscd to inteI1Jl'et all ECGs. In the 
second scenario, all ECGs were initially intelpreted by the MEANS program and only 
the positive findings were verified by cardiologists. In the third scenar'io, all ECGs were 
independently judged by both the research physician and the MEANS program, arId 
those ECGs on which they disagreed were judged by cardiologists. 
In all scenarios we used the standmd procedure of the MEANS program for 
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classification of AMI, IMI and LYH and the cardiologists' interpretation in the present 
study was taken as the reference. 
Results 
General characteristics of the Rotterdam Study participants (n=3057) and the study 
sample (n=381), and the prevalence of ECG abnormalities according to the MEANS 
program are presented in Table 1. Due to the emichment procedure, history of MI and 
major ECG abnormalities are more prevalent in the study sample. The other charac-
teristics of the participants included in the study sample and the Rotterdam Study popu-
lation are comparable, except for current smoking which is less prevalent in the study 
sample. 
Sensitivity and specificity for the ECG interpretations of the MEANS program, using 
the standard procedure for dichotomization, and of the research physician, are presented 
in Table 2. Overall, sensitivity and specificity of the MEANS program and the resem'dl 
physician were high. Sensitivity of the MEANS program ranged from 73.8% (95%CI: 
58.9-88.7) to 92.9% (95%CI: 85.9-99.8), whereas sensitivity of the research physician 
ranged from 71.8 % (95%CI: 56.8-86.7) to 96.9% (95%CI: 93.0-100). Both the 
MEANS program and the research physician had the lowest sensitivity for the diagnosis 
Table 1. General characteristics and prevalence of ECG abnormalities according to 
MEANS in the sample and study population of the Rotterdam Study. Values are means 
(with standard deviations) and percentages (with standard errors). 
Sample Study population 
(n=3S1) (n=3057) 
Men (%) 49.0 39.0 
Age (years) 72.7 (9.6) 70.1 (S.9) 
Body mass index (kg/m') 26.0 (3.S) 26.3 (3.7) 
Systolic BP (mmHg) 143.4 (22.6) 140.2 (22.S) 
Diastolic BP (mmHg) 74.6 (13.0) 73.7 (11.7) 
Cholesterol (mmoVI) 6.6 (1.3) 6.6 (1.2) 
Current smoking (%) 27.4 (2.3) 40.3 (0.9) 
History ofM! (%) 17.3 (1.9) 9.3 (0.5) 
MI on the ECG (%) 14.7 (1.S) 4.4 (0.4) 
LVH on the ECG (%) 9.4 (1.5) 4.S (0.4) 
Left bundle branch block ('!o) 5.0 (1.1) 2.2 (0.3) 
Right bundle branch block (%) 6.0 (1.2) 3.2 (0.3) 
Abbreviations: BP, blood pressure; MI, myocardial infarction; LVl-I, left ventricular 
hypertrophy 
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Table 2. Sensitivity and specificity of the ECG interpretation of the research physician and of the 
MEANS program, using the standard dichotomization procedure, as compared to the reference 
ECG interpretation of cardiologists. 
Anterior "MI 
Inferior MI 
LVH 
LBBB 
RBBB 
Research physician 
Sens (95%CI) Spcc (95%CI) 
71.8 (56.8·86.7) 97.7 (97.0·98.4) 
72.7 (59.9·85.4) 98.4 (97.7·99.2) 
78.2 (66.0·90.5) 96.3 (95.8·96.8) 
95.2 (89.2·100) 99.3 (98.9·99.6) 
96.9 (93.0·100) 99.6 (99.2·100) 
MEANS program 
Sens (95%CI) 
73.8 (58.9·88.7) 
90.1 (77.5·100) 
88.9 (77.5· 100) 
92.9 (85.9·99.8) 
88.7 (81.7·93.6) 
Spec (95%CI) 
97.5 (96.8·98.2) 
97.6 (96.8·98.4) 
99.1 (98.7·99.5) 
99.8 (99.5· 100) 
99.6 (99.2·100) 
Abbreviations: Sells, sensitivity; Spec, specificity; cr, confidence interval; MI, myocardial 
infraction; L VH, left ventricular hypertrophy; LEEE, left bundle branch block; RBBB, right 
bundlc branch block. 
AMI. Compared to the research physician, the MEANS program had a higher sensitivity 
for AMI, !MI and LVH and a lower sensitivity for LBBB and RBBB, but confidence 
intervals are wide. Specificity of the MEANS program ranged from 97.5% (95%CI: 
96.8·98.2) to 99.8% (95%CI: 99.5-100) and specificity of the research physician ranged 
from 96.3% (95%CI: 95.8-96.8) to 99.6% (95%CI: 99.2-100). Specificity of MEANS 
was higher than that of the research physician for the diagnosis L VH and LBBB, equal 
for RBBB, and slightly lower for AMI and !MI. 
Effects of changing the threshold for dichotomization of the classification of AMI, !MI 
and LVH of the MEANS program on sensitivity and specificity for the program arc 
presented in Table 3. As expected, shifting the threshold for presence of an ECG 
abnormality one level down, i.e. taking 'possible' abnormalities as 'presence of 
abnOlmality', improved sensitivity, while specificity decreased. 111e reverse oceun'ed 
when the tln'eshold for presence of an ECG abnormality was shifted one level up, i.e. 
taking 'probable' abnormalities as 'absence of abnol1nality'; specificity improved and 
sensitivity decreased. 
Table 4 shows estimates of prevalence, proportions correctly diagnosed cases and 
controls, and the workload for research physicians and cardiologists, for the three 
scenarios of ECG interpretation in health surveys that we examined. Scenario A, 
using the MEANS program only, pelforrns satisfactorily in diagnosing L VH, LBBB 
and RBBB. However, the prevalences of AMI and IMI are overestimated, 4.3% 
versus 2.5% for AMI and 5.1 % versus 3.1 % for IMI, and cases of AMI and IMI are 
30 
Diagnostic ECG inte'1J1'etation in population-based research 
Table 3. The standard procedure and two alternative procedures for the classification of 
anterior and inferior MI and L VH by the :MEANS program. The MEANS program uses four 
levels of certainty ('no'. 'possible', 'probable', 'definite') to classify EeG abnormalities, which 
are dichotomized to estimate sensitivity and specificity. The procedures differ in the threshold to 
dichotomize the classification ofECG abnormalities: 
Sta1ldard procedure: threshold for presence of an abnormality between 'possible' and 
'probable'; 
Procedure A: threshold for presence of an abnormality between 'no' and 'possible'; 
Procedure B: threshold for presence of an abnonnality between 'probable' and 'defmite'. 
Standard ~rocedure Procedure A Procedure B 
Sens SEcC Sens Spec Seils SEcC 
AnteriorMI 73.8 97.5 82.3 97.0 69.4 97.9 
Inferior MI 90.1 97.6 90.1 95.8 81.0 98.9 
LVH 88.9 99.1 94.3 94.0 77.4 99.8 
Abbreviations: Sens, sensitivity; Spec, specificity; MI, myocardial infarction; LVH, left 
ventricular hypertrophy. 
correctly diagnosed in only 43% and 54% of the cases respectively. On the other 
hand, there is no workload for research physician and cardiologists. 
Scenario B, in which all positive diagnoses of the MEANS program are verified by 
a cardiologist, is the best procedure for all ECG diagnoses to identify cases with an 
ECG abnormality, but underestimates the prevalence of ECG abnormalities, for 
instance 1.9% instead of 2.5% for AMI. The workload is much less than that of 
scenario C, but following this scenario would require that, depending on the specific 
ECG abnormality, 2 to 5 percent of all ECGs have to be interpreted by cardiolo-
gists. Overall, scenario C, in which all ECGs are judged independently by a re-
search physician and the MEANS program, and only those ECGs on which they dis-
agree are judged by a cardiologist, provides the best estimates of prevalence and the 
highest proportions correctly classified as normal, but also has by far the highest 
workload: 100 percent of all ECGs should be interpreted by research physicians 
and, depending on the specific ECG diagnosis, I to 9 percent by cardiologists. 
Discussion 
The results of our study indicate that in population-based research the sensitivity 
and specificity of the diagnostic ECG interpretation by the MEANS computer 
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Table 4. Three different scenarios for interpreting ECGs in population-based studies. Estimated 
prevalence in the Rotterdam Study (n=7,983), proportion of ECGs correctly classified as abnormal 
or normal, and workload for human readers are presented, \Vorkload is expressed as the percentage 
of all ECGs in the study to be interpreted by research physician or cardiologist. 
Scenario A: all EeGs are interpreted by the :MEANS program only; 
Scenario B: all positive findings of the :MEANS program are checked by a cardiologist; 
Scenario C: independent interpretation by the research physician and the MEANS program and 
only those ECGs on which they disagree are interpreted by a cardiologist. 
Reference Scenario Estimated Correctly Correctly Workload Workload 
prevalence'! prevalence classified as classified research cardiologist 
abnormal as normal physician 
n (%) n (%) (%) (%) (%) (%) 
AMI 201 (2.5) A 343 (4.3) 43.1 99.3 0 0 
B 148 (1.9) 100 99.3 0 4.3 
C 242 (3.0) 75.1 99.8 100 5.3 
1M! 245 (3.1) A 409 (5.1) 54.0 99.7 0 0 
B 221 (2.8) 100 99.7 0 5.1 
C 232 (2.9) 95.3 99.7 100 8.1 
LYH 268 (3.4) A 306 (3.8) 78.1 99.6 0 0 
B 238 (3.0) 100 99.6 0 3.8 
C 253 (3.2) 100 99.8 100 9.4 
LBBB 183 (2.3) A 184 (2.3) 91.8 99.8 0 0 
B 169 (2.1) 100 99.8 0 2.3 
C 193 (2.4) 94.4 100 100 0.9 
RBBB 258 (3.2) A 256 (3.2) 88.5 99.6 0 0 
B 226 (2.8) 100 99.6 0 3.2 
C 272 (3.4) 95.0 100 100 0.9 
'I according to cardiologists; 
Abbreviations: RP, research physician; AMI, anterior myocardial infarction; 11\.11, inferior 
myocardial infarction; LVH,left ventricular hypertrophy; LBBB, left bundle branch block; RBBB, 
right bundle branch block. 
program, taking cardiologists as a reference, is high. The performance is at least as 
good as that of a research physician using an extensive form for structured clinical 
EeG evaluation. 
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In population-based research an attractive approach is to use the MEANS program, 
without human readers, to diagnose LYH, LBBB and RBBB (Scenario A), while 
having all positive findings of AMI and IMI by the MEANS program verified by a 
cardiologist (Scenario B). This will result in reasonable estimates of prevalence of 
ECG abnormalities and classification of normal and abnormal ECG findings, while 
the workload for human readers is kept to a minimum. 
The results of this study may also be applied in a primary care setting. A-physician 
with little experience in interpreting ECGs can use the computer program to 
interpret ECGs and have positive computer findings checked by a cardiologist. A 
more experienced physician may use the ECG interpretation by the computer pro-
gram and take his own independent judgment as a second opinion. If he agrees with 
the computer, the ECG interpretation is probably right. If he disagrees with the com-
puter it is worthwhile to have the ECG judged by a cardiologist. 
Nowadays, with physicians becoming less experienced in interpreting ECGs, the 
usc of a computer program for ECG interpretation may improve the quality of ECG 
interpretation in health care. 
In the CSE study sensitivity of the MEANS program with cardiologists as a refe-
rence was 89.4% for AMI, 81.1% for IMI and 83.1 % for LVH!4. These values lie 
within the confidence intervals of the sensitivity estimates of the MEANS program 
in the present population-based study, except for AMI, which is just outside. Due to 
methodological differences specificity Calmot be compared. 
In this study the cardiologists' interpretation served as a reference. By definition, 
the performance of the MEANS program and the research physician can never be 
better than this reference!'. This may be a problem if the reference is of poor 
quality. In this study three experienced cardiologists formed the reference and we 
consider the quality of their interpretation high. The confidence intervals of sensi-
tivity estimates are wide, due to a relatively low frequency of ECG abnormalities, even 
after ell1'iclnnent. 
We conclude that diagnostic ECG interpretation by a computer can be very useful in 
population-based research. To detect cases of LYH, LBBB and RBBB, use of our 
computer program alone gives satisfactorily results. Cases of AMI or IMI, according 
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to our computer program, should preferably be interpreted also by a cardiologist. 
Interpretation of the MEANS computer program is at least as good as ECG inter-
pretation by trained research physicians using a form for structured clinical evalua-
tion, but Illuch Illore efficient and therefore less expensive. 
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CHAPTER 2.2 
REPRODUCIBILITY OF COMPUTERIZED ECG MEASUREMENTS 
AND CODING IN A NON-HOSPITALIZED ELDERLY POPULATION 
Abstract 
The standard 12-lead ECG is used in many epidemiological studies to diagnose and 
predict cardiovascular disease. In view of this, knowledge about the reproducibility 
of ECG measurements and coding is essential. We assessed minute-to-minute, day-
to-day, and year-to-year variability of ECG measurements, composite scores, and 
Minnesota Code classification, using a computer program, in 101 non-hospitalized 
elderly men and women. 
ECG interval measurements were more reproducible than amplitude measurements. 
The best reproducibility was found for overall QTc interval (coefficient of variation: 
3.1 %, 4.0%, and 5.2% for the minute-to-minute, day-to-day, and year-to-year 
group, respectively) and the poorest for the Cardiac Infarction Injury Score 
(coefficient of variation 67.1 %, 78.5%, and 94.3%). 
Minnesota Code discrepancies occurred in 16%, 19% and 22% of the ECGs in the 
minute-to-minute, day-to-day and year-to-year group, respectively. Reproducibility 
within specific code categories was much better. Overall, variability tended to 
increase with time. In the routine setting, electrode positioning had relatively little 
effect on the total variability. 
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Introduction 
Measurements obtained from the standard 12-lead electrocardiogram (ECG) and 
classification of the ECG according to the Minnesota Code]' 2 are used in many epi-
demiological studies to diagnose and predict cardiovascular disease. In addition, 
serial changes in ECG characteristics are being studied for their value as determi-
nants of future events. In clinical practice, the relevance of a diagnostic or prog-
nostic factor heavily depends on its reproducibility in the individual. In view of this, 
knowledge about the reproducibility of ECG measurements and coding is essential. 
Variability of ECG measurements and coding originates from multiple sources. One 
important source is intra- and inter-observer variability among physicians inter-
preting ECGsJ -5 , which does not apply to computer programs for ECG analysis. Dif-
ferences in recording technique, especially electrode placement, arc another source. 
The magnitude of the variation induced by changes in electrode positions can be 
estimated by comparing minute-ta-minute variation with marked electrode positions, 
to day-to-day variation withont marked electrode positions. Other sources of varia-
tion that cmmot easily be disentangled are: (I) random physiological fluctuations, 
for example, respiration movements, fluctuations in autonomic balance, and changes 
in body position; (2) signal-analysis errors of the computer program, and (3) true 
clinical and subclinical changes in health status. An impression of the contribution 
of changes in health status to the variability of the ECG can be obtained by com-
paring year-to-ycar with day-to-day variability. 
Published reports on the variability of ECG measurements and coding are scarce. 
Most studies on the reproducibility of measurements were performed many years 
ago on manual ECG measurements]' 6 , or on measurements obtained from computer-
processed vectorcardiograms" 8 • Reports on the reproducibility of ECG measure-
ments and coding by computer are limited to year-ta-year variation in wave measu-
rements' and indices of left ventricular hypertrophy (LVH) 10. 11, and to day-to-day 
variation of Minnesota Code categories I and 3". Reproducibility of QT dispersion" 
and QT interval" have been studied in manual measurements only. 
No information is available on minute-to-minute and day-to-day variability of com-
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puterized ECG measurements and of most Minnesota Codes in population-based 
studies. Furthermore, reproducibility data are lacking for some relatively new ECG 
characteristics of which a predictive value for future heart disease has been repor-
ted, notably the Cardiac Infarction InjUly Score (CIIS)'" 16, the QTc interval17·n , and 
left ventricular mass index (LVMI)" . To our knowledge, minute-to-minute, day-to-
day, and year-to-year variability have not been studied together in the same popu-
lation. These issues are addressed in the present study, using computerized ECG 
measurement and coding, in a non-hospitalized elderly population. 
Methods 
Study populatiol1 alld EGG recordil1gs 
A random sample of 101 subjects participating in the population-based Rotterdam 
Study was invited for the present research. Objectives, methods and data collection 
of the Rotterdam Study have been described elsewhere" . Briefly, all men and 
women aged 55 years or older, living in the Oturnoord district of the city of 
Rotterdam, were invited to participate. Of 7,983 participants (response rate 78%) 
baseline data were collected from 1990 to 1993, including medical history and esta-
blished cardiovascular risk factors, as well as a 12-lead resting ECG. 
During the second round of the Rotterdam Study, one to two years later, a second 
ECG was recorded. Year-to-year variability was studied by comparing the baseline 
ECG with the second ECG. As part of the protocol of the present study, two to three 
weeks later a third ECG was recorded. Day-to-day variability was assessed by com-
paring the second and the third ECG. A fourth ECG was recorded IS to 30 minutes 
after the third, with marked electrode positions, and the latter two ECGs were used 
to compute minute-to-minute variability. All ECGs were recorded with an ACTA 
electrocardiograph (ESAOTE, Florence, Italy) at a sampling rate of 500 Hz. 
Four ECGs that could not be processed due to excessive noise or signal clipping 
were excluded. Thus, minute-to-minute and day-to-day variability were assessed in 
97 paired ECGs. In the year-to-year comparison, 12 tracings were not available, 
mainly due to temporary technical problems with the ECG recorder during the 
baseline visit, resulting in 85 paired ECGs in the year-to-year comparison. None of 
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the subjects reported signs or symptoms of intercurrent heart disease to the research 
physician, the general practitioner, or the cardiologist in the period between the first 
and last ECG. Thus, no clinical changes in health status occurred. 
ECG analysis 
Each ECG was analyzed by the Modular ECG Analysis System (MEANS)" . Both 
the measurement and the classification section of MEANS have extensively been 
evaluated by the researchers themselves and by others"'''. 
Measurements are derived from the representative complex that results from selec-
tive averaging of dominant beats. The QT interval is determined commonly over all 
12 leads. To adjust the QT interval for heart rate Bazett's formula is used" . 
To measure QT dispersion, the program takes the location of the overall end of the 
T wave as a starting point and searches each lead forward and backward to establish 
the lead-specific end of the T wave. QT dispersion was defined as the difference 
between the maximum and minimum QT interval in the 6 precordial leads, the shor-
test extremity lead and the median of the 5 other extremity leads. As measllres of 
LVH, the Sokolow index (S in VI + maximum R in V5 01' V6) and the left ventri-
cular mass index (L VMI)21 were studied. 
To determine a classification according to the Milmesota Code, MEANS was adap-
ted to comply with the measurement and coding rules as specified in the Minnesota 
Code standard30 • The only difference is that MEANS operates on averaged beats 
whereas the standard prescribes the analysis of individual beats and then applies a 
majority rule to arrive at the final code. The Minnesota coding of MEANS showed 
excellent performance in a recent evaluation study". Every code from categories 1 
to 7 was analyzed. For categories 8 and 9, only codes 8-3-1 (Atrial fibrillation) and 
9-2 (ST-segment elevation) were taken into account. 
Data analysis 
Variability of ECG measurements was expressed by the standard deviation (SD) of 
the difference between paired measurements and by the coefficient of variation, 
taken as the SD of the difference between paired measurements divided by the mean 
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Table 1. General characteristics of the study sample and the Rotterdam Study 
population. Values are means (standard deviations) or percentages. 
Characteristics Study sample Rotterdam Study 
Gender (% men) 
Age (y) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mruHg) 
Cholesterol (mmolll) 
History of myocardial infarction (%) 
Angina pectoris (%) 
of the pooled measurements" . 
n~97 n~6,202 
45 40 
65 (7) 69 (9) 
132.5 (23.8) 139.4 (22.4) 
72.1 (10.2) 73.5 (11.6) 
6.8 (1.2) 6.6 (1.2) 
5.3 6.9 
7.4 6.8 
If no P wave was detected in either ECG in the comparison, the subject was ex-
cluded from the analysis of PR-interval durations and P-wave amplitudes. Similarly, 
a subject was excluded from the analysis of Q-wave amplitudes if no Q wave was 
present in both ECGs in the comparison. Relabeling of Q waves, which occurs for 
example when a small initial R wave that is present in one ECG disappears in the 
other ECG, can result in large differences in Q-wave amplitudes. When relabeling 
occurred, Q-wave measurements were excluded from the analysis (n=3 in the 
minute-to-minute group, n=2 in the day-to-day group, and n=3 in the year-to-year 
group). In the comparison of the Cardiac Infarction Injury Score, subjects were 
excluded if relabeling of the Q wave in lead III or a VL occurred. 
Minnesota Code items were compared for each coding category separately. If a case 
did not qualify for any code from the category under consideration, a zero code was 
assigned. Thus, for each category separately, all ECGs were given a code. For 
categories I, 4,and 5, where coding (partly) follows a graded scale", we considered 
the codes of paired ECGs to be in agreement if the difference was not more than 
one grade. All other changes were considered discrepancies. 
With the help of an experienced cardiologist, the reasons for discrepancies in the 
Minnesota coding were analyzed and classified as: (1) wave-detection or waveform-
recognition errors of the computer program, or (2) random fluctuations caused by 
physiological variations, electrode-position variations or signal disturbances. 
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Table 2. Variability of paired ECG measurements (amplitudes in ~V and durations in fiS) !V 
tv 
Mean Minute-te-minute Day-to-day Year-to-year 
n=97 n=97 n=97 n=85 
n SD* Coef. Vart n SD CoefVar n SD CoefVar 
(%) (%) (%) 
PR interval 172.5 (22.5) 91 7.6 4.4 92 8.3 4.8 81 11.8 6.8 
QRS interval 99.6 (19.0) 97 6.5 6.5 97 6.4 6.4 85 9.5 9.4 
QTc interval 423.8 (23.0) 97 12.9 3.1 97 16.9 4.0 85 22.0 5.2 
..,. 
0 QT dispersion 50.0 (22.6) 97 32.5 66.2 96 32.9 62.2 84 33.1 65.8 
P amplitude rr 11 0.3 (37.2) 91 20.0 18.5 92 26.7 24.6 81 29.8 27.2 
Sokolow 2110.8 (587.4) 97 257.9 12.2 97 317.4 14.9 85 394.7 17.8 
LVMI 110.8 (23.6) 97 10.9 9.8 96 15.3 13.7 84 15.9 13.8 
T amplitude a VF 140.4 (96.0) 97 37.8 27.5 97 40.2 29.0 85 53.3 42.1 
Q amplitude a VF -76.5 (51.3) 45 24.9 32.5 44 31.9 35.5 42 62.2 61.8 
Q amplitude V6 -62.0 (58.3) 66 15.1 24.4 67 30.0 48.3 60 31.3 47.1 
crrs 7.2 (9.5) 92 4.9 67.1 90 5.6 78.5 74 6.6 94.3 
*SD=standard deviation of the difference; t Coef Var= coefficient of variation. 
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Results 
General characteristics 
The baseline characteristics of the participants in the study sample and of the 
Rotterdam Study population were very similar (Table I). Characteristics of the 
subjects included in thc year-to-year comparison (n=85) did not substantially differ 
from those in the minute-to-minute and day-to day comparison (n=97). 
Variability of paired ECG measurements is shown in Table 2. Overall, variability 
tended to increasc with time. Interval measurements tended to be more reproducible 
than amplitude measurements. Best reproducibility was found for QTc interval 
(coefficient of variation 3.1%, 4.0%, and 5.2% for the minute-to-minute, day-to-
day, and year-to-year group, respectively) and PR interval (coefficient of variation 
4.4%,4.8%, and 6.8%). Reproducibility was poorest for QT dispersion (coefficient 
of variation 66.2%, 62.2%, and 65.8%) and the Cardiac Infarction Injury Score 
(coefficient of variation 67.1 %, 78.5%, and 94.3%). Findings in men and women 
were similar. Exclusion of cases with definite ECG abnormalities according to 
MEANS, or of cases with a history of myocardial infarction did not substantially 
influence the results. 
Table 3 shows that the prevalence of Minnesota Code items, determined in the third 
ECG (n=97) of the present study, was relatively low as can be expected in a non-
hospitalized population. The total number of discrepancies increased with time: 15 
in the minute-to-minute group, 18 in the day-to-day group, 24 in the year-to-year 
group. Reproducibility within code categories was much better. No changes 
occurred for code 2 (QRS axis deviation) and code 6 (Atrioventricular conduction 
defects) in any of the comparison groups. Variability was highest for code 4 (ST-
segment depression), varying from 4.1 % in the minute-to-minute group to 7.1 % in 
the year-to-year group. Since a single pair of ECGs may have more than one 
discrepancy in Millllesota Code items, we also assessed the total number of ECGs in 
at least one discrepancy occurred: 15 (16%) in the minute-to-minute group, 18 
(19%) in the day-to-day group, and 19 (22%) in the year-to-year group. 
All IS code discrepancies in the minute-to-minute group were due to random 
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fluctuations. In the day-to-day group, 17 (95%) of the discrepancies were due to 
random fluctuations and 1 (5%) was due to a P-wave detection error, giving a 
discrepancy for code 8-3-1. In the year-to-year group, 22 (92%) discrepancies were 
due to random fluctuations, and 2 (8%) were due to P-wave detection errors. 
Discussion 
This study in a non-hospitalized elderly population demonstrates that minutc-to-
minute variability comprises a major part of total variability of computerized ECG 
measurements and coding. As the time span increases and therewith the number of 
sources of variation, the variability of the ECG measurements and coding increases 
as well. In a routine setting, electrode positioning has relatively little effect on the 
total variability of ECG measurements and coding, as day-to-day variability is only 
slightly larger than minute-to-minute variability. Although clinical cardiovascular 
events did not occur during one to two years of follow-up in this 'healthy' popula-
tiOll, subclinical changes in health status may have given rise to changes in ECG 
measurements. However, the difference between day-to-day and year-to-year varia-
tion is small compared to the total variation. 
Minnesota Code discrepancies occurred frequently, in 16%, 19% and 22% of the 
ECGs in the minute-to-minute, day-to-day and year-to-year group, respectively. 
Within code categories variability was much smaller. As the prevalence of Milllle-
Table 3, Variability in Minnesota Code items. 
Minnesota Code category Prevalence Minute-ta-minute Day-to·day Year-ta-year 
n=97 n=97 11=97 n=85 
11 (%) 11 (%) 11 (%) n(%) 
I Q and QS pattenlS to (10.3) 4 (4.1) 3 (3.1) 2 (2.4) 
2 QRS axis deviation 2 (2.1) 0(0.0) 0(0.0) 0(0.0) 
3 High-amplitude R waves 3 (3.t) I (1.0) 2 (2.1) 5 (5.9) 
4 ST-segment depression 5 (5.2) 4 (4.1) 5 (5.2) 6(7.1) 
5 T-wave items 19 (19.6) 0(0.0) 2(2.1) 3 (3.5) 
6 Atrioventricular conduction 6 (6.2) 0(0.0) 0(0.0) 0(0.0) 
defects 
7 Ventricular conduction 16 (16.5) 2 (2.1) 2 (2.1) 4 (4.7) 
defects 
8-3-1 Atrial flbrillntion 1 (1.0) 0(0.0) I (1.0) 2 (2.4) 
9-2 ST-segment elevation 2 (2.1) 4 (4.1) 3 (3.1) 2 (2.4) 
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sota Codes was rather small in our sample, no reliable reproducibility estimates for 
specific codes can be obtained from our data. However, our findings do show what 
overall variability of Minnesota Codes is to be expected in population-based studies. 
Part of this variability may be explained by the all-or-none fashion in which most 
codes are decided, using a single threshold. For borderline measurements, a few 
microvolts or milliseconds difference may clinch the coding. Minor measurement 
differences may thus result in major coding differences. 
Since our study sample was representative for the complete population of the Rot-
terdam Study, we believe our findings are gcneralizable to other populations of non-
hospitalized older adults. However, our findings may not be applicable to hospital 
settings, as prevalence and severity of disease in hospitalized subjects differ consi-
derably from the general population. 
Comparison with prior studies 
Two early studies were performed on reproducibility of manual ECG measure-
ments'·'. The day-to-day variability of PR duration, QRS duration, P amplitude in 
lead II and T -wave amplitude in a YF of our computerized measurements were 
found to be within the 'permissible' range, as defined in one of these studies'. Year-
to-year variation in computerized ECG measurements in non-hospitalized adult men 
and women has been reported by Michaelis' . The year-to-year variability in QRS 
duration and T-wave amplitude in lead aYF was very similar to our findings. The 
variation in Q-wave amplitudes as reported by Michaelis was smaller than our 
observation. This may be explained by the fact that we, in contrast to Michaelis, 
excluded paired ECGs that had no Q wave in both ECGs. 
In two studies on variability of LYH criteria smaller minute-to-minute variability of 
the Sokolow index was found than in the present study 10. II • This can be explained 
by the fact that in these studies minute-to-minute variability was assessed by two 
ECGs measured 1 to 2 minutes apart with an unchanged position of the patient, 
whereas in our study I although electrode positions were marked, participants were 
allowed to move in the 30 minutes between the two ECG recordings. Our day-to-
day variability of the Sokolow index is similar to the findings in these studies. 
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Day-to-day variability of QT dispersion has been rcported in a small group of men 
and women 13.14. In these studies, like in the present study, the reproducibility of QT 
dispersion is poor. In view of this, the relatively large differenccs in QT dispersion 
between cardiovascular cases and control subjects that have been reported in many 
clinical studies are remarkable. Due to poor measurement precision, the reported as-
sociation between QT dispersion and morbidity or mortality will bc strongly diluted. 
Day-to-day variation of computerized Minnesota coding of categOlY I (Q waves) 
and category 3 (high- amplitude R waves) has been assessed in 104 paired ECGs in 
the MRFIT studyl2. In this study, 17.3% discrepancics in category 1 and 9.6% dis-
crepancies in category 3 were reported. However, in this study Minnesota Codes 
were grouped differently, and these numbers arc difficult to compare with our re-
sults. In anothcr study in manually coded ECGs, 7% discrepancies occurred in the 
minute-to-minute group and 17% in the day-to-day group for category 310. A com-
parison with our results is hampered bccause codes 3-1 and 3-3 wcre combined in 
one category and population characteristics differ. 
Clinical implications 
In the present study, rcproducibility was better for interval measurements than for 
amplitude measurements. Reproducibility of the CllS and QT dispersion was velY 
poor. Also, Minnesota coding was fairly unstable. 
One way to deal with the problem of poor reproducibility is the use of repeated 
measurements to establish a measurement value. This procedure is best known from 
the measurement of blood pressure. As far as Minnesota Codes are concerned, re-
producibility may be improved by including additional codes that allow gradual 
transition, instead of using a dichotomous classification based on a single threshold. 
The results of this study can also be applied for serial ECG analysis. Usually, twice 
the standard deviation of the serial difference in measurements is used as the 
'normal' variation. Although this choice is rather arbitrary, for out-clinic patients 
two times the standard deviation of the day-to-day variability may be used as the 
normal variation in ECGs. Changes within these 'normal limits' may be due to 
random error and not necessarily reflect a change in hcalth status. For continuous 
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ECG monitoring, our results for minute-to-minute variability may be used to 
determine confidence limits of 'normal' variation. 
Availability 
The dataset is available from the authors for further investigations by other resear-
chers. 
References 
t. Blackburn H. Keys A, Simonson E. The electrocardiogram in population based studies: a 
classification system. Circulation 1960;21: 1160-1175. 
2. Rautaharju PM. Electrocardiography in epidemiology and clinical trials. In: Macfarlane 
PW, Lawrie TDV, eds, Comprehensive electrocardiography. Theory and practice in health and 
disease. 1 ed. Oxford: Pergamon Press, 1989: 1219-1266. 
3. Simonson E, Brozek J, Keys A. Variability of the electrocardiogram in normal young men. 
Am Heart 1. 1949;38:407-422. 
4. Bjornson J, Hjermann I, Lereo P. Reproducibility of the BeG classification system of the 
Minnesota code in the study of patients with coronary heart disease. Acta Med SCllnd 1973; 193:211-
214. 
5. Elgrishi I. Ducimetiere P, Richard JL. Reproducibility of analysis of the electrocardiogram 
in epidemiology using the 'Minnesota code'. Br J Pre\' Soc Med 1970;24: 197-200. 
6. Michaels L, Cadoret RJ. Day-to-day variability in the normal electrocardiogram. Br Heart J 
1967;29:913-919. 
7. 'Villems JL, Poblete PF, Pipberger HV. Day-to-day variation of the normal orthogonal 
electrocardiogram and vectorcardiogram. Circulation 1972;45:1057-1064. 
8. McManus CD, Doyle JT, Pipberger HV. Year-to-year variation of the orthogonal 
electrocardiogram and vectorcardiogram among 243 normal white males. J Electrocardial 
1984; 17: 107-114. 
9. Michaelis J, Lippold R, Gluck E, Schindler W, Scheidt E. Automated serial ECG-analysis 
within an epidemiological study. J Electrocardiol1987;20 (Suppl):34-36. 
10. Van den Hoogen J, Mol 'YH, Kowsolcea A, Van Ree J, Thien T, Van Weel C. 
Reproducibility of electrocardiographic criteria for left ventricular hypertrophy in hypertensive 
patients in general practice. Eftr Heart J 1992;13: 1606-1610. 
11. Farb A, Devereux RB, Kligfield P. Day-to-day variability of voltage measurements used in 
electrocardiographic criteria for left ventricular hypertrophy. J Am Call Cardia! 1990;15:618-623. 
12. Rautaharju PM, Brosle SK, Prineas RJ, Eifler 'YJ, Crow RS, Furberg CD. Quality control 
procedures for the resting electrocardiogram in the Multiple Risk Factor Intervention Trial. Control 
CUll Trials 1986;7:46S-65S. 
13. Fei L, Statters DJ, Camm Al. QT-interval dispersion on 12-lead electrocardiogram in 
normal subjects: its reproducibility and relation to the T wave. Am Heart J 1994;127:1654-1655. 
14. Kautzer J, Gang Y, Camm Al, Malik M. Short- and Long-term reporducibility of QT, QTc, 
and QT dispersion measurement in healthy subjects. PACE 1994;17:928-937. 
15. Dekker JM, Schouten EG, Pool J, Kok FJ. Cardiac Infarction Injury Score predicts 
cardiovascular mortality in apparently healthy men and women. Br Heart J 1994;72:39-44. 
45 
Chapter 2.2 
16. Dekker JM, Schouten EO, Kromhout D, Klootwijk P, Pool J. The Cardiac Infarction Injury 
Score and coronary heart disease in middle-aged and elderly men: the Zutphen Study. J Clill 
EpidemioI1995;48:833-840. 
17. Ahnve S. QT interval prolongation in acute myocardial infarction. EliI' Heart J 
1985;6(suppl D):85-95. 
18. Aigra A, Tijssen JO, Roelandt JR. Pool 1, Lubsen 1. QTc prolongation measured by 
standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac 
arrest. Circulatioll 1991 ;83: 1888-1894. 
19. Dekker 1M, Schouten EG, Klootwijk P, Pool J, Kromhout D. Association between QT 
interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulatioll 
1994;90:779-785. 
20. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, 
'Veitkarnp L, Vincent OM, Garson Al, et al. The long QT syndrome. Prospective longitudinal study 
of 328 families. Circulation 1991 ;84: 1136-1144. 
21. Schouten EO, Dekker 1M, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval 
prolongation predicts cardiovascular mortality in an apparently healthy population. CirculatioJ! 
1991 ;84: 1516-1523. 
22. Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with 
myocardial infarction. Circulatioll 1978;57: 1074-1077. 
23. Rautaharju PM, LaCroix AZ, Savage DD, Haynes SG, Madans JH, Wolf HK, Hadden W, 
Keller J, Cornoni-Huntley 1. Electrocardiographic estimate of left ventricular Illass versus 
radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiologic 
follow-up study of the First National Health and Nutrition Examination Survey. Am J Cardio/ 
1988;62:59-66. 
24. Hofman A, Grobbee DE, De Jong PTVM, Van den Ouweland FA. Determinants of disease 
and disability in the elderly: the Rotterdam Elderly Study. EliI' J Epidemia/ 1991;7:403-422. 
25. Van Bemmel JH, Kors lA, Van Herpen O. Methodology of the modular ECG analysis 
system MEANS. Metllods In! Med 1990;29:346-353. 
26. \Villems JL, Abreu-Lima C, Arnaud P, van Bemmel JH, Brohet C, Degani R, Denis B, 
Gehring 1, Graham T, van Herpen G. The diagnostic pcrformance of computer programs for the 
interpretation of electrocardiograms. N Engl J Med 1991;325:1767-1773. 
27. Zywietz C, \Villems JL, Arnaud P, Van Bemmel lH, Degani R, MacFarlane P\Y. Stability 
of computer ECG amplitude measurements in the presence of noise. Camptlt Blomed Res 
1990;23: 10-31. 
28. Willems JL, Arnaud P, van Bemmel JH, Bourdillon PJ, Brohet C, DalJa Volta S, Damganrd 
Andersen J, Degani R, Denis B, Demeester M, Dudeck 1, Harms FMA, Macfarlane P'Y, Mazzocca 
G, Meyer J, Michaelis J, Pardaens J, PappI S, Reardon BC, Ritsema van Eck HJ, Robles de Medina 
EO, Rubel P, Talmon lL, Zywietz C. Assessment of the performance of electrocardiographic 
computer programs with the lise of a reference data basco Circulation 1985;71 :523-534. 
29. Bazett HC, All analysis of time relations of the electrocardiogram. Heart 1920;7:353-370. 
30. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic 
findings: standards and procedures for measurement and classification. Boston: Littlejohn M, 1982. 
John Wright-PSG J (ed). 
31. Kors JA, Van Herpcn G, \Yu J, Zhang Z, Prineas RJ, Van Bemmel JH. Validation of a new 
computer program for Minnesota Coding. J Electrocardiol 1996;29:83-88. 
32. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of 
clinical measurement. Wllce! 1986;i:307-31O. 
46 
CHAPTER 2.3 
PREVALENCE, DETERMINANTS AND MIS CLASSIFICATION 
OFMYOCARDIAL INFARCTION IN THE ELDERLY 
Abstract 
We evaluated the prevalence, determinants and misclassification of different types 
of myocardial infarction (M!) in 3272 men and women age 55 years or older. We 
defined self-reported MI with electrocardiographic (ECG) evidence as "typical Mr'. 
We defined self-reported MI withont ECG evidence, but verified with additional 
clinical information, as "Iloll-Q-wal'e Mr'. Finally, we defined MI detected by ECG 
that was not self-reported as "silent Mr', after verification of absence of symptoms. 
Overall, the prevalence of "typical MI" was 4.1 % (95%CI 3.5-4.9), of "non-Q-wave 
MI" 2.8% (95%CI 2.2-3.4) and of "silent MI" 3.9% (95%CI 3.2-4.5). "Silent MI" 
was more prevalent in women, in hypertensives, cigarette smokers, and in those 
with higher post-load blood glucose. Self-reported MI withont ECG characteristics 
could be verified as MI by means of additional clinical information in 56% of the 
cases. 
We conclude that MIs occur frequently in the elderly without typical symptoms or 
ECG changes. As all these manifestations of MI convey an increased risk of 
symptomatic heart disease or death, they require further attention. Misclassification 
due to limited sources of information can be considerable and should be taken into 
account in the design and interpretation of epidemiologic studies. 
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Introduction 
Myocardial infarction (MI) accounts for a considerable proportion of deaths and is 
an important risk indicator for future cardiac events in both men and women I.'. 
There are different manifestations of MI, notably with or without symptoms of 
cardiac distress and with or without lasting electrocardiographic characteristics. To 
assess the occurrence of these different types of MI, multiple sources of informa-
tion, such as a patient interview, an electrocardiogram (ECG), and additional clini-
cal information from a general practitioner or a cardiologist, are necessary. 
The ECG characteristics of MI are due to changes in electrical properties of 
ischemic or necrotic areas of the heart. Depending on the size or location of the 
injured region of the heart, however, typical ECG characteristics mayor may not 
appear'. Moreover, typical ECG characteristics may disappear with time'. Another 
reason for absence of ECG abnormalities may be that somc patients reporting MI in 
reality did not suffer from MI, but, for instance, had a severe attack of chest pain or 
underwent coronary artery bypass surgery'. 
Subjects with electrocardiographic MI who do not report MI may either have for-
gotten their MI or never have noticed the MI because there were no serious symp-
toms. The mechanisms that underlie silent ischelnia arc not fully understood, bnt it 
is an accepted phenomenon that occurs frequently and has an unfavorable prog-
nosis6,7. 
All MIs, with or without symptoms or ECG characteristics, are associated with an 
increased risk of future cardiac events" 6.1', but little is known about their frequency 
in the population at large or about their detenninants. The aim of this study was to 
assess the prevalence and determinants of different manifestations of MI in older 
men and women, and to study the degree of misclassification of MI resulting from 
the different methods by which MI can be assessed. 
Methods 
Study design 
The Rotterdam Study is a population-based cohort study in which cm'onic diseases 
in the elderly are studied. Objectives, methods and data collection of the Rotterdam 
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Study have been described in detail elsewhere". Briefly, all men and women age 55 
years or older, living in the district Onmloord of Rotterdam, were invited to 
participate. Of 7983 participants (response rate 78%) baseline data were collected, 
including medical history, presence of angina pectoris, smoking habits, body-mass 
index, blood pressure, serum cholesterol, use of medications and results of the Mini 
Mental State Examination as a measure of cognitive function16 , 
We calculated body mass index as weight/length2 in kglm2. We calculated blood 
pressure as the average of two consecutive measurements with a random zero 
sphygmomanometer. A 12-lead ECG was recorded with an ACTA cardiograph 
(Esaote, Florence) with a sampling frequency of 500 Hz and stored digitally. 
Questions on history of MI included the following: "Did you ever have a heart 
attack?" and, if so, "At what age?", HWho made the diagnosis?H and "Were you 
admitted to a hospital?". 
The preseut study is restricted to the first 3272 participants of the Rotterdam Study. 
The ECGs of these participants were evaluated by research physicians, blinded for 
other clinical information, using a protocol for standardized clinical ECG eva-
luation. All ECGs with possible or definite MI according to the research physicians 
were checked by an experienced cardiologist who determined the final diagnosis. In 
addition, all ECGs of subjects with self-reported MI without ECG evidence were 
analyzed by the Modular ECG Analysis System (MEANS)17.I8 to detect cases of 
electrocardiographic MI that had been missed by the research physician. The final 
diagnosis for these cases was made by another cardiologist, who specialized in 
reading ECGs. This review led to reclassification of 29 cases of self-reported MI 
withont ECG characteristics to self-reported MI with ECG characteristics. 
Of subjects with self-reported MI without ECG evidence and subjects with no self-
report of MI but with ECG evidence, additional information was collected from the 
general practitioner or cardiologist (Figure I). In addition, of a sample of 29 cases 
of self-reported MI with ECG evidence additional clinical information from the 
general practitioner or cardiologist was obtained. Since all these 29 cases were 
verified as having symptomatic MI with matching ECG evidence or elevated cardiac 
enzymes in the acute phase, we classified all other subjects with self-reported MI 
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with EeG evidence as such. 
Definitiolls 
By using all available information we distinguished three main categories of MI 
(Figure I). 
1. Typical MI: Self-reported MI with matching EeG characteristics, e.g., 
pathological Q-waves or a significant loss of R-wave potential in the precordial 
leads of a single EeG. In addition, we classified a MI based on EeG without a self-
report but where additional information from the general practitioner or cardiologist 
revealed that the MI had been symptomatic, as "typical MI". 
2. Silent MI: MI based on the EeG of subjects who reported never to have suffered 
from MI and for which the absence of symptoms of MI was confirmed by general 
practitioner or cardiologist. 
3. Non-Q-wave MI: Self-reported MI without matching EeG characteristics, while 
additional clinical information from general practitioner or cardiologist confirmed 
the diagnosis of MI based on elevated cardiac enzymes or prior EeG abnormalities. 
This group includes subjects in which a prior pathologic Q-wave disappeared. 
In addition, two secondary diagnostic categories arose when a self-reported MI 
without EeG evidence could not be verified as MI by means of additional 
information from the general practitioner or cardiologist (Figure 1): 
4a. Ischemic heart disease, no MI: Self-reported MI, without EeG evidence, in 
which additional clinical information from general practitioner or cardiologist 
showed evidence of angina pectoris, coronary bypass grafting or percutaneous 
transluminal coronary angioplasty, but no MI. 
4b. No ischemic heart disease, no MI: Self-reported MI, without EeG evidence, in 
which additional clinical information from the general practitioner or cardiologist 
could not confirm MI or other ischemic heart disease. 
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Data analysis 
We calculated prevalence of different Iypes of MI among the 3272 men and women 
and used multivariale logistic regression analysis 10 identify determinants of "non-
Q-wave MI" and "silent MI" in comparison with "typical Mr', adjusting for age and 
gender. In a second analysis we studied determinants of unconfirmed self-reports of 
MI without ECG evidence (categories 3 and 4). Within the group of patients with 
self-reported MI without ECG characteristics were compared patient characteristics 
of those in whom MI could be confirmed as non-Q-wave MI with those in whom 
MI could not be verified as such, by using additional clinical information from the 
general practitioner or cardiologist. 
Table 1. Prevalence of categories of myocardial infarction (MI) of the ftrst 3272 
participants aged 55 years or older in the Rotterdam Study (Figure 1). 
Prevalence 95%CI* Number 
(%) (%) (n) 
"Typical MI" 4.1 3.5-4.9 135 
men 7.3 5.9-8.9 93 
women 2.1 1.5-2.8 42 
"Non-Q-wave MI" 2.8 2.2-3.4 91 
men 4.4 3.3-5.5 56 
women 1.8 1.2 -2.4 35 
"Silent MI" 3.9 3.2-4.5 127 
men 4.6 3.5-5.8 58 
women 3.5 2.7-4.3 69 
Total MI 10.8 9.7-11.9 353 
men 16.3 14.3- 1 8.4 207 
women 7.3 6.2-8.5 146 
Self-reported MI: 
Ischemic heart disease, no MI 
men 1.0 0.7-1.4 33 
women 0.9 0.4-1.5 II 
1.1 0.7-1.7 22 
Self-reported MI: 
No ischemic heaI1 disease, no MI 
men 0.9 0.6-1.3 29 
women 1.1 0.6-1.8 14 
0.8 0.4-1.2 15 
*' CI _ confidence interval; t MI = myocardial infarction 
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Results 
Among 3272 men and women in our study, 289 (8.8%, 95% CI 7.9 - 9.9) reported 
having suffered from MI, 262 (8.0%, 95% CI 7.1 - 8.9) had ECG characteristics of 
MI and 128 (3.9%, 95% CI 3.3 - 4.6 ) had both a self-report of MI and MI by ECG. 
Overall, 353 (10.8%, 95% CI 9.7 - 11.9) of the participants had suffered from MI. 
The prevalence of the different diagnostic categories of MI as defined above are 
presented in Table I. In men, "typical MI" (7.3%, 95% CI 5.9 - 8.9) was more 
frequent than "non-Q-wave MI" (4.4%, 95% CI 3.3 - 5.5) and "silent MI" (4.6%, 
95% CI 3.5 - 5.8). In women, "silent MI" ( 3.5%, 95% CI 2.7 - 4.3) was most 
frequent, followed by "typical MI" (2.1 %, 95% CI 1.5 - 2.8) and "non-Q-wave MI" 
(1.8%,95% CI 1.2 - 2.4). Of the 91 cases of "non-Q-wave MI", in 58 cases (64%) a 
Q-wave had never occurred, in 17 cases (18%) a prior pathologic Q-wave had 
decreased or had disappeared and in 16 cases (18%) no information on prior ECG 
characteristics was available. 
In men, the prevalence of all manifestations of MI increased from the age of 55 
years until the age of 75 years (Table 2). After age 75, the prevalence of "non-Q-
wave MI" and "typical MI" decreased and the prevalence of "silent MI" slightly 
increased. In women, the prevalence of all types of MI increased with age, except 
for "typical MI", which was less common in the very old. 
We present general characteristics and cardiovascular risk factors of the different 
manifestations of MI in Table 3. There was no difference in both general charac-
teristics and cardiovascular risk factors between those with "typical Mr and "non-
Q-wave MI", although "non-Q-wave MI" occurred somewhat more often in those 
with a higher body mass index (age and gender adjusted OR 1.08 per kglm', 95% CI 
0.99 - 1.18). "Silent MI", as compared with "typical Mr', was more frequent in wo-
men than in men (adjusted OR 2.45, 95% CI 1.46-4.10), in those with hypertension 
(adjusted OR 2.59, 95% CI 1.37 - 4.94), in those with higher post load blood 
glucose levels (adjusted OR 1.10, 95% CI 1.00 - 1.22), and in cigarette smokers 
(adjustcd OR 1.93, 95% CI 1.06 - 3.53). A histoty of angina pectoris was associated 
with a lower frequency of "silent MI" (adjusted OR 0.23, 95% CI 0.10 - 0.57). 
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Table 2. Age and sex specific prevalence of "typical myocardial infarction (MI)". "silent MI", 
"non-Q-wave MI", and of unconftrmed self-reported MI classified as "ischemic heart disease 
(IHD), no MI" and "no IHD, no 1vII", 
55-64 65-74 75-84 >85 
(years) (years) (years) (years) 
Typical MI* Men 4.6 8.9 8.8 7.5 
'Vomen l.l 2.2 3.6 1.2 
Silent 1vlI Men 2.6 5.0 6.5 7.5 
Women 2.0 2.5 4.7 9.8 
Non-Q-wave :MI Men 3.3 5.4 5.0 0 
'Vomen 0.6 1.8 2.6 3.7 
IHDt , no MI Men 0.2 1.2 1.5 0 
\Varnen 0.2 1.5 1.3 2.5 
noIRD, noMI Men 0.2 1.7 0.8 5.0 
Women 0.2 0.8 1.3 1.2 
* MI = myocardial infarction; t IHD = ischemic heart disease; 
Self-reports of MI without ECG evidence that could not be confirmed as MI with 
additional clinical information from the general practitioner or cardiologist were 
classified as "ischemic heart disease, no MI" in 33 cases (53%) and "no ischemic 
heart disease, no MI" in 29 cases (47%). Probable reasons for self-reporled MI in 
the category "no ischemic heart disease, no MI" were sterno-costal pain (n=3), 
gastric pain (n=3), pulmonary disease (n=2), cholecystitis (n=l), nervousness (n=I), 
and hospital admissions for other reasons (n=6). In 13 subjects no apparent reason 
for a self-report of MI could be found. 
We compared subjects with unconfirmed self-reported MI without ECG evidence 
with those with self-reported MI without ECG evidence that could be confirmed as 
a MI. Unconfirmed self-reports were more frequent in women (OR 2.2; 95% CI 1.1 
- 4.3), when the MI had occurred farther in the past (OR 1.08 per year; 95% CI 
1.02-1.15) and in those who lVere not hospitalized for their MI (OR 0.16; 95% CI 
0.06 - 0.42). In a multivariate logistic model the difference in the frequency of 
unconfirmed self-reports between men and women was partly explained by the fact 
that women were less often admitted to hospital. 
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Table 3. General characteristics and cardiovascular risk factors of subjects with a "typical 
myocardial infarction (MI)", "non-Q-wave MI" and "silent MI", and of subjects with unconflfIned 
self-reported MI classified as "ischemic heart disease (nID), no MI" or "no IHD, no MI". Values 
are means or proportions (%). 
"typical "silent "non-Q- "IHD, "no lliD, 
W"* MI" waveMI" noMI"t noMI" 
Total number (n) 135 127 91 33 29 
\Vomen (%) 31.1 54.3 38.5 67 55 
Age (y) 72.0 74.2 72.1 75.2 74.4 
Reported time since MI (y) 8.0 8.1 9.5 12.4 
Age at last MI (y) 63.8 63.7 65.3 60.8 
Hospital admission (%) 89 92 70 55 
MMSE (0-30) :j: 27.0 26.3 26.7 26.7 27.0 
Body mass index (kg/m2) 26.2 26.4 27.1 27.4 27.5 
Systolic BP (mroHg) § 137.0 146.2 135.1 145.2 135.6 
Diastolic BP (mmHg) 71.2 75.2 70.3 72.3 73.2 
Hypertension (%): 15.6 31.4 16.5 33.3 10.3 
Cholesterol (mmolll) 6.5 6.4 6.7 6.4 6.6 
Smoking (ever) (%) 83.7 63.8 79.1 54.5 65.5 
Angina pectoris (%) 20.0 5.5 21.9 36.4 13.7 
Diabetes mellitus (%)~ 24.1 27.0 24.7 37.5 31.0 
Stroke (%) 7.5 6.3 6.7 6.1 7.4 
* MI = myocardial infarction; t IHD = ischemic heart disease; § BP = blood pressure 
+ 1vfMSE = Mini Mental State Examination; 
: Hypertension:::: systolic blood pressure:2: 160 or diastolic blood pressure;;? 95 
" Diabetes Mellitus:::: non-fasting blood glucose> 11.1 mmolll or antidiabetic medication 
Discussion 
The results of our study indicate that among older subjects MI frequently occurs 
without symptoms or ECG characteristics. Overall, the prevalence of "typical MI" 
(4.10/0) is only slightly higher than the prevalence of "silent MI" (3.90/0) and "non-
Q-wave MI" (2.80/0). Patient characteristics, notably the cardiovascular risk profile, 
of those with "non-Q-wave MI" were similar to those with "typical MI". "Silent 
MI" as compared with "typical MI" was more frequent in women, in those with 
impaired glucose tolerance, in those with hypertension, among cigarette smokers 
and among subjects without angina pectoris. Self-reports of MI without ECG 
characteristics could be confirmed with additional clinical information in 560/0 of 
the cases. Self-reported MI was more likely to be confirmed in men, in those who 
were hospitalized. and in more recent Ml. 
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Studies on the prevalence of different manifestations of MI in the population at 
large are scarce"-", Uusitopa et al. studied 1194 patients who had an ECG recorded 
shortly before death and who had an autopsy'O, They found that depending on the 
Minnesota Code criteria used, MI had occurred without a Q-wave in 38% to 62% of 
all cases, In MIs that occurred longer ago a Q-wave was coded less frequently than 
in recent MIs; in 29% and 51 % respectively in men, and in 32% and 50% respec-
tively in women, These results are in accordance with our findings, In the Bronx 
Aging Study among 390 men and women aged 75 to 85 years, 62% of the reported 
MI were "non-Q-wave MI", which also accords with our findings!', In the same 
study MI occurred silently in 60% of the cases, The Cardiovascular Health Study 
reported that in men 45% and in women 69% of MIs were silent, again similar to 
our estimates", Findings on the absolute prevalence of MI across these studies 
cannot easily be compared, owing to differences in population characteristics and 
methods to diagnose MI. 
Little is known about determinants of "silent MI", Most studies were pelformed in 
men only, Both the Framingham Heart Study and the Cardiovascular Heart Study 
confirm our finding that "silent MI" occurs relatively more often in women" ", This 
finding may result from differences in presentation of symptoms of ischemic heart 
disease between sexes or from differences in the health care sought by, or given to, 
women with symptoms suggestive of ischemic heart disease 23, 24, Classical ECG 
characteristics of MI are largely based on studies in men and not may be accurate 
for women", On the other hand, denial of symptoms may playa part, as well as a 
delay in performance of adequate diagnostic procedures or referral. Special attention 
for women with atypical or incomplete symptoms of ischemic heart disease seems 
justified, The association between "silent MI" and glucose metabolism is still 
unclear. Although diabetic neuropathy might predispose to "silent Mr' owing to 
decreased pain perception30, studies have shown contradictory results9. 26.30, 
Several studies have validated self-reported MI in the general popUlation, but little 
is known about the reliability of self-reported MI in the elderly, Rosamond et al. 
checked self-reported MI in a study of 3703 patients aged 25 years or older admitted 
to a coronary care unit with suspicion of acute MI, A previous MI could be 
substantiated in 60%', False-positive reporting was related to previous cardiac 
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hospitalizations in 40% of the cases. Although this study was performed in a 
different setting, the results are similar to ours. 
In many epidemiologic studies, a history of MI is defined as a self-report of MI with 
hospital admission. We found, however, that a substantial part (43%) of all self-
reported MI without hospital admission could still be confirmed as an MI by addi-
tional clinical information. From our data we can estimate misclassification of MI 
depending on the sources of information used to assess MI in epidemiological re-
search. If only an interview is used, "silent MI" will be completely missed, accoun-
ting for 28% and 33% of all MIs in older men and women, respectively. Moreover, 
22% of self-reported MI are not confirmed as MI by additional clinical information. 
If only an ECG is used, all "non-Q-wave MIs" will be lnissed, accounting for 27% 
and 24% of all MIs in older men and women respectively. Finally, verification with 
additional clinical information from the general practitioner and cardiologist will 
reduce the prevalence of "non-Q-wave MI" by 40% and of "silent MI" by 5%, while 
the prevalence of "typical MI" will increase by 5% (Figure 1). 
Depending 011 the purpose of the assessment of MI, misclassification will have 
different consequences. For the selection of cases of MI ill a case-control study, 
complete assessment of MI is not as important as a correct diagnosis. Therefore, it is 
important to use a combination of sources of information, notably self-report and 
ECG with, preferably, additional clinical information from the patient record. In 
cohort studies the consequences of misclassification of MI are similar to those in 
case control studies. 
Our strategy to assess the occurrence of MI was to be highly sensitive at the start 
with the question "Did you ever have a heart attack" and to refine diagnostic 
categories with additional clinical information. This strategy also applied to ECG 
diagnosis of MI: selecting all cases of possible or definite MI according to the 
research physicians or the MEANS computer program, and refining this diagnosis 
with the judgment of a experienced cardiologist. In general, this can be an efficient 
approach to assess MI in large studies. 
Our results arc based on a single 12-lead ECG recording. Serial ECG analysis may 
improve the diagnosis ofMI on the ECG. 
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In this study we benefited from the unique situation in the Dutch health care system, 
in which the general practitioner plays a pivotal role. In principal, patients are 
refened to hospital only through their general practitioner and information of each 
hospital stay is reported in discharge letters to the general practitioner and kept in 
the primary care patient record. Without this reporting system it would have been 
difficult to conduct a study like this. In other respects, care for patients with 
symptoms suggestive of MI is similar in the Netherlands to that in other indus-
trialized countries. 
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CHAPTER 2.4 
PROLONGED QT INTERVAL: A TRICKY DIAGNOSIS? 
Abstract 
Prolonged heart-rate adjusted QT intervals on the electrocardiogram (ECG) are 
associated with an increased risk for coronary heart disease and sudden death. 
However, the diagnosis of prolonged QT interval in practice is hampered by a lack 
of standards. We studied variation in the prevalence of prolonged QT, based on 
different prevailing definitions, in a large non-hospitalized population, and compa-
red our results with other studies applying the same definitions. The study 
population consisted of 2200 male and 3366 female participants of the Rotterdam 
Study, age 55 ycars or older. The QT interval was computed by the Modular ECG 
Analysis System (MEANS). Three different formulas to adjust QT for heart rate 
were used: Bazett's formula (QT,), a linear regression equation (QT,,), and the QT-
index (QTI). Prolonged QT occurred frequently both in men and women, and its 
prevalence increased with age. Women had longer heart-rate adjusted QT intervals 
than men (mean QT, 433 ms versus 422 ms), and mean values for QT" were lower 
than for QT, (mean QT. 422 ms in women and 412 ms in men). Prevalence was 
highest for prolonged QT. (31 % in men and 26% in women) and lowest for 
prolonged QTI (6% in men and 9% in women). Comparison with other studies 
applying the same cOlTcction formulas showed large discrepancies in prevalence 
estimates of prolonged QT, and QT", and to a lesser degree of prolonged QTI, 
probably largely attributable to differences in measurement techniques. Future 
research is needed, relating QT interval to prognosis, to obtain measurement 
technique specific reference values of heart-rate adjusted QT measurements and 
agc- and sex-specific threshold values for prolonged QT. Such data is needed to use 
the QT interval in practice with confidence. 
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Introduction 
The QT interval is of potential use in cardiovascular risk profilinl6, but the 
diagnosis of patients with prolonged QT intervals in practice may be hampered by 
the lack of consensus regarding measurement techniques', formulas to adjust QT for 
heart rate8•1" and criteria to define prolonged QTI2. Little is known about the 
influence of these formulas and cut-off criteria on the prevalence of prolonged QT. 
Furthermore, comparison of the few studies that were published was limited by the 
application of different formulas to adjust QT for heart rate6•9,13, In the present study 
we examined the distribution of QT interval length and the prevalence of prolonged 
QT, adjusted for heart rate, in a large non-hospitalized population of men and 
women aged 55 years or older. Three different formulas to adjust the QT interval 
for heart rate were used in order to establish differences between formulas and to 
compare our findings with published data from other population-based studies, 
Methods 
Study population and data collection 
This study is part of the Rotterdam Study, a population-based cohort study aimed at 
assessing the occurrence and risk factors of chronic diseases in the elderly, 
Objectives and methods of the Rotterdam Study are described in detail elsewhere l ', 
Briefly, in the Rotterdam Study all men and women aged 55 years or older, living in 
the Rotterdam district Ommoord, were invited to participate, Of 7,129 participants 
(response rate 69%) baseline data, collected from 1990 to 1993, included an ECG, 
information on history of cardiovascular disease, established cardiovascular risk 
factors and use of medications, A digitally stored ECG was available in 6,160 
(86%) participants, Fourteen percent was missing mainly due to temporruy technical 
problems with the ECG recorder, Participants with arrhythmias (n=290) and those 
with complete left or right bundle branch block (n=304) were excluded, leaving 
2,200 men and 3,366 women in the present study, 
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QT measurement and correction/or heart rate 
A 12-lead resting ECG was recorded with an ESAOTE-ACTA cardiograph with a 
sampling frequency of 500 Hz, and stored digitally. All ECGs were processed by 
the Modular ECG Analysis System (MEANS),,·I' to obtain ECG measurements and 
diagnostic interpretations. The QT interval was determined over all leads in one 
representative complex that resulted from selective averaging of dominant beatsls . 
To adjust QT for heart rate tluee different methods were used. First, we calculated 
QT, according to Bazetl's formula: QT, = QTI..JRR, where RR is the RR interval in 
secondsl7 • Second, we used a linear regression equation that was also applied in the 
Framingham Study: QT. = QT + ~*(l-RRl'. Both QT, and QT. can be interpreted 
as the QT interval at a heart rate of 60 beats per minute. Third, we computed the 
QT-index as used in the Cardiovascular Health Study: QT!=QT/QTp, where QTp is 
the predicted interval and equals: QT m"/( 1 + 0.01 *heart rate), with QT m,,=656 ms 18. 
For example, a QT! of 110 denotes a QT interval that is 10 percent longer than the 
predicted QT interval. Based on the literature, four definitions of prolonged heart-
rate adjusted QT interval were used: QT, longer than 440 ms' and 460 ms l ', QT. 
longer than 420 ms in men and longer than 432 ms in women', and QT! greater than 
11013. 
Data Analysis 
The mean values of QT, RR, QT" QT,,, and QT!, and the prevalence of prolonged 
heart-rate adjusted QT, defined in four different ways, were assessed in men and 
women separately and in different age groups. In addition, we studied whether QT" 
QT,,, and QT! were still associated with RR interval using a linear regression model. 
If this is the case this would indicate that the correction for heart rate with the 
formula is not complete. Prevalences from published reports were compared with 
adjusted results from our study, using the same exclusion rules and, if necessary, 
adjusting for age using linear regression analysis. All analyses were pelformed for 
men and women separately, using BMDP statistical software (version 7, 1990). 
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Table 1. General characteristics of the study population. Values are means (with standard 
deviations) or proportions. 
All Men Women 
(n=5,566) (0=2,200) (n=3,366) 
Age (years) 68.6 (S.8) 67.4 (8.0) 69.3 (9.2) 
Body mass index (kg/m') 26.3 (3.7) 25.7 (3.0) 26.S (4.1) 
Systolic blood pressure (mmHg) 139.0 (22.2) 138.5 (21.8) 139.3 (22.5) 
Diastolic blood pressure (mmHg) 73.6 (11.5) 74.6 (11.5) 73.0 (11.4) 
Serum total cholesterol (nlllloll1) 6.7 (1.2) 6.3 (1.1) 6.9 (1.2) 
Serum total potassium (mmoVl) 4.1 (0.3) 4.1 (0.3) 4.1 (0.3) 
Current cigarette smoking (%) 23.3 29.5 IS.9 
Systemic hypertension' (%) 18.4 17.1 19.3 
Antihypertensive medication use (%) 30.4 27.4 32.3 
Diabetes mellitus' (%) 11.6 11.5 11.6 
HistoryofMI' (%) 12.5 17.8 9.1 
Left ventricular h('pertrophy by ECG (%) 4.7 5.6 4.1 
Negative T-wave (%) 7.7 8.4 7.3 
Mean heart rate (beats per minute) 70 (12) 68 (12) 71 (II) 
*: Hypertension: systolic blood pressure> 160 mmHg or diastolic blood pressure> 95 mmHg; 
t: Diabetes mellitus: non-fasting blood glucose> 11.1 mlTIolll or antidiabetic medication; 
f: History of MI: myocardial infarction by interview or by ECG 
5: Negative T-wave: at least 1.0 mm deflection in any of leads I-III, aVL, aVF, V2-V6. 
Results 
General characteristics of the 2,200 men and 3,366 women are presented in Table I. 
Women were slightly older, had higher cholesterol levels, smoked less, and had a 
lower prevalence of myocardial infarction than men. 
QT interval alld heart rate 
The relation between QT and RR using linear regression formulas in our study was 
QTt,=QT+0.140*(I-RR) in men and QTk=QT+0.163*(l-RR) in women. In the Fra-
mingham Study, application of the linear regression equation had very similar re-
sults: QTk=QT+0.147*(l-RR) in men and QTk=QT+0.167*(I-RR) in women9• Exa-
mination of the linear relation between QT" QT .. and QTI with RR showed a nega-
tive association of QT, (regression coefficient 1'=-0.08, p<O.OOI) and QTI (1'=-0.01, 
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p<O.OOI) with RR. Consequently, QT, and QTI do not completely correct QT for 
heart rate. As expected, there was no significant linear association of QTl' with RR. 
Distribution of/leart rate adjusted QT-intel1,als 
In Table IIa and IIb the mean values of QT, RR, QT" QT1h and QTI are presented 
for different age groups. On average, the unadjusted QT interval was similar in both 
sexes. Women had shorter RR intervals and consequently longer heart-rate adjusted 
QT intervals than men. In men, mean QT, increased from 415 ms in those aged 55 
to 59 years to 430 ms in those over 80 years. In women, the corresponding values 
were 429 ms and 437 ms. Overall, QT,ranged from 345 to 628 ms in men and from 
329 to 538 ms in women. In both men and women, mean QT IT was about 10 ms 
shorter than mean QT, in all age groups. Mean QTI increased from 100.0 to 103.4 in 
men and from 102.9 to 104.7 in women, from the youngest to the oldest age group. 
Table 2a. Mean values of heart-rate adjusted QT by age in men. 
QT (ms) RR (ms) QT;(ms) QTrr(ms)' QTI' 
55-59 (n=434) 396 921 415 407 100.0 
60-64 (n=520) 397 905 420 410 101.1 
65-69 (n=495) 399 896 424 414 102.1 
70-74 (n=350) 399 893 424 414 102.3 
75-79 (n=231) 402 894 428 417 103.1 
>80 (n=170) 400 876 430 417 103.4 
All (n=2200) 398 901 422 412 101.8 
*: QT,=QT8RR; t: QTJrQT+0.140*(1-RR); f: QTI-QT/(656/(1+0.01*heart rute)). 
Table 2b. Mean values of hear Hate adjusted QT by age in women, 
QT (ms) RR (IllS) QT,' (IllS) QTrr(ms)' QTIf 
55-59 (n=606) 398 868 429 419 102.9 
60-64 (n=678) 397 854 431 421 103.4 
65-69 (11=604) 399 857 432 422 103.7 
70-74 (n=566) 398 847 434 423 103.9 
75-79 (n=431) 400 854 434 423 104.1 
>80 (n=481) 400 843 437 426 104.7 
All (n=3366) 398 854 433 422 103.7 
*: QT,=QT/~RR; t: QTrr=QT+O.l63*(l-RR); f: QTI=QT/(656/(1 +0.0 1 *heart rute)). 
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Prevalellce o/prolollged heart-rate adjusted QT imerval 
The prevalence of prolonged heart-rate adjusted QT, using the four different defi-
nitions, is shown in Figures la and lb. The presence of prolonged QT" defined as 
QT,>440 ms ranged from 13.8% in men and 29.7% in women aged 55 to 59, to 
34.7% in men and 44.3% in women older than 80 years, and was similar to the pre-
valence of prolonged QTI' , but much more prevalent than prolonged QT! intervals. 
The prevalence of prolonged QT, , defined as QT,>460 ms, was similar to the 
prevalence of QT!, ranging from 2.5% in men and 6.4% in women aged 55 to 59, to 
11.8% in men and 17.5% in women in the oldest age group. 
Comparison with other studies 
Prevalences reported by tluee other studies and the adjusted prevalence in the 
Rotterdam Study, applying the same exclusion criteria and adjusting for age, are 
presented in Table III. Mean QT, in men aged 65 to 84 was 411(SD 27) ms in the 
Zutphen Study, about 10 ms shorter than the adjusted mean QT, in the Rotterdam 
Study, which was 425 (SD 22) ms. Mean QT. was about 375 ms ill men and 388 ms 
in women participating in the Framingham Study, whereas the adjusted mean values 
of QTk were 401 (SD 19) ms in men and 416 (SD 18) ms in women in the 
Rotterdam Study. Prevalences of prolonged QT, and prolonged QTI' were markedly 
higher in the Rotterdam Study than in published reports using the same formulas. 
Prevalence of prolonged QT! was lower in women in the Rotterdam Study 
compared to women in the Cardiovascular Health Study, except for the highest age 
group, but estimates for men were similar. 
Discussion 
The results of this study show that a prolonged heart-rate adjusted QT interval is 
more frequent in women than in men and that the prevalence in both sexes increases 
markedly with age. Mean values of heart-rate adjusted QT interval and prevalence 
of prolonged heart-rate adjusted QT vmy substantially according to the correction 
formulas and threshold values used. 
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Figure la. Prevalence of prolonged QT interval adjusted for heart rate, using four different 
defmitions, in men (%). 
QTc=QT/~RR; Ql1r=QT +O.140'(lOOO·RR); Ql1=QT/(656/(I+O.0I *heart rate)) 
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Figure lb. Prevalence of prolonged QT interval adjusted for heart rate, using four different 
definitions, in women (%). 
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Table 3. Prevalence of prolonged QT in the Rotterdam Study compared to three population-based 
studies. 
Zutphen Study6 
men, age 65-84 
Framingham Study9 
men, age 29-62 
women, age 28 - 62 
Cardiovascular Health Studyl3 
men, 
age 65-69 
age 70-74 
age 75-79 
age SO-84 
age >S5 
\vomen, 
age 65-69 
age 70-74 
age 75-79 
age SO-84 
age >S5 
*: QT,=QT/~RR; 
Definition 
prolonged QT 
QTc'>420ms 
QTct>420 ms 
QTct>432 ms 
QT1'>11O 
N 
720 
2239 
2779 
625 
626 
381 
201 
73 
1097 
836 
541 
229 
76 
Prevalence 
(95%Cl) 
34.9 (31.4-38.5) 
2.5 (1.9-3.2) 
2.5 (1.9-3.1) 
6.7 (4.9-9.0) 
8.0 (6.0-10.4) 
12.3 (9.2-16.1) 
12.4 (8.2-17.8) 
19.2 (10.9-30.1) 
13.4 (11.4-15.6) 
16.4 (13.9-19.1) 
16.3 (13.3-19.6) 
20.1 (15.1-25.9) 
22.4 (13.6-33.4) 
t: QTc=QT +0.140*(I-RR) in men and QTc=QT+O.163*(I-RR) in women; 
1': QTI=QT/(656/(1+0.01 *heart rate»). 
Adj. prevalence§ 
Rotterdam Study 
(95%CI) 
57.3 (54.4-60.2) 
14.7 (13.1-16.4) 
17.1 (15.7-18.5) 
6.5 (4.5-9.0) 
6.9 (4.4-10.0) 
10.4 (6.S-15.1) 
11.1 (5.9-IS.6) 
11.3 (4.7-21.9) 
8.1 (6.1-10.6) 
9.2 (6.9-11.9) 
12.3 (9.3-15.8) 
13.7 (9.S-18.5) 
19.7 (14.7-25.6) 
§: Adj. prevalence = adjusted prevalence after applying the same exclusion criteria as in the 
comparison study and adjusting for age using linear regression if nccesary. Numbers of participants 
in different age groups in the Rotterdam Study are presented in Table II. 
Comparison of our findings with data presented from other studies showed that even 
if the same formulas to adjust QT for heart rate are used, large differences in 
estimates of prevalence of prolonged QT can be observed. 
As QT" was the only formula without a residual linear association with RR interval, 
this formula may be preferable to QT, and QTI when linear associations of QT with 
cardiovascular determinants are examined. The linear regression coefficients esti-
mated from the Framingham Study were very similar to our estimates. Thus, in stu-
dies with a relatively small number of participants, regression coefficients need not 
be derived, but coefficients from the Framingham Study or from the present study 
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can be used. 
Comparison to previous studies showed that marked differences in prevalence 
estimated of prolonged QT were present between studies using the same correction 
formulas. These discrepancies may at least partly be explained by differences in 
measurement techniques. In the Rotterdam Study the QT interval was measured by 
computer over all leads. Largest_differences were found between the Rotterdam 
Study and two studies using manual measurements. In the Zutphen Study, ECG 
intervals were measured manually with a digitizing tablet taking the longest QT 
interval from leads I, II, ill, V2 or V6, and in the Framingham Study measurements 
were pelformed manually in all 12 leads. Our findings were more similar to those of 
the Cardiovascular Health Study in which a computer program was used in combi-
nation with an interactive graphics procedure for correcting computer measurement 
errors. This computer program applies another method to detect the end of the T 
wave than our MEANS program. This is important in view of the large variability 
reported between different human observers, different computer programs, and be-
tween human observers and computer programs, in measurements of the end of the 
T wave'. Another explanation for part of the discrepancies in prevalence estimates 
between populations may be differences in prevalences of cardiovascular risk indi-
cators, such as body mass index, medication use, or coronary heart disease. 
Which measurement technique should be preferred to diagnose prolonged QT is 
unclear. Even though QT intervals have been found to differ systematically, the 
association of prolonged QT intervals, established with different measurement tech-
niques, with future cardiovascular disease has been shown in many studies. How-
ever, it seems clear that computerized QT measurements using a single program, 
and excluding the problem of intra- and inter-observer variability among different 
physicians measuring EeGs, are preferable to manual measurements. 
The definition of prolonged heart-rate adjusted QT, depending on the threshold 
value used to distinguish between normal and prolonged QT, can be based on prog-
nostic implications for clinical endpoints. Depending on the purpose of diagnosing 
prolonged QT, higher or lower thresholds and associated risk levels may be con-
sidered relevant, which also influences the number of subjects detected with pro-
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longed QT. Instead of dichotomous thresholds, also several categories or continuous 
estimates of the heart-rate adjusted QT may be studied. As women have syste-
matically longer (about 10 ms)heart rate adjusted QT intervals5.9.2o~", it seems that 
the threshold value for prolonged QT, and QT, should be higher in women than in 
men. 
Using data from large population-based follow-up studies, such as the Rotterdam 
Study, may offer an opportunity to circumvent the problem of the lack of standards 
by establishing specific reference values for each ECG computer program or manual 
measurement technique separately. For each method, age- and sex-specific normal 
values of QT interval can be assesscd, together with threshold values for prolonged 
heart-rate adjusted QT interval. Thresholds should depend on the additional risk 
associated with a certain length of the heart-rate adjusted QT interval, for example a 
two- or threefold risk for cardiovascular morbidity or mortality. This would 
facilitate uniform diagnoses of those with prolonged heart-rate adjusted QT 
intervals, and link them to established levels of risk. Consequently, prevalence of 
prolonged heart-rate adjusted QT can be compared between different populations. 
More importantly, this would enable physicians to target preventive measures at 
patients with QT intervals inferring increased cardiovascular risk. At present, in the 
absence of these measurement-technique specific reference values, prolonged QT 
interval remains a tricky diagnosis. 
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CHAPTER 3.1 
PROLONGED QT INTERVAL PREDICTS CARDIAC AND 
ALL-CAUSE MORTALITY IN THE ELDERLY: THE ROTTERDAM 
STUDY 
Abstract 
Objective To examine the association between heart-rate adjusted QT prOlongation 
and cardiac and all-cause mortality in the population-based Rotterdam Study among 
men and women aged 55 years or older and to compare the prognostic value of heart 
rate adjusted QT interval, using different formulas to correct for heart rate. 
Background. In several studies it has been suggested that a prolonged QTc interval 
on the ECG is an independent predictor of cardiovascular disease and mortality. 
However, only few studies were performed in non-hospitalized populations showing 
controversial results. 
Methods After exclusion of participants with arrhythmias or bundle branch block on 
the ECG, the study population consisted of 2,083 men and 3,158 women. During 
the 3 to 6 years (mean 4 years) follow-up period, 217 (10.4%) men and 236 (7.5%) 
women died. The QT interval was computed by the Modular ECG Analysis System 
(MEANS). Data were analyzed using Cox' proportional hazards model. 
Results. Participants in the highest quartile of heart-rate adjusted QT interval had 
about a 70% age- and sex-adjusted increased risk for both all-cause mortality 
(hazard ratio (HR) 1.8; 95%CI:1.3-2.4) and cardiac mortality (HR 1.7; 95%CI: 1.0-
2.7) compared to those in the lowest quartile. In women, increased risk associated 
with prolonged QT for cardiac death was more pronounced than in men. These risk 
estimates did not change after adjustment for potential confounders, including 
history of myocardial infarction, hypertension and diabetes mellitus. 
Conclusions. A prolonged heart-rate adjusted QT interval is an independent 
predictor for cardiac and all-cause mortality in older men and women. The risk 
associated with prolonged QT is hardly affected by the heart-rate correction formula 
used. 
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Introduction 
Prolonged heart-rate adjusted QT interval on the 12-lead electrocardiogram (ECG) 
is associated with an increased risk for ventricular arrhythmias, sudden death, and 
coronary heart disease. This relation has been reported in patients with the long QT 
syndrome!, in patients after myocardial infarction"', and in diabetic patients with 
autonomic neuropath/. Only few studies have been performed in the population at 
large'" and they have shown controversial results. In the Dutch Civil Servants Stu-
dy', men and women with prolonged heart-rate adjusted QT had a twofold increased 
risk for death from coronary heart disease. In the Zutphen Study·, a two- to fOUlfold 
increased risk for coronary heart disease mortality associated with prolonged heart-
rate adjusted QT was observed in middle-aged men and a threefold increased risk in 
elderly men. In contrast to these findings, prolonged heart-rate adjusted QT was not 
associated with total mortality. sudden cardiac death or coronary artery disease 
mortality in both men and women in the Framingham Heart Study'. 
The duration of the QT interval is strongly correlated with heart rate. Previous 
studies on prognostic implications of prolonged QT interval all used Bazett's formu-
la' to adjust QT for heart rate, but its adequacy has been questioned. Several new 
formulas have been proposed'·I2. In clinical practice, the formula which best pre-
dicts heart disease will be most valuable. In analogy, the definition of prolonged QT 
should be based on prognostic implications for clinical endpoints, for example a 
two- or threefold risk for cardiac mortality. 
Until now, the threshold value for prolonged QT, notably the value to distinguish 
between normal and prolonged QT, was often based on the distribution of QT inter-
val duration in the male population. As women have systematically longer heart-rate 
adjusted QT intervals, clinically useful threshold values for prolonged QT in men 
and women may differ. 
In the present study we examined the association between heart-rate adjusted QT 
prolongation and cardiac and aU-cause mortality in men and women aged 55 years 
or older, participating in the popUlation-based Rotterdam Study. We eompar'ed the 
prognostic value of heart-rate adjusted QT interval, applying different formulas 
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available to correct QT for heart-rate. 
Methods 
Study populatioll alld baselille data col/ectioll 
This study is part of the Rotterdam Study, a population-based cohort study aimed at 
assessing the occurrence and risk factors for chronic diseases in the elderly. Objec-
tives and methods of the Rotterdam Study have been described in detail elsewhere 13. 
Briefly, in the Rottcrdam Study all men and women aged 55 years or older, living in 
the district Ommoord of the city of Rotterdam, were invited to participate (response 
rate 78%). Of 7,129 participants the baseline data, collected from 1990 to 1993, in-
cluded an ECG, information on history of cardiovascular disease, established car-
diovascular risk factors, and use of medications. 
A digitally stored ECG was available in 6,160 (86%) participants. An ECG was 
missing in 14% of the participants, mainly due to temporary technical problems of 
the ECG recorder. Blood pressure was calculated as the average of two consecutive 
measurements with a random zero mercury manometer. Body mass index was 
calculated as weighlllength2 in kg/m2• Hypertension was defined as systolic blood 
pressure above 160 mmHg or diastolic blood pressure above 95 ImnHg or use of 
antihypertensive medication for the indication hypertension. Diabetes mellitus was 
defined as a non-fasting blood glucose above 11.1 mmolll or use of anti-diabetic 
medication. HistOlY of myocardial infarction (MI) was defined as self-reported MI 
with hospital admission, or MI on the ECG I4 . Presence of angina pectoris was 
established through the Rose questionnaire". 
After exclusion of participants with arrhythmias (n=256) or complete left or right 
bundle branch block (n=290), and of subjects without follow-up data, mainly 
because they moved to unknown addresses (n=345), the study population consisted 
of 2,093 men and 3,176 women. 
Follow-up procedures 
The follow-up period, starting at the baseline examination and for the present 
analysis lasting until April 1996, comprised 3 to 6 (mean 4) years. With respect to 
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the vital status of participants, information was obtained at regular intervals from 
the municipal health service in Rotterdam. Information on fatal and non-fatal 
endpoints was obtained from the general practitioners (GPs) working in the study 
district of Ommoord. These 20 GPs, covering about 8S% of the cohort, all have 
their practice computerized and report possible non-fatal and fatal events of parti-
cipants on computer file to the Rotterdam Study data-center on a regular basis. All 
possible events reported by the GP are verified by research physicians from the 
Rotterdam Study through patient records of the participating GPs and medical 
specialists. In April 1996, the medical records of participants with GPs outside the 
Ommoord area, about IS% of the cohort, were cheeked by research physicians and 
of all possible events additional information for coding was collected. Causes and 
circumstances of death were obtained shortly after reporting of death by the muni-
cipal health service or the GP, by questionnaire from the GP and by sC11ltinizing 
information fi"om hospital discharge records in case of admittance or referral. 
Overall, follow-up information was available for 94% of the population of the 
present study. Compared to subjects included in the present study, subjects without 
follow-up on average were 3.S years older (73.9 years), had a lower prevalence of 
hypertension (2S% versus 30%) and diabetes (10% versus 14%). No other diffe-
rences in baseline characteristics were found. 
Classification of event's was based on the International Classification of Diseases, 
10th edition (ICD_IO)I6. We defined cardiac mortality as death from myocardial 
infarction (ICD-IO: 121-24), chronic ischemic heart disease (ICD-IO: 12S), pul-
monary embolism or other pulmonary heart disease (ICD-l 0: 126-28), cardio-
myopathy (lCD-IO: 142-43), cardiac arrest (ICD-IO: 146), arrhythmias (ICD-IO:147-
49), heart failure (ICD-IO: ISO), or sudden cardiae death. Sudden cardiae death was 
defined as death occurring instantaneously or within 1 hour after onset of symptoms 
or unwitnessed death, in which a cardiac cause could not be excluded 17,JS, 
All events were classified independently by two research physicians. If there was 
disagreement. a consensus was reached in a separate session. Finally, all events 
were verified by a medical expert in the field of cardiovascular disease. In case of 
discrepancies, the judgment by this expert was considered definite. 
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ECG intelpretatioJ1 {(nd measurements 
A 12-lead resting ECG was recorded with an ESAOTE-ACTA cardiograph at a 
sampling frequency of 500 Hz, and stored digitally. All ECGs were processed by 
the Modular ECG Analysis System (MEANS) to obtain ECG measurements and 
interpretations. The MEANS program has been extensively evaluatedI9-21 • 
The MEANS program determines the overall QT interval for all twelve leads 
together on a representative beat, which results from selective averaging of domi-
nant beats. To adjust QT for heart rate we used five formulas that have also been 
used in other population-based studies: 
I) Bazett's formula': QTe = QT*RR I12 ; 
2) Fredericia's cubic root": QTc = QT*RRIIJ ; 
3) Linear regression formula lo: QTc = QT + P*(I-RR) with P=O.l40 in men and 
P=0.163 in women. 
4) The normogram method l2 : QTc= QT + P*(I-RR), with P=0.116 for heart rates 
less than 60 beats per minute, P= 0.156 for heart rates from 60 through 99 beats per 
minute and P= 0.384 for heart rates of 100 beats per minute or more. 
5) QT index (QTl)": QTl=QT/QTp, where QTp is the predicted interval and equals 
QTmax I (l + 0.01 *HR), with QTmax=656 ms, and HR is the heart rate in beats per 
minute. 
In formula I to 4, QTc can be interpreted as the length of the QT interval at a heart 
rate of 60 beats per minute. In formula 5, QTl reflects the length of the measured 
QT interval relative to the predicted QT interval. For example, a QTl of 110 can be 
interpreted as a 10% prolongation of the QT interval. 
Left ventricular hypertrophy (LVH) was determined using voltage as well as 
repoIarization criteria. Negative T-waves were defined as negative T-wave deflec-
tions of at least 1.0 mm in any of leads I -Ill, a YR, a VF, and V2-V6. 
Data Allalysis 
Differences in baseline characteristics between those with and without follow-up 
data were examined by means of one way analysis of covariance, adjusting for age 
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and gender when appropriate. 
To evaluate whether certain patient characteristics could confound the relationship 
between QTc and the endpoints studied, differences in the distribution of cardiovas-
cular risk indicators between subjects in quartiles of Bazett's QTc interval were 
examined through the use of one-way analysis of covariance, adjusting for age and 
gender. 
For the five correction formulas under study, heart-rate adjusted QT values were 
categorized in sex-specific quartiles. By means of Cox' proportional hazards analy-
sis, age- and sex-adjusted hazards ratios for cardiac and all-cause mortality for 
subjects in the three highest quartiles, with the lowest quartile as a reference group, 
were calcnlated for each formula separately. We adjusted for two sets of con-
founders: (I) age and sex, and (2) all potential confounders resulting from the 
analysis of covariance. 
Influence of age and history of myocardial infarction on the risk for cardiac death 
Table 1. General characteristics of the study popUlation. Values are means (standard deviation) or 
percentages. P-values are presented for equality of values in sex-specific quartiles of BazeU's QTc 
interval, adjusted for age and sex using one-way analysis of covariance. 
Characteristics All QI' Q2' Q3' Q4' p-value 
Age (y) 6S.2 (S.7) 67.2 6S.2 6S.2 71.4 <0.01 
Systolic blood pressure (mmHg) 139.1 (22.2) 136.9 13S.6 13S.9 141.6 <0.01 
Diastolic blood pressure (mmHg) 73.6 (11.5) 71.9 73.1 73.S 75.3 <0.01 
Body mass index (kg/m2) 26.3 (3.7) 26.0 26.1 26.5 26.S <0.01 
Current cigarette smoking (%) 21.4 19.0 20.2 24.1 22.3 <0.01 
Serum cholesterol (mmollI) 6.7(1.2) 6.6 6.6 6.7 6.7 NS 
Hypertension (%) 29.1 26.6 27.1 27.3 35.1 <0.01 
Diabetes mellitus (%) 11.9 9.6 9.6 11.7 16.2 <0.01 
History of MI" (%) 12.2 II.! 9.3 11.5 16.7 <0.01 
History of angina pectoris ~%) 6.5 6.6 6.9 6.2 6.2 NS 
Electrocardiographic LVH (%) 4.7 5.7 4.1 3.5 5.6 <O.Ot 
Negative T-w<\ve (%) 7.4 9.3 6.2 6.7 7.6 <0.05 
*Q 1: lowest quartile of QTc «406 illS in men; <418 ms in women) 
tQ2: second quartile ofQTc (406-421 rus in men; 418-432 ms in women) 
fQ3: third quartile of QTc (421-437 ms in men; 432-446 ms in women) 
§Q4: highest quartile of QTc (>437 InS in men; >446 ms in women) 
II "MI :::::: myocardial infarction; 11 LVH:::::: left ventricular hypertrophy 
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associated with prolonged QTc was examined through Cox' proportional hazards 
analysis within strata of these possible effect modifiers. 
To estimate the risk associated with published threshold values for prolonged QTc 
interval, we studied risk for cardiac and all-cause mortality of subjects with Bazetl's 
QTc intervals above 420 ms, 440 ms, and 460 ms, relativc to those with Bazett's 
QTc-intervals below 420 ms. 
All analyses were pelformed for men and women separately. 
Results 
The participants of the present study were on average 6S years old. Most 
cardiovascular risk indicators under study, apart from selUm cholesterol and histOlY 
of angina pectoris, showed a positive association with heart-rate adjusted QT-
interval duration (Table I). 
Prognostic value of heart-rate adjusted QT interval obtained with different formulas 
Risk for all-cause mortality (Table 2) and cardiac mortality (Table 3) in the three 
upper quartiles of heart-rate adjusted QT interval, relative to those in the lowest 
quartile, was hardly influenced by the correction formula used. For men, the highest 
age-adjusted hazard ratios (RR) in the fourth quartile were obtained for QTI, both 
for all-cause mortality (RR I.S; 95%CI 1.2-2.9) and cardiac mortality (RR 1.7; 
95%CI 0.S-3.6). For 1V0men, the highest hazard ratios in the fourth quartile were 
obtained for Bazetl's formula, both for all-cause mortality (RR 1.9; 95%CI 1.3-2.9) 
and cardiac mortality (RR 2.4; 95%CI 1.1-5.3). 
In all formulas, but least pronounced in Bazet!'s formula, the risk for cardiac mor-
tality in the second quartile of heart-rate adjusted QT interval seemed to be lower 
than in the first quartile, suggesting a J- or U-shaped curve, especially in women. 
Depending on the correction formula used, men in the highest quartile of heart-rate 
adjusted QT interval had a 50 to SO percent increased risk for all-cause mortality 
and a non statistically significant 30 to 70 percent increased risk for cardiac mor-
tality. In women in the highest quartile of heart-rate adjusted QT interval the increa-
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Table 2. Age-adjusted hazard ratios for afl-cause mortality of men and women in the three highest 
quartiles of heart-rate adjusted QT, relative to those in the lowest quartile, using five different 
formulas to adjust the QT interval for heart rate. 
Formula Group Percentile Hazard ratio Hazard ratio Hazard ratio 
25th 50th 75th Q2* Q3t Q4' 
1. Bazett8 MI 406 421 437 0.9 (0.6-1.4) 1.2 (0.S-1.9) 1.5 (1.0-2.3) 
F: 41S 432 446 I.3 (0.S-2.0) 1.5 (1.0-2.3) 1.9 (1.3-2.9) 
All' 1.2 (0.S-1.6) 1.4 (1.0-2.0) I.S (1.3-2.4) 
2. Fredericia22 M 401 413 426 1.0 (0.6-1.6) 1.4 (0.9-2.2) 1.6 (1.1-2.4) 
F 40S 420 432 1.0 (0.7-1.5) 1.1 (0.7-1.7) 1.6 (1.1-2.3) 
All 1.0 (0.7-1.3) 1.2 (0.9-1.7) 1.6 (1.2-2.1) 
3. Linear M 400 411 424 0.9 (0.5-1.4) 1.5 (1.0-2.3) 1.5 (1.0-2.3) 
regression lO F 410 421 433 1.0 (0.7-1.6) l.l (0.7-1.7) 1.7 (1.2-2.4) 
All 0.9 (0.7-1.3) 1.3 (1.0-1.7) 1.6 (1.2-2.1) 
4. Normogram12 M 403 414 427 l.l (0.7-1.7) 1.6 (1.0-2.5) 1.7 (l.l-2.6) 
F 410 421 433 l.l (0.7-1.7) 1.2 (0.S-1.9) 1.7 (1.2-2.5) 
All 1.1 (0.S-1.5) 1.4 (1.0-1.9) 1.7 (1.3-2.2) 
5. QTindexll M 9S.3 101.5 104.S 1.3 (0.S-2.1) I.S (l.l-2.9) I.S (1.2-2.9) 
F 100.5 103.4 106.6 1.0 (0.6-1.5) 1.2 (O.S-I.S) 1.8 (1.2-2.6) 
All l.l (0.8-1.5) 1.4 (l.l-2.0) I.S (1.3-2.3) 
';'Q2:::: second quartile; tQ3 :::: third quartile; 'I'Q4 = fourth quartile 
SM= male; :F= female;'U All: combining sex-specific quartiIes 
sed risks for cardiac mortality were more pronounced than in men. 
All risk estimates were independent from other cardiovascular risk indicators, as 
additional adjustment for body-mass index, cigarette smoking, hyperlension, 
diabetes mellitus, history of MI, eleclrocardiographic L VH, and presence of 
negative T-waves did not materially change the results. 
Subgroup analysis showed that the risk for all-cause mortality associated with heart-
rate adjusted QT was more pronounced in those under 70 years of age Ihan in older 
subjects (HR of the highest versus lowest quarlile of Bazett's QTc interval 2.8; 
95%CI 1.5-5.2 versus 1.5; 1.1-2.0). History of MI did not modify the association of 
all-cause and cardiac mortality with heart-rate adjusted QT, but the number of cases 
of cardiac dealh was too small to allow for definite conclusions. 
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Table 3. Age-adjusted hazard ratios for cardiac mortality of men and women in the three highest 
quartiles of heart-rate adjusted QT. relative to those in the lowest quartile, using five different 
formulas to adjust the QT interval for heart rale. 
Formula Group Percentile Hazard ratio Hazard ratio Hazard ratio 
25th 50th 75th Q2* Q3t Q4
' 
1. Bazett8 M' 406 421 437 0.7 (0.3-1.5) 0.7 (0.3-1.5) 1.3 (0.7-2.4) 
Fi 418 432 446 1.0 (0.4-2.6) 1.8 (0.8-4.1) 2.4 (1.1-5.3) 
All' 0.8 (0.5-1.5) 1.1 (0.6-1.9) 1.7 (1.0-2.7) 
2. Fredericia2:l M 401 413 426 1.0 (0.4-2.2) 1.1 (0.5-2.5) 1.6 (0.8-3.3) 
F 408 420 432 0.5 (0.2-1.3) 1.2 (0.5-2.5) 1.9 (0.8-4.4) 
All 0.7 (0.4-1.3) 1.1 (0.7-2.0) 1.7 (1.1-2.8) 
3. Linear M 400 411 424 0.9 (0.4-2.1) 1.2 (0.6-2.7) 1.6 (0.8-3.3) 
regression 1O F 410 421 433 0.5 (0.2-1.4) 1.3 (0.6-2.9) 2.1 (1.1-4.2) 
All 0.7 (0.4-1.4) 1.3 (0.7-2.2) 1.8 (1.1-3.0) 
4. Normogram l2 M 403 414 427 1.0 (0.5-2.3) 1.0 (0.5-2.2) 1.5 (0.5-2.3) 
F 410 421 433 0.6 (0.2-1.6) 1.3 (0.6-2.9) 2.1 (1.0-4.1) 
All 0.8 (0.5-1.5) 1.3 (0.7-2.2) 1.7 (1.1-2.9) 
5. QTindex ll M 98.3 101.5 104.8 1.2 (0.6-2.7) 1.1 (0.5-2.5) 1.7 (0.8-3.6) 
F 100.5 103.4 106.6 0.4 (0.2-1.2) 1.1 (0.5-2.3) 1.7 (0.9-3.3) 
All 0.8 (0.5-1.5) 1.1 (0.6-1.9) 1.7 (1.0-2.7) 
*Q2 = second quartile; tQ3 = third quartile; lQ4 = fourth quartile 
!M= male; : F;;;: female;4fJ All: combining sex-specific quartiles 
Risk associated with published threshold values for prolonged QTc 
Participants with Bazett's QTc intervals above 420 ms had an increased risk for all-
cause mortality (RR 1.6; 95%CI 1.2-2.1 in men and RR 1.6; 95%CI 1.1-2.2 in 
women). For this threshold value, the positive association between QT interval and 
cardiac mortality was not statistically significant in both men and women (RR 1.3; 
95%CI 0.8-2.2 in men and RR 1.5; 95%CI 0.9-2.9 in women). Increasing the 
tlHeshold for prolonged QTc to 440 ms resulted in higher risk estimates for all-cause 
mortality (RR 1.8; 95%CI 1.3-2.5 in men and RR 1.7; 95%CI 1.2-2.5 in women) 
and cardiac mortality (RR 1.6; 95%CI 0.9-2.9 in men and RR 1.9; 95%CI 1.0-3.7 in 
women). Those with Bazett's QTc intervals above 460 ms had a more than twofold 
risk for all-cause mortalily (RR 2.4; 95%CI 1.5-3.8 in men and HR 2.1; 95%CI 1.4-
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3.2 in women) and cardiac mortality (HR 2.2; 95%CI 1.0-5.2 in men and HR 2.3; 
95%CI 1.1-5.1 in women). 
Overall, the risk for all-cause mortality associated with a certain threshold value was 
somewhat higher in men than in women, while the risk for cardiac mortality 
associated with a certain threshold value was higher in women than in men. 
Discussion 
Results from the present study show that prolonged heart-rate adjusted QT interval 
predicts all-cause and cardiac mortality in older men and women, independent from 
other cardiovascular risk indicators. The risk for all-cause and cardiac mortality 
associated with heart-rate corrected QT is hardly influenced by the formula used for 
correction. 
Our results support the association between prolonged heart-rate adjusted QT and 
cardiac mortality reported in two previous studies in non-hospitalized populations in 
the Netherlands'·6. In these studies measurement of QT interval was performed 
manually in a subset of leads, and absolute values of QTc interval are systematically 
smaller than those measured by the MEANS program in the population of the 
Rotterdam Study. In the Zutphen Study6, elderly men with Bazett's QTc intervals 
above 420 ms had a threefold risk for coronary heart disease death (HR 3.1;95%CI 
1.3-7.6). This is even higher than the risk for cardiac mortality associated with 
prolonged QTc above 460 ms in men in the Rotterdam Study. This may partly be 
explained by the definition of endpoints, as our definition of cardiac mortality is 
wider than the definition of coronmy heart disease mortality in the Zutphen Study. 
In the Dutch Civil Servants Study' among 3,000 healthy middle-aged men and 
women, Bazett's QTc above 440 ms was associated with a twofold risk for both all-
cause mortality (odds ratio (OR) 1.8 in men and OR 1.9 in women) and cardiac 
mortality (OR 2.0 in men and OR 1.9 in women), after 15 years. No clear diffe-
rences in risk estimates between men and women, slIch as we found, were reported. 
This may partly be explained by differences in population characteristics, as our po-
pulation is older and selective survival may playa role, especially in men. Men with 
heart disease die on an earlier age than women and the men who survive until older 
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age may be healthier than women of the same age. 
It has been suggested that the absence of the association between Bazett's QTc 
interval and cardiac death in the Framingham Heart Study' may be explained by a 
U-shaped relationship, confcrring increased mortality in those with short and in 
thosc with prolonged QT intervals. Although we did find a U-shaped relationship of 
heart-rate adjusted QT with cardiac mortality in women with all correction for-
mulas, this was least pronounced in Bazet!' s formula, and virtually absent for all 
formulas in men. In an additional analysis (data not shown) we found a statistically 
significant positive linear association of Bazett's QTc interval with aU-cause and 
cardiac mortality in men and women. This suggests that the U- or J-shaped asso-
ciation is weak and the risk associated with QT prolongation is present over thc 
whole range of QT intcrval duration. 
The relationship between prolonged heart-rate adjusted QT and future cardiac 
mortality may be attributed to ventricular electrical instability and dispersion of 
repolarizatioll, which give rise to early afterdepolarizations23 . As in these mecha-
nisms parasympathetic activity exhibits beneficial effects, an unfavorable balance in 
sympathetic and parasympathetic activity may play an important role. This is in ac-
cordance with the positive association of QTc interval with blood pressure and heart 
rate. In addition, patchy myocardial fibrosis, with or without clinical symptoms, 
may lead to ventricular electrical instability and dispersion of repolarization. This is 
supported by the positive associations of heart-rate adjusted QT interval with a 
history of MI in our study. 
Womcn have longer heart-rate adjusted QT intervals than men (median of Bazetl's 
QTc 432 ms versus 421 ms in the present study). It has been suggested that, based 
on the distribution of heart-rate adjusted QT interval, the threshold for prolonged 
QT should be higher in women than in men. However, the risk for cardiac mortality 
associated with certain tln'eshold levels of prolonged QTc is at least as high in 
womcn as in men. Thcrefore, the threshold for prolonged hcart-rate adjusted QT in 
women should be comparable to that in men. 
As the prevalence of prolonged heart-rate adjusted QT is higher and the relativc risk 
for cardiac mortality is somcwhat higher in women than in men, the proportion of 
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cardiac deaths attributable to prolonged QT interval is larger in women than in men. 
lt should be emphasized, however, that the absolute risk for cardiac death is larger 
in men than in women. 
The risk associated with heart-rate corrected QT interval is hardly influenced by the 
correction formula used. In an additional analysis (data not shown) the unadjusted 
QT interval itself had hardly any prognostic value for cardiac mortality. When we 
added RR interval as an independent variable to the model, we found hazard ratios 
similar to those for Bazett's formula. Although all formulas may be used for risk 
stratification. there is no reason to discard Bazett's formula, which is most fre-
quently used in reported studies as well as in the medical practice. 
In this study we used the extensively validated MEANS computer program2!.24 to 
measure the QT interval, without supervision of human EeG interpreters. The use 
of a computer program offers a standardized and efficient way to interpret EeGs, 
without the intra- and inter-observer variation of human observers measuring and 
interpreting EeGs. The results of the present study imply, that heart-rate adjusted 
QT interval obtained with the MEANS program can be used to identify subjects at 
risk for future cardiac and all-cause mortality in the population at large and in a 
clinical setting. As system-specific thresholds for prolonged QT interval corrected 
with Bazetl's formula, obtained by the MEANS program, 440 or 460 ms can be 
used. If another measurement technique is used, absolute values of QTc interval and 
precision of the QT measurement may differ systematically from our method2!, and 
this 1V0uid require modifications of the thresholds applied. 
In conclusion, QTc interval is an independent predictor of cardiac and all-cause 
mortality in men and women. In clinical practice, prolonged heart-rate adjusted QT 
can be easily determined, manually as well as by computer, and may be used to 
identify subjects at increased risk for future mortality. 
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CHAPTER 3.2 
QTc DISPERSION PREDICTS CARDIAC MORTALITY IN THE 
ELDERLY: THE ROTTERDAM STUDY 
Abstract 
Background Increased QTc dispersion has been associated with an increased risk 
for ventricular anhytlmlias and cardiac death in selected patient populations. We 
examined the association between computerized QTc-dispersion measurements and 
mortality in a prospective analysis of the population-based Rotterdam Study among 
men and women aged 55 years or older. 
Methods and Results QTc dispersion was computed by the Modular ECG Analysis 
System (MEANS) as the difference between the maximum and minimum QTc-
interval in 12 leads and in 8 leads (i.e. the 6 precordial leads, the shortest extremity 
lead and the median of the 5 other extremity leads). After exclusion of those without 
a digitally stored ECG the population consisted of 2358 men and 3454 women. 
During the 3 to 6.5 (mean 4) years of follow-up, 568 (9.8%) subjects died. Degree 
of QTc dispersion was categorized into tertiles. Data were analyzed using Cox' 
proportional hazards model, adjusting for age. For QTc dispersion in 8 leads, those 
in the highest tertile relative to the lowest telii1e, had a twofold risk for cardiac 
death (hazard ralio 2.5; 95%CI 1.6-4.0) and sudden cardiac death (HR 1.9; 95%CI 
1.0-3.7), and a forty percent increased risk for lotal mortality (HR 1.4; 95%CI 1.2-
1.8). Additional adjustment for potential confounders, including history of 
myocardial infarction, hypertension, and overall QTc, did not materially change the 
risk estimates. Hazards ratios for QTc dispersion in 12 lcads were comparable to 
those found for QTc dispersion in 8 leads. 
Conelusion QTc dispersion is an important predictor of cardiac mortality in older 
men and women, 
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Introduction 
Recent clinical studies have suggested that the interlead variability of the QT 
interval in the standard electrocardiogram (ECG), defined as QT dispersion, 
reflects regional differences in ventricular repolarization.1,2 Increased dispersion of 
recovery time is believed to increase the risk for serious ventricular arrhythmias.'" 
It is hypothesized that an important entity underlying QT dispersion is patchy 
myocardial fibrosis, resulting from myocardial ischemia, ventricular dilatation, and 
neurohormonal activation.3,? This is supported by findings of increased QT 
d· ., . . I . d I QT . I I 8 d' I .. < . 2 9 10 lsperSlOIl In patients WIt 1 acqUire ang mtefva " myocar Ia llllarctloll, ' , 
hypertrophic cardiomyopathy, 11.12 hypertension and left ventricular hypertrophy, 13 
and in diabetic patients with autonomic neuropathy.I4 Moreover, QT dispersion has 
been associated with increased risk for ventricular a!Thythmias and sudden death in 
patients with chronic heart failure/ 5 mitral valve prolaps,I6 myocardial infarction/? 
and familial long QT syndrome, I and with an increased risk for cardiac mortality in 
patients with peripheral arterial disease? and myocardial infarction. Is 
In these previous studies QT dispersion was measured retrospectively and manually 
in a limited number of cases and controls, by one or more observers using a 
digitizing tablet. Evidence from large, prospective studies on the prognostic 
implications of QT dispersion is lacking. The use of a computer program to measure 
QT dispersion facilitates large studies and excludes intra- and interobserver 
variability. 
We assumed that the risk associated with increased QT dispersion not only applies 
to patient populations, but also to the popUlation at large. Therefore, we examined 
whether increased QT dispersion, established by computer, was associated with a 
higher risk for total mortality, cardiac death, sudden cardiac death, and non-fatal 
cardiac disease in a large non-hospitalized popUlation of older adults. 
Methods 
Study population and baseline data collectio1l 
This study is part of the Rotterdam Study, a population-based cohort study aimed at 
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assessing the occurrence and risk factors for chronic diseases in the elderly. 
Objcctives and methods of the Rotterdam Study are described in detail elscwhere. 19 
Briefly, in the Rotterdam Study all men and women aged 55 years or older, living in 
the Rotterdam district Ommoord, were invited to participate (response rate 78%). 
Of 7,129 participants, the bascline data, collccted from 1990 to 1993, included an 
ECG, information on history of cardiovascular disease, established cardiovascular 
risk factors and use of medications. 
A digitally storcd ECG was available in 6,160 (86%) participants. An ECG was 
missing in 14% of the participants, mainly due to temporary technical problems of 
the ECG recorder. Blood pressure was calculated as the average of two consecutive 
measurements with a random zero mercmy manometer. Body mass index was 
calculated as weight/length' in kglm'. Hypertension was defined as systolic blood 
pressure above 160 mmHg or diastolic blood pressure above 95 mmHg or use of 
anti-hypertensive medication for the indication hypertension. Diabetes mellitus was 
defined as a non-fasting blood glucose above 11.1 mmolll or use of anti-diabetic 
medication. History of myocardial infarction (M!) was defined as self-reported MI 
with hospital admission, or MI on the ECG. Presence of angina pectoris was 
established through thc Rose questionnaire.'o 
After exclusion of 345 subjects without follow-up data, mainly because they moved 
to unknown addresses, and 3 subjects with ECGs of poor technical quality which 
could not be interpreted by the computer program, the study population consisted of 
2,358 men and 3,454 women. 
Follow-lip procedures 
The follow-up period, starting at the baseline examination and in the present 
analysis lasting until April 1996, ,vas 3 to 6.5 (mean 4) years. With respect to the 
vital status of participants, information was obtained ,at regular intervals from the 
mUnicipal health service in Rotterdam. Information on fatal and non-fatal endpoints 
was obtained from the general practitioners (GPs) working in the study district of 
Ommoord. These GPs, covering around 85% of the cohort, all havc their practice 
computerized and report possible fatal and non-fatal events of participants on 
computer file to the Rotterdam Study data-center on a regular basis. All possible 
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events reported by the OP were verified by research physicians from the Rotterdam 
Study through patient records of the participating OPs and medical specialists. In 
April 1996, the medical records of participants with OPs from outsidc the Ommoord 
area, around 15% of the cohort, were checked by research physicians and of all 
possible events additional information for coding was collected. 
Cause and circumstances of death were established, shortly after reporting of death 
by the municipal health service or the OP, by questiomlaire from the OP and by 
scrutinizing information from hospital discharge records in case of admittance or 
referral. 
Overall, complete follow-up information was available for 94% of the population 
of the Rotterdam study. Participants in whom no follow-up information was 
available were similar to those included in the present study. Those without follow-
up were on average 3.5 years older (73.9 years), had a lower prevalence of 
hypertension (25% versus 30%), and diabetes (10% versus 14%). No other 
differences in baseline characteristics were found. 
Classification of fatal and non-fatal events was based on the International 
Classification of Diseases, 10th version.2I We defined cardiac mortality as death 
from myocardial infarction (ICD-IO: 121-24), chronic ischemic heart disease (ICD-
10: 125), pulmonary embolism or other pulmonary heart disease (ICD-IO: 126-28), 
cardiomyopathy (ICD-IO: 142-43), cardiac arrest (ICD-IO: 146), arrhythmias (ICD-
10:147-49), heart failure (ICD-IO: 150), or sudden cardiac death. Sudden cardiac 
death was defined as death occurring instantaneously or within I hour after onset of 
symptoms or unwitnessed death, in which a cardiac cause could not be excluded.22 • 
23 Non-fatal cardiac events were defined as myocardial infarction (ICD-IO: 121-24), 
cln'onic ischemic heart disease (ICD-IO: 125), coronary artery bypass graft (no ICD-
10 code), or percutaneaous transluminal coronaty angioplasty (no ICD-1O code). 
All events were classified independently by two research physicians. If there was 
disagreement, a consensus was reached in a separate 'session. Finally. all events 
were verified by a medical expert in the field of cardiovasculat· disease. In case of 
discrepancies, the judgment reached by this expert was considered definite. 
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EeG inteJprefation Gild meaSllrements 
A 12-lead resting ECG was recorded with an ESAOTE-ACTA cardiograph with a 
sampling frequency of 500 Hz, and stored digitally. All ECGs were processed by 
the Modular ECG Analysis System (MEANS) to obtain ECG measurements and 
diagnostic interpretations. The MEANS program has been extensively evaluated by 
the developers themselves and others,,4-26 To adjust QT for heart rate, we calculated 
QT, according to Bazett's formula: QT, = QT/'>/RR, where RR is the RR interval in 
seconds?7 
Normally, the MEANS program determines an overall end of T waves for all 12 
leads together using a representative beat, that results from selective averaging of 
dominant beats, and thus QTc dispersion in not disclosed. The program was, 
therefore, adjusted to determine the end of the T wave per lead. Taking the location 
of the overall end of the T wave as a starting point, the program searches forward 
and backward to establish the lead-specific end of the T wave. If the T wave 
amplitude is less than 50 11 Y, the T wave is considered to be flat and the lead is 
excluded from further analysis. QTc dispersion is determined as the difference 
between the maximum and minimum QTc in all considered leads. Analogously, QT 
dispersion is determined as the difference between the maximum and minimum QT 
interval, without correction for heart rate, in all considered leads. 
QTc dispersion measured by the MEANS program was validated against two human 
observers on a set of 100 ECGs (unpublished data, 1997). Both observers 
independently marked the end of the T wave in each lead with the cursor on a. high-
resolution computer screen. We found a mean QTc dispersion difference between 
MEANS and pooled data from both observers of 5.1 (SD 29.3) ms. These results are 
comparable with the interobserver variability between the two human observers 
(mean 6.7 (SD 28.4) ms). Therefore, we concluded that the performance of the 
program was comparable to that of human observers. 
Left ventricular hypertrophy (LYH) was determined using voltage as well as 
repolarization criteria. A negative T-wavc was defined as at least 1.0 mm negative 
deflection of the T-wave in lead II, a YF, or the precordial leads. 
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Lead selection for QTc dispersion 
Traditionally, QTc dispersion is defined as the difference between the maximum 
and minimum QTc-interval in 12 leads. However, in the standard 12-lead ECG, 
only two of the six extremity leads are actually recorded. The other four are derived 
mathematically from these tlVO leads. 
It can be shown that, if there is a shortest T wave in one of the extremity leads, the 
other five extremity leads must have the same end of T (see appendix). As a 
consequence, true QTc dispersion Calmot exist among these leads and QTc 
dispersion measured in these leads can only be the result of measurement 
inaccuracy. 
Therefore, we defined QTc dispersion as the difference between the maximum and 
the minimum QTc interval in 8 leads, i.e. the 6 precordial leads, the shortest 
extremity lead and the median of the 5 other extremity leads. In addition, we 
computed QTc dispersion in 12 leads. ECGs in which QTc dispersion could be 
measured in less then 9 of the 12 leads were excluded (n=16 of the 5812 subjects in 
the present study). 
Data Analysis 
Differences in baseline characteristics between those with and without follow-up 
data were examined using one-way analysis of covariance, adjusting for age and 
gender when appropriate. 
Degree of QTc dispersion in both 8 and 12 leads was categorized in tertiIes, with 
inter-tertiIe values of 39 ms and 60 ms (in 8 leads), and 47 ms and 66 ms (in 12 
leads) respectively. Also QT dispersion in 8 and 12 leads was categorized in tertiIes. 
All analyses were petfonned for both 8 and 12 lead measures of dispersion. 
To evaluate the association between QTc dispersion and potentially confounding 
factors, differences in the distribution of selected baseline characteristics between 
subjects in tertiIes of QTc dispersion were examined by means of one-way analysis 
of covariance, adjusting for age and gender when appropriate. 
Cox' proportional hazards model was used to examine the risk for cardiac and total 
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mortality and non-fatal cardiac events in relation to tertiie of baseline QTc and QT 
dispersion, adjusted for two sets of confounders: (1) age and gender (the latter only 
when non sex-specific risks were estimated), and (2) all possible confounders, 
excluding other ECG abnormalities, resulting from the analysis of covariance 
(p<O.05). The lowest tertiie of QTc dispersion or QT dispersion was taken as the 
reference category. In order to minimize the effect of missing data in the 
multivariate analysis, missing values of categorical variables were replaced by 
dummies. Missing values of continuous variables were replaced by the average 
value and a dununy variable (to indicate that the participant's individual value was 
missing) was added to the model." 
To compare predictive value of QTc dispersion with that of other commonly used 
cardiovascular risk indicators, age and sex-adjusted hazard ratios for cardiac 
mortality of important cardiovascular risk indicators were computed" 
Influence of age and history of MI on the risk for cardiac death associated with 
Table I. Baseline characteristics of study participants according to tertiles of QTc dispersion, values 
are means (standard deviation) or percentages. P-values are presented for equality of tertile specific 
values (TI-T3) for tertiles of QTc dispersion in 8 leads, adjusted for age and gender using one way 
analysis of covariance. 
Characteristic All Tl" 1'2' T3' p-value 
(n=5812) <39 ms 39-60ms >60ms 
Age 69.3 (9.0) 68.4 69.1 70.0 <0.01 
Gender (% women) 59.4 58.4 59.1 60.5 NS 
Systolic blood pressure 139.4 (22.4) 138.0 138.5 141.3 <0.01 
Diastolic blood pressure 73.5 (11.6) 73.1 73.2 74.0 <0.05 
Body mass index (kglm2) 26.3 (3.7) 26.5 26.4 26.2 NS 
Cholesterol (mmoVl) 6.6 (1.2) 6.6 6.6 6.6 NS 
Current smoking (%) 23.1 22.0 23.0 23.9 NS 
Use of cardiovascular medication (%) 36.0 34.4 36.1 37.2 NS 
Hypertension (%) 29.6 27.4 28.4 32.2 <0.01 
Diabetes (%) 12.7 1l.2 11.9 14.4 <0.01 
Angina pectoris (%) 6.8 7.1 7.5 6.0 NS 
Myocardial infarction (%) 13.0 11.5 12.5 14.5 <0.05 
Overall QTc (ms) 431 (29) 429 430 434 <0.01 
Negative T-wave (%) 7.8 5.6 7.6 9.4 <0.01 
LVH'on ECG (%) 4.9 3.4 4.8 6.1 <0.01 
* Tl- lowest tertile of QTc dispersion; t T2:::: middle tertile of QTc dispersion; f T3:::: highest tertile 
of QTc dispersion; § L VH::::left ventricular hypertrophy 
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increased QTc dispersion was examined through subgroup analyses for these 
possible effect modifiers. 
Results 
Baseline characteristics of participants in different tertiles of QTc dispersion are 
presented in table I. Statistically significant differences existed between the three 
comparison groups with regard to age, systolic and diastolic blood pressure, 
hypertension, diabetes mellitus, history of MI, overall QTc interval, presence of 
negative T -waves, and electrocardiographic L VH. 
The distribution of QTc dispersion, measured in both 8 and 12 leads, in cases of 
cardiac death during the follow-up period was shifted to the right compared to 
survivors (Figure I). In addition, QTc dispersion in 12 leads was shifted to the right 
compared to the distribution in 8 leads, reflecting larger dispersion in 12 leads than 
in 8 leads. 
During the 3 to 6.5 (mean 4) years of follow-up, 568 (9.8%) subjects died; 166 
(2.9%) died of a cardiac cause and 73 (1.3%) died suddenly. In 193 (3.3%) of the 
subjects at least one non-fatal cardiac event occurred. Cardiac mortality according 
to tertile of QTc dispersion is presented in men and women is presented in Figure 2a 
and 2b. It appears that in men increased risk for cardiac mortality starts at a lower 
level of QTc dispersion than in women. 
Participants in the highest tertile relative to the lowest tertile of QTc dispersion in 8 
leads, had a more than twofold age- and sex-adjusted risk for cardiac death (hazard 
ratio 2.5; 95%CI 1.6-4.0) and sudden cardiac death (HR 1.9; 95%CI 1.0-3.7), and 
an increased risk for total mortality (HR 1.4; 95%CI 1.2-1.8) and non-fatal cardiac 
events (HR 1.3; 95%CI 0.9-1.8), although the latter result was not statistically 
significant (Table II). Additional adjustment for hypertension, diabetes, and history 
of MI, did not materially change hazards ratio estimates for cardiac and all-cause 
mortality, although the 95% confidence intervals of the adjusted hazards ratios for 
sudden death events included one. Inclusion of other ECG abnormalities, notably 
L VH, negative T waves and maximum QTc interval, in this model did not influence 
the results. 
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Table 2. Hazards ratios in subjects in the middle (T2) and highest (T3) tertile relative to the lowest 
tertile of QTc dispersion measured in 8 leads, adjusted for age and sex (Model A) and for all 
possible confounders (Model B). 
End point Subgroup Model A' ModelB' 
1'2' T3' 1'2 T3 
39-60 ms >6011ls 39-60 ms >60ms 
Total mortality All 1.3 (!.l-I.7) 104 (1.2-1.8) 1.3 (1.0-1.6) 1.3 (1.1-1.6) 
Men 1.5 (1.0-2.0) 104 (1.0-1.9) 104 (1.0-2.0) 1.2 (0.8-1.6) 
\Vomen 1.2 (0.9-1.7) 1.5 (1.1-2.0) !.l (0.8-1.5) 104 (1.0-1.9) 
Cardiac mortality All 2.1 (1.3-304) 2.5 (1.6-4.0) 1.9 (1.2-3.1) 2.0 (1.3-3.2) 
Men 3.3 (1.6-6.9) 2.5 (1.2-5.2) 3.2 (1.5-6.6) 1.8 (0.9-3.9) 
Women 1.2 (0.6-2.5) 2.5 (104-4.6) !.l (0.5-2.2) 2.1 (1.2-4.0) 
Sudden cardiac death All 1.8 (0.9-3.5) 1.9 (1.0-3.7) 1.7 (0.8-3.3) 1.6 (0.S-3.1) 
Men 3.0 (!.l-S.I) 204 (0.9-6.6) 3.0 (!.l-S.I) 2.0 (0.7-5.6) 
Women 0.9 (0.3-2.5) 1.6 (0.6-3.S) 0.9 (0.3-204) 1.5 (0.6-3.6) 
Non-fatal cardiac All 0.9 (0.6-1.3) 1.3 (0.9-1.8) 0.8 (0.6-1.2) !.l (0.8-1.6) 
events Men 0.8 (0.5-1.3) 1.2 (0.S-1.8) O.S (0.5-1.3) 1.0 (0.5-1.6) 
'Vomen 1.0 (0.5-2.0) 1.6 (0.9-3.0) 0.9 (0.5-1.9) 1.5 (0.8-2.S) 
Table 3. Hazards ratios in subjects in the middle (T2) and highest (T3) tertile relative to the lowest 
tertile of QTc dispersion measured in 12 leads, adjusted for age and sex (Model A) and for all 
possible confounders (Model B). 
End point Subgroup Model A' ModelB' 
1'2' T3' 1'2 T3 
47-66 ms >66ms 47-66 illS >66m5 
Total mortality All 1.3 (1.0-1.6) 1.3 (!.l-1.6) 1.2 (1.0-1.6) 1.2 (0.9-104) 
Men 1.5 (1.1-2.1) 1.2 (0.8-1.6) 1.5 (1.1-2.0) 1.0 (0.7-1.4) 
\Vomen 1.1 (0.S-1.5) 104 (!.l-1.9) 1.0 (0.8-104) 1.3 (1.0-1.7) 
Cardiac mortality All 1.9 (1.2-3.0) 2.2 (104-304) 1.7 (1.1-2.8) I.S (!.l-2.7) 
Men 2.9 (1.5-5.6) 1.9 (1.0-3.8) 2.7 (104-5.3) 104 (0.7-2.9) 
Women 1.2 (0.6-2.3) 204 (104-4.3) l.l (0.5-2.1) 2.0 (!.l-3.6) 
Sudden cardiac death All 1.8 (0.9-304) 1.7 (0.9-3.1) 1.2 (0. 5-2. S) 1.9 (0.9-4.0) 
Men 2.1 (0.8-5.S) 1.9 (0.7-5.5) 3.6 (0.8-16.3) 4.7 (1.1-19.5) 
Women I.S (0.6-5.8) 2.6 (1.0-6.6) 0.7 (0.1-3.9) 2.0 (0.6-6.3) 
Non-fatal cardiac All 0.9 (0.7-1.4) 1.3 (0.9-1.8) 1.0 (0.7-1.6» 1.4 (1.0-2.0) 
el'ents Men 0.9 (0.5-1.4) 1.3 (0.9-2.0) 0.9 (0.5-1.5) 1.3 (0.8-2.0) 
\Vomen 1.2 (0.6-2.4) 1.2 (0.6-2.2) 1.4 (0.6-3.2) 1.4 (0.6-2.9) 
* Model A: adjusted for age; t Model B: adjusted for age, overall QTc, and pre..<;ence of 
hypertension, diabetes mellitus, history of myocardial infarction, negative T-wave, and left 
ventricular hypertrophy; f T2=middle tertile of QTc dispersion; § T3= highest tertile of QTc 
dispersion. 
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QTc dispersion in both 8 and 12 leads ranks among the strongest predictors for 
cardiac mortality (Figure 3). The highest age- sex adjusted hazard ratios for cardiac 
mortality were found for LVH (HR 2.6; 95%CI 1.7-4.0) and QTc dispersion in 8 
leads larger than 60 ms (HR 2.5; 95%CI 1.6-4.0), while in the multivariate model 
QTc dispersion in 8 leads larger than 60 ms was the strongest predictor for cardiac 
mortality, followed by histOlY of MI (HR 2.0; 95%CI 1.5-2.5). The corresponding 
multivariate hazard ratio for cardiac death for QTc > 440 ms was identical to the 
age-and sex adjusted hazard ratio, notably 2.3 (95%CI: 1.0-2.1). 
Subgroup analysis showed that the risk for cardiac death associated with increased 
QTc dispersion for participants in the highest relative to the lowest tertile of QTc 
dispersion was not modified by age, but was more pronounced in those without a 
history of MI (HR 3.5; 95%CI 1.8-6.9) than in those with a history of MI (HR 
1.8;95% CI 0.8-3.9). 
Figure 1. Distribution of QTc dispersion measured in 8 and 12 leads, in those who die from a 
cardiac cause and in survivors, among 5,812 men and women aged 55 year or older. 
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Figure 2a. Cardiac mortality (percentage) by tertile of QTc dispersion in Sleads in men. 
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Figure 2b. Cardiac mortality (percentage) by tertile of QTc dispersion in Sleads in women. 
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The risk estimates for the various endpoints associated with QT dispersion, without 
conection of the QT interval for heart rate, in 8 and 12 leads, were similar, but had 
wider confidence limits, compared to the risk estimates for QTc dispersion in 8 and 
12 leads. 
The risks associated with QTc dispersion based on 12 leads was very similar to the 
risk associated with QTc dispersion in 8 leads (Table III). Hazards ratios tended to 
be higher in QTc dispersion in 8 leads compared to QTc dispersion in 12 leads, but 
95% confidence intervals hardly differed. 
Figure 3. Age- ad sex adjusted hazard ratios QTc dispersion in 8 and 12 leads and other commonly 
used cardiovascular risk indicators and ECG abnormalities. 
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Discussion 
The results of this study show that increased QTc dispersion is a strong and 
independent risk factor for cardiac mortality in older men and women. 
Previous studies were performed in patient populations. Their findings that QT 
dispersion is larger in those with myocardial infarction," 9. 10 hypertension, left 
ventricular hypertrophy, IJ and in diabetes mellitus!4 are cOnImned by ours. 
Increased risk for cardiac mortality associated with QTc dispersion has been 
reported in patients with peripheral artery disease7 and myocardial infarction.!8 Our 
findings provide support for an association of increased QTc dispersion and cardiac 
death in those with and without coronary heart diseasc. However, differences in 
mean values of QTc dispersion in those who die from a cardiac cause compared to 
survivors, were much more pronounced in these earlier studies: 25 to 30 ms versus 4 
to 6 ms in the Rotterdam Study. This may be explained by differences in severity of 
thc underlying disease in the popUlation at largc compared to patient popUlations. 
Also differences in measurement techniques may playa role. 
Our findings are in accordance with the hypothesis that QTc dispersion is due to 
patchy myocardial fibrosis, resulting from myocardial ischemia, ventricular 
dilatation, and neurohormonal activation, as we found a positive association of QTc 
dispersion with many cardiovascular risk indicators. 
Irrespective of the technique used, QTc dispersion is difficult to measurc. The end 
of repolarization, assessed as the end of the T-wave, is a gradual process, and 
therefore hard to define. The definition of the end of the T-wave is further 
complicated by low-amplitude T-waves and the presence of U-waves. Differences 
in measurement techniques, either by hand or computer, are known to be the source 
of large variations in absolute values of QT intervals.'6 Prior studies have shown 
that measurement of QTc dispersion suffers from large measurement error and has a 
poor reproducibility in both manual and computerized measurements.29-33 Therefore, 
reported risk estimates arc likely to be substantially diluted. 
QTc dispersion in 12 leads was larger than QTc dispersion in 8 leads. As this 
difference is probably mainly due to measurement error it seems preferable to 
Illeasure QTc dispersion in 8 leads, although any difference between QTc dispersion 
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in 8 and 121eads hardly has any effect on the risk associated with QTc dispersion. 
We conclude that QTc dispersion is a strong and independent predictor of cardiac 
mortality in older men and women. Further studies are warranted to study the 
mechanism underlying QTc dispersion and to search for the most accurate measure 
of this mechanism. 
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Appendix 
Relatiol/ship between extremity leads 
In the standard 12-lead ECG, only two of the six extremity leads are actually 
recorded, for instance leads I and II, and the other four are derived from 
mathematical relationships imposed by the lead system. Thus, for the amplitUdes in 
the extremity leads at any time instant it holds that III = II - I, aVR = -(I + II)/2, 
a VL = (I - I1I)12, and a VF = (II + III)12. If all T waves end at the same moment, of 
course QT dispersion (QTD) = O. Suppose the T wave in one lead, say I, is shorter 
than in the other ones, ending at some time instant tl. Then, lead I being zero, ill = 
II for t > t I. This means that II and III must end at the same time. Let us assume this 
moment to be t2. In the time interval tl-t2 lead I = 0 and, using the above basic 
relationships, a VR = -W2, a VL = -IIlI2, and a VF = II = ill. Thus, the T waves in 
all augmented leads end when also the T waves in the leads II and ill end, i.e., at t2. 
Mutatis mutandis the argument can be applied to any extremity lead other than I, 
Einthoven or augmented. It is always tIue that if there is a shortest T wave in one of 
the extremity leads ending at some time instant tl, the T waves in the other five 
extremity leads must all end at the same time instant t2 > t1. As a consequence, 
QTD cannot exist among these leads and any QTD measured can only be the result 
of measuring inaccuracy. The only possible tIue dispersion is between these five 
leads and the single short lead, viz. QTD = t2-tl. 
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T AXIS: A NEW RISK INDICATOR FOR CARDIAC EVENTS IN THE 
ELDERLY 
Abstract 
Background The electrical T axis was hypothesized to be a general marker of 
repolarization abnormality, indicative of subclinical myocardial damage. The aim of 
this investigation was to assess the prognostic importance of the T axis for fatal and 
non-fatal cardiac events in a prospective cohort study among men and women aged 
55 years and older. 
Methods The study population consisted of 2,352 male and 3,429 female 
participants in the population-based ROllerdam Study. Electrocardiographic 
measurements were determined by a computer program. T axes were categorized as 
normal, borderline, and abnormal. Data were analyzed using Cox' proportional 
hazards models, adjusting for age and sex. 
Results During the 3 to 6 (mean 4) years of follow-up, 165 (2.8%) fatal and 192 
non-fatal (3.3%) cardiac events occurred. Subjects with an abnormal T axis had 
increased risks for cardiac death (hazard ratio 3.9; 95%CI 2.8-5.6), sudden cardiac 
death (4.4; 2.6-7.4), non-fatal cardiac events (2.7; 1.9-3.9), and combined fatal or 
non-fatal cardiac events (3.2; 2.5-4.1). Additional adjustment for established 
cardiovascular risk indicators resulted in lower, but still highly significant risks for 
all endpoints. The risks associated with an abnormal T axis were higher than those 
of any other cardiovascular risk indicator. Additional subgroup analyses indicated 
that the risk for cardiac death was not SUbstantially modifed by age, sex, or history 
of myocardial infarction. 
COHc!US;OJlS The T axis is a new, strong, and independent risk indicator of fatal and 
non-fatal cardiac events in the elderly. 
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Introduction 
Ischemia and hypertrophy of the myocardium carry an increased risk for fatal and 
non-fatal cardiac events. Electrocardiographic (ECG) changes of ventricular repo-
larization may reflect, possibly subclinical, myocardial damage. Consequently, 
repolarizatioll abnormalities as manifested by various ECG parameters, such as 
changes in the ST-T segment'·8 and increased QT dispersion9, have been found to 
predict the occurrence of coronary heart disease. However, a disadvantage of most 
of these parameters is that their measurement is tedious, has poor reproducibility, 
and requires analysis of all ECG leads. 
We therefore sought to find a simpler ECG measurement to represent disturbances 
of ventricular repolarization. Electrical activity of the heart during repolarization is 
represented by the orientation of the electrical T axis. This suggests that the Taxis 
may provide an alternative measure of repoiarization abnormality. The purpose of 
this lrivestigation was to determine whether an abnormal T axis is a marker of in-
creased risk for cardiac events in older adults. 
Methods 
Study population and baseline data collection 
The present investigation is part of the Rotterdam Study, a population-based cohort 
study aimed at assessing the occurrence of and risk indicators for chronic disease in 
the elderly. Objectives and methods of the Rotterdam Study have been described in 
detail elsewhere lO• Briefly, in the Rotterdam Study all men and women aged 55 
years or older, living in the Rotterdam district of Ommoord, were invited to 
participate (response rate 78%). Of 7,129 participants, baseline data were collected 
from 1990 to 1993, including established cardiovascular risk indicators, use of 
medications, history of cardiovascular disease, and an EeG. 
Hypertension was defined as systolic blood pressure above 160 mmHg or diastolic 
blood pressure above 95 mmHg 01' use of antihypertensive medication for the indi-
cation hypertension. Diabetes mellitus was defined as a non-fasting blood glucose 
level above II.I mmolll or use of antidiabetic medication. History of myocardial 
106 
T axis: a lIew risk indicator/oJ' cardiac events 
infarction was defined as self-reported myocardial infarction with hospital admis-
sion. Presence of angina pectoris was established through the Rose questionnaire ll . 
Digitally stored ECOs of 6,160 (86%) participants were available. Missing ECOs 
were mainly due to temporary technical problems with the ECO recorder. 
After exclusion of 345 subjects without follow-up data, mainly due to unknown 
addresses, and 34 subjects with ECOs that could not be processed by the computer 
program, the study population consisted of 2,352 men and 3,429 women. 
Follow-up procedures 
The follow-up period, starting at the baseline examination and for the present 
analysis lasting until April 1996, was 3 to 6 (mean 4) years. With respect to the vital 
status of participants, information was obtained at regular intervals from the muni-
cipal health authorities in Rotterdam. Information on fatal and non-fatal endpoints 
was obtaincd from the general practitioners (OPs) working in the study district of 
Ommoord. These OPs, covering about 85% of the cohort, all have their practice 
computerized and report possible fatal and non-fatal events of participants on com-
puter file to the Rotterdam Study data-center on a regular basis. All possible events 
reported by the OPs were vcrified by research physicians from the Rotterdam Study 
by consulting the patient records of thc participating OPs and of medical specialists. 
In April 1996, the medical rccords of participants under the care of OPs outside the 
Ommoord arca, about 15% of the cohort, were also checked by research physicians. 
Shortly aftcr a report of dcath by thc municipal health service or the OP, cause and 
circumstances of dcath were established by questionnaire from the OPs and by 
scrutinizing information from hospital discharge records. 
Ovcrall, complete follow-up information was available for 94% of the population. 
Differences in baseline characteristics between those with and without follow-up 
data were examined using one-way analysis of covariance, adjusting for age and sex 
when appropriate. Those without follow-up data were on average older (73.9 versus 
70.4 years) and had a lower prevalence of hypertension (25% vcrsus 30%) and 
diabetes (10% versus 14%). No other differences in baseline characteristics were 
found. 
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Classification of fatal and non-fatal events was based on the 10th revision of the 
International Classification of Diseases (ICD_IO)12. We defined cardiac mortality as 
death from myocardial infarction or other heart diseases (ICD-IO: 121-28. 42, 43, 
46-50), or sudden cardiac death. Sudden cardiac death was defined as death occur-
ring within one hour after onset of symptoms, or unwitnessed death while a cardiac 
cause could not be exciudcd13.!4. Non-fatal cardiac evcnts were dcfined as myo-
cardial infarction or chronic ischemic heart disease (121-25), coronary artelY bypass 
graft, or percutaneaous transluminal coronary angioplasty (no ICD-IO codes). 
All events were classified independently by two rescarch physicians. If therc was 
disagreement. a consensus was reached in a separate session. Finally, all events 
were verified by a medical cxpert in thc field of cardiovascular disease. In case the 
expert disagreed with the research physicians, thc expert's judgment was considered 
final. 
ECG measurements alld illleJpretalioJl 
A 12-lead resting ECG was recorded with an ACTA electrocardiograph (ESAOTE, 
Florence) at a sampling frcquency of 500 Hz, and stored digitally. All ECGs were 
processed by the Modular ECG Analysis System (MEANS)!'. MEANS computcs a 
representative averaged beat for each of thc 12 leads from which ECG measure-
ments and a diagnostic interpretation are derived. The program is also able to 
perform a classification according to the Mimlesota Codel6. MEANS has been 
extensively evaluated, both by the developers themselves l'.17 and by others!8,I'. 
T axes were computed from vectorcardiographic X, Y and Z leads which can, in 
good approximation, be reconstructed from the standard ECG leads2o.21 . The mean 
spatial axis is obtained by vectorially adding the instantaneous heart vectors during 
the T wave. The mean frontal axis is then taken to be the angle between the X axis 
and the projection of the mean spatial axis on the frontal XY plane; the mean 
horizontal axis is the angle betwcen the X axis and the projection of the mean 
spatial axis on the horizontal XZ plane. 
An overall QT interval was determined from the common QRS onset and T offset 
for all 12 leads together. To adjust for heart rate, Bazett's formula (QTc = QT/YRR) 
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Taking the location of the overall end of T as a starting point, the computer program 
determines the end of the T wave in each separate lead. QT dispersion was com-
puted as the difference between the maximum and the minimum QT interval in the 
six precordial leads, the shortest extremity lead and the median of the five other 
extremity leads9. 
ST-T depression was taken as Mimlesota Code 4.1 or 4.2. T-wave inversion was 
defined as Mimlesota Code 5.1 or 5.2. Myocardial infarction by ECG was based on 
a comprehensive set of criteria that partly derive from the Minnesota Code. 
Electrocardiographic left ventricular hypertrophy was determined using voltage as 
well as repolarization criteria. 
Data analysis 
Based on previously published reports""6, both ti'ontal and horizontal T axes were 
classified into three groups: "normal" (15° to 75°), "borderline" (-15° to 15° and 
75° to 105°), and "abnormal" (-180° to -15° and 105° to 180°). 
Differences in baseline characteristics between those with normal, borderline, and 
abnormal T axes were examined using one-way analysis of covariance, adjusting for 
age and sex when appropriate. 
Cox' proportional hazards analysis27 was used to determine the risk for cardiac 
death, sudden cardiac death, non-fatal cardiac events, and fatal or non-fatal cardiac 
events associated \vith borderline and abnormal T axes, taking subjects with normal 
T axes as the reference group. We adjusted for two sets of possible confounders: 
age and sex (model A), and age, sex, and established cardiovascular risk indicators: 
body mass index, cholesterol, current cigarette smoking, diabetes, hypertension, 
history of angina, and history of myocardial infarction (model B). 
Subgroup analyses were carried out to assess the modifying influence of age, sex, 
and history of myocardial infarction on the risk for cardiac mortality associated with 
an abnormal Taxis. 
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TabJc 1. Baseline characteristics of all participants and according to three categories of the 
frontal T axis.' Category-specific values have been adjusted for age and sex using one-way 
analysis of covariance, 
Characteristic 
Age (year) 
Female sex (%) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (mmHg) 
Body mass index (kglm2) 
Cholesterol (mmolll) 
Current smoking (%) 
Use of cardiovascular medication (%) 
Hypertension (%) 
Diabetes mellitus (%) 
History of angina pectoris (%) 
History of MI' (%) 
QTc interval (ms) 
QTc dispersion (ms) 
ST depression (%) 
T-wave inversion (%) 
MI by ECG (%) 
LVH' by ECG (%) 
. Values are means ± SD or proportions; 
All 
(0=5,781) 
69.3 ± 9.0 
59.4 
Normalt 
(n=4,690) 
68.2 
61.3 
139.4 ± 22.4 138.5 
73.5 ± 11.6 73.3 
26.3 ± 3.7 
6.6 ± 1.2 
21.0 
36.0 
29.6 
12.7 
6.8 
7.1 
431 ± 27 
53 ±29 
10.3 
8.1 
9.3 
4.9 
26.3 
6.6 
21.1 
32.0 
28.3 
11.3 
5.7 
4.4 
430 
56 
4.0 
2.0 
7.0 
1.6 
Borderlinet 
(11=482) 
71.6 
50.7 
141.7 
73.7 
26.5 
6.7 
20.0 
44.2 
31.8 
16.8 
9.2 
15.9 
430 
61 
18.4 
13.3 
15.5 
5.2 
Abnomlul§ 
(n=609) 
75.4 
50.8 
144.5 
74.7 
26.4 
6.4 
21.7 
59.2 
37.8 
14.8 
12.5 
21.5 
438 
66 
52.3 
50.9 
22.1 
29.6 
t Normal::::: 15° < Taxis < 75°; * Borderline = _15° < Taxis < 15° or 75° < Taxis < 105°; § 
Abnormal =_180° < Taxis <_15° or 105° < Taxis < 180°; 
n MI = myocardial infarction; 1 L VH = left ventricular hypertrophy. 
Results 
Table I shows baseline characteristics of all participants and of those with normal, 
borderline, and abnormal frontal T axes, after adjusting for age and sex. Most 
variables have a clear association with the T axis. Similar results were obtained for 
the horizontal Taxis. 
During the follow-up period, 165 (2.8%) subjects died from a cardiac cause, of 
whom 73 (1.3%) died suddenly. Non-fatal cardiac events were experienced by 192 
(3.3%) participants. Eleven individuals had a non-fatal cardiac event followed 
months or years later by a fatal cardiac event during the follow-up period. Table 2 
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Table 2. Number of fatal and non-fatal cardiac events and incidence rates for three 
categories of the frontal Taxis. 
Endpoint Nonllal' Borderlinet Abnormalt 
(n=4,690) (n=482) (n=609) 
n rate§ n rate n rate 
Cardiac death 78 4.2 23 12.9 64 27.4 
Sudden cardiac death 34 1.9 10 5.8 29 13.2 
Non-fatal cardiac event 130 6.9 20 11.3 42 18.9 
Fatal or non-fatal cardiac event 203 10.7 40 21.6 103 41.2 
'Normal:::: 15° < Taxis < 75°; t Borderline:::: _15° < Taxis < 15° or 75° < Taxis < 105°; t 
Abnormal:::: ~180° < Taxis < _15° or 105° < Taxis < 180°. 
§Pcr 1,000 person-years. 
shows the number of events and the etude incidence rates for subjects in different 
categories of the frontal Taxis. 
Subjects with an abnormal frontal T axis had about a fOUIfold age- and sex-adjusted 
risk for cardiac death (hazard ratio (HR) 3.9; 9S%CI 2.8-S.6) and sudden cardiac 
death (HR 4.4; 9S%CI 2.6-7.4) (Table 3). In addition, a marked increased risk for 
non-fatal cardiac events (HR 2.7; 95%CI 1.9-3.9) and for fatal and non-fatal cardiac 
events combined (HR 3.2; 9S%CI 2.5-4.1) was observed. The risks associated with 
a borderline T axis were also significantly increased for all outcomes, except non-
fatal cardiac events. 
After adjustment for different established cardiovascular risk indicators (model B), 
the hazard ratios associated \vith an abnormal T axis attenuated, but remained 
statistically highly significant for all endpoints. 
For comparison purposes, Table 3 also shows the risk for cardiac death associated 
with each of the other cardiovascular risk indicators. For both models, the risk 
associated with an abnormal T axis proved to be higher than that of any other risk 
indicator. 
Subgroup analyses indicated that relative risk estimates for cardiac death associated 
with an abnormal frontal T axis were only slightly modified by age (HR 4.3 (95%CI 
2.4-8.0) for age s 7S years and 3.6 (95%CI 2.4-S.S) for age> 7S), by sex (HR 3.7 
(95%CI 2.3-6.0) for males and 4.2 (9S%CI 2.5-6.8) for females), and by histOlY of 
myocardial infarction (HR 3.2 (95%CI 2.0-S.0) in subjects without and 3.0 (95%CI 
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Table 3, Hazard ratios (95% CI) of abnormal and borderline T axis and cardiovascular 
risk indicators for cardiac death, sudden death, non-fatal cardiac events, and fatal or non-
fatal cardiac events. 
End point 
Cardiac death 
Sudden death 
Non-fatal 
cardiac event 
Variable 
Borderline T axist 
Abnormal T axis§ 
History ofMI 
History of angina 
Diabetes mellitus 
Hypertension 
Current smoking 
Cholesterol> 8 mmoUI 
BMI> 25 kg/m' 
Borderline Taxis 
Abnormal Taxis 
Borderline T a.xis 
Abnormal Taxis 
Model A' Model Bt 
2.1 (1.3-3.3) 1.7 (1.0-2.8) 
3.9 (2.8-5.6) 2.9 (2.0-4.3) 
3.0 (2.0-4.4) 1.9 (1.3-2.9) 
2.4 (1.6-3.7) 1.9 (1.2-3.0) 
2.4 (1.6-3.4) 1.9 (1.3-2.8) 
1.4 (1.0-1.9) 1.4 (1.0-1.9) 
1.4 (0.9-2.0) 1.5 (1.0-2.2) 
1.3 (0.8-2.2) 1.1 (0.6-1.9) 
0.9 (0.6-1.2) 0.9 (0.6-1.2) 
2.1 (1.1-4.4) 1.7 (0.8-3.6) 
4.4 (2.6-7.4) 3.1 (1.7-5.5) 
1.4 (0.9-2.2) 1.1 (0.7-1.8) 
2.7 (1.9-3.9) 1.8 (1.3-2.7) 
Fatal or non-fatal Borderline Taxis 1.6 (1.1-2.3) 1.3 (0.9-1.9) 
cardiac event Abnormal Taxis 3.2 (2.5-4.1) 2.3 (1.7-3.0) 
• Model A: each variable entered separately, adjusting for age and sex; t Model B: Taxis 
and cardiovascular risk indicators entered simultaneously, adjusting for age and sex. 
{Borderline Taxis =_15° <T axis < 15° or 75° <Taxis < 105°; 
§ Abnormal Taxis = _180° < Taxis < _15° or 105° < Taxis < 180°. 
1.6-5.5) in subjects with a history of myocardial infarction). 
All analyses were also carried out for abnormal and borderline horizontal Taxes 
with essentially similar results (data not shown). 
DisclIssion 
The T axis is a strong and independent risk indicator of cardiac events in our study 
population of older adults. Its prognostic importance was higher than that of any 
other established cardiovascular risk indicator. 
To the best of our knowledge, this is the first study to report on the prognostic value 
of the T axis. In diagnostic vectorcardiography, the abnormal T axis has for long 
been known to provide a global measure of repolarization abnormalities26 . Such 
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abnormalities have been attributed to ischemic changes in the heart, but the 
mechanisms underlying ventricular repolarization are far from having been clarified 
as we are only beginning to discover the characteristics and complex 
interrelationships of different types of cells in the myocardium. Thus, the 
physiological meaning of an abnormal T axis remains unclear. 
In previous studies, ST-T changes, either "silent" or in combination with other 
ischemic or hypertrophic changes, have been associated with coronary heart 
disease'·6.'. In the present study, most ECG variables were strongly associated with 
the T axis (Table I). When we adjusted for age, sex, and these other ECG variables 
in the multivariate analysis, an abnormal T axis still proved to be associated with an 
almost tln'eefold risk for cardiac death (HR 2.8; 95%CI 1.8-4.5), suggesting that an 
abnormal T axis carries additional information beyond that available through other 
ECG variables. Thus, the T axis appears an important, general marker for 
(subclinical) myocardial damage. 
Our results were obtained in a population of older adults. Considering the strong 
relationship between T axis and ST -T changes and the fact that the latter have been 
identified as an important predictor for coronmy heart disease in a wide diversity of 
populations, we expect the T axis to be an important predictor for cardiac events in 
younger age groups as well, but this remains to be established. 
The thresholds to distinguish between different T -axis categories were based on 
values reported in previous studies23.'6. Most of these studies mention normal ranges 
for the axis of the maximal T vector in the frontal or horizontal plane, but not for 
the (mean) T axis. Since the normal spatial T loop often has an elongated, spindle-
like shape, we considered the difference between the maximal and mean T axes to 
be negligible. 
The precise choice of threshold values docs not appem' to be very critical. When we 
decreased all thresholds by 15° and repeated our analyses, the results remained 
essentially the same. We also considered a dichotomization of T axes based on 
percentiles, taking the upper and lower limits of intervals that contained 75 or 90 
percent of the T axes as boundaries, but again results did not change substantially. 
However, for risk stratification or screening purposes Uoptimal" boundaries may 
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need to be determined. 
It may come as a surprise that there is little to choose between horizontal and frontal 
T axes. At first sight one would perhaps expect one to carry more information than 
thc other. It must, however, be understood that, except for the case that the spatial T 
axis is lying exactly in either the horizontal or the frontal plane, any change in its 
direction will be projected on both planes and that both horizontal and frontal Taxis 
will represent this information. 
The calculation of T axes by computer is difficult to replicate by humans. However, 
many modern electrocardiographs can synthesize the vectorcardiogram from the 
recorded 12-lead ECG and optionally print projections of the spatial P-QRS-T loop 
in the frontal and horizontal planes, from which T axes are easily derived. 
Alternatively, the frontal T axis can readily be estimated similarly to the physician's 
derivation of the frontal QRS axis: using the same leads, the procedure is simply 
applied to the T wave instead of the QRS complex. When we simulated this 
procedure by computer, using only the peak-to-peak amplitude of the T waves in 
leads I and aVF, and repeated our analyses, very similar results were obtained (e.g., 
the agc- and sex-adjusted hazard ratio for cardiac death associated with an abnormal 
T axis was 3.85; 95%CI 2.68-5.51 versus 3.94; 95%CI 2.78-5.58 in our previous 
analysis). Whether determined automatically or manually, measurement of the T 
axis is likely to be less troubled by noise and problems of definition than many of 
the existing amplitude and interval measurements in the ECG. 
In conclusion, the Taxis seelllS to be an important, general marker of myocardial 
damage and is a strong, independent predictor for fatal and non-fatal cardiac events. 
If confirmed, its measurement should be considered in identifying individuals prone 
to develop coronary heart disease both in clinical practice and in screening 
programmes. 
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BOTH DECREASED AND INCREASED HEART RATE VARIABILITY 
ON THE STANDARD IO-SECOND ELECTROCARDIOGRAM PREDICT 
CARDIAC MORTALITY IN THE ELDERLY: THE ROTTERDAM STUDY 
Abstract 
Decreased heart rate variability (HRV) has been associated with an adverse 
prognosis in patients after myocardial infarction. Studies in the population at large 
show contradictory results. We examined the association between heart rate varia-
bility on a standard to-second electrocardiogram (ECG) and cardiac and all-cause 
mortality in the Rotterdam Study, a population-based cohort study in men and wo-
men aged 55 years or over. HRV, taken as the standard deviation of normal RR 
intervals (SDNN), was computed by the Modular ECG Analysis System (MEANS), 
using only RR intervals between two adjacent normal dominant beats. After exclu-
sion of subjects without a digitally stored ECG, and those with less than 6 normal 
RR intervals, or with arrhythmias, the study population consisted of 2,088 men and 
3,184 women. During the 3 to 6 (mean 4) years of foHow-up 69 (3.4%) men and 63 
(2.1 %) women died from a cardiac cause. SDNN was categorized into quartiles, 
with 25-, 50- and ?5-percentile values of 9.6, 15.2, and 25.9 ms. Cox' proportional 
hazards model was used to examine the age- and sex-adjusted risk for cardiac, non-
cardiac, and total mortality in relation to quartiles of SDNN, using the third quartile 
of SDNN as the reference category. Subjects in the lowest quartile relative to those 
in the third quartile of SDNN, had an 80 percent age- and sex-adjusted increased 
risk for cardiac mortality (HR 1.8; 95%CI: 1.0-3.2). The corresponding hazard ratios 
for non-cardiac mortality and all-cause mortality were 1.3 (95%CI:0.9-1.8) and 1.4 
(95%CI:1.0-1.8), respectively. Interestingly, for subjects in the highest quartile of 
SDNN compared to those in the third quartile an even more pronounced risk for car-
diac mortality was present (HR 2.3; 95%CI: 1.3-4.0). Additional adjustment for pos-
sible confounders, including diabetes, body mass index, and heart rate, did not ma-
terially change the risk estimates. HRV measured in the standard to-second ECG 
can bc used to identify older men and women with an increased risk for cardiac 
mortality. Increased HRV is an even stronger indicator of cardiac mortality than 
decreased HRV. 
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Introduction 
Heart rate variability (HRV) has been put forward as a promising marker of 
autonomic activit/. HRV is influenced by various physiological and pathological 
conditions, such as aging2, 3, respiration4 , diabetic neuropathy5, congestive heart 
failure6, and coronary heart disease7-9 , In the last two decades, ample evidence has 
emerged for the adverse prognostic implications of reduced HRV in patients after 
d· l'·c . 10·15 myocar 1a llllarctlOll . 
Several studies reported an association between decreased HRV and all-cause and 
cardiac mortality in middle-aged and elderly subjectsI6.,o. However, no association 
of reduced HR V with cardiac and all-cause mortality was found in elderly men and 
women in the Bronx Aging Study'l. Surprisingly, in the latter study, an association 
of increased HRV with cardiac events was present in women. A similar association 
was reported in elderly men in the Zutphen Study17. 
The report of the Task Force on HRV reconmlends that, in order to standardize 
clinical studies, only two types of HRV measurements should be used l; (a) short 
term measurements on 5 minute electrocardiograms (ECGs) made under physio-
logically stable conditions, processed by frequency-domain methods, and (b) 24-
hour recordings processed by time-domain methods. However, two prior popu-
lation-based studies, restricted to men, have reported an association between 
decreased HRV, measured in lO-beat ECGs l8 and 20-second ECGs 17, and total and 
cardiac mortality. Provided the predictive value of HRV measurements is esta-
blished, the standard 12-lead ECG would offer a useful tool for risk stratification in 
large populations, as it is mueh easier and less costly to obtain than the standardized 
5-minute ECG or the 24-hour holter ECG. 
In the present study we examined the association between decreased and increased 
HRV on the standard lO-second ECG and cardiac and all-cause mortality in the 
Rotterdam Study, a population-based cohort study in men and women aged 55 years 
or over. 
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Methods 
Study population and baseline data collection 
This study is part of the Rotterdam Study, a population-based cohort study aimed at 
assessing the occurrence and risk factors of chronic diseases in the elderly. Objec-
tives and methods of the Rotterdam Study are described in detail elsewhere22 • 
Briefly, in the Rotterdam Study all men and women aged 55 years or older, living in 
the Rotterdam district Ommoord, were invited to participate (response rate 78%). Of 
7,129 participants baseline data, collected from 1990 to 1993, included an ECG, 
information on history of cardiovascular disease, cardiovascular risk factors, and 
use of coffee, alcohol, and medications. 
A digitally stored ECG was available in 6,160 (86%) participants. An ECG was 
missing in 14% of the participants, mainly due to temporary technical problems of 
the ECG recorder. Blood pressure was calculated as the average of two consecutive 
measurements with a random zero mercury manometer. Body mass index was 
calculated as weight/length2 in kg/m2. Hypertension was defined as systolic blood 
pressme above 160 mmHg or diastolic blood pressure above 95 mmHg or use of 
antihypertensive medication for the indication of hypertension. Diabetes mellitus 
was defined as a non-fasting blood glucose above 11.1 nunolll or use of antidiabetic 
medication. History of myocardial infarction (Ml) was defined as self-reported MI 
with hospital admission, or MI on the ECG. Presence of angina pectoris was 
established through the Rose questionnaire2J. 
Subjects with arrhythmias (n=232: 162 atrial fibrillation, 14 atrial flutter, 23 atrial 
rhythm, 32 ideoventricular rhythm, I supraventricular tachycardia) and subjects in 
whom less than 6 intervals on the ECG could be analyzed for HRV measurements 
(n=25 I ), were excluded. In addition, 345 subjects without follow-up data (mainly 
because they moved to unknown addresses) and 71 subjects with ECGs of poor 
technical quality, in which cardiac rhythm could not be analyzed, were excluded. 
The final study population consisted of2,088 men and 3,184 women. 
Follow~IlP procedures 
The follow-up period, starting at the baseline examination and in the present a'naly-
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sis lasting until April 1996, was 3 to 6 (mean 4) years. Information on the vital 
status of participants was obtained at regular intervals from the municipal autho-
rities in Rotterdam. Information on fatal and non-fatal endpoints was obtained from 
the general practitioners (GPs) working in the study district of Ommoord. These 
GPs, covering about 85% of the cohort, all have their practice computerized and 
report possible fatal and non-fatal events of participants on computer file to the Rot-
terdam Study data center on a regular basis. All possible events reported by the GPs 
arc verified by research physicians from the Rotterdam Study through patient 
records of the participating GPs and medical specialists. In April 1996, the medical 
records of those participants with GPs from outside the Ommoord area (about 15% 
of the cohort) were checked by research physicians and of all possible events 
additional information for coding was collected. 
Cause and circumstances of death were obtained, shortly after reporting of death by 
the GP or municipal authorities, from the GP by questionnaire and by scrutinizing 
information from hospital discharge records in case of admittance or referral. 
Complete follow-up information was available for 94% of the population of the 
Rotterdam study. Differences in baseline characteristics between those with and 
without follow-up data were examined using one-way analysis of covariance, 
adjusting for age and gender when appropriate. Those without follow-up were on 
average older (73.9 years versus 70.4 years), had a lower prevalence of hyper-
tension (25% versus 30%) and diabetes (10% versus 14%). No other differences in 
baseline characteristics were found. 
Classification of fatal and nOll-fatal events was based on the International 
Classification of Diseases, 10th version (TCD-IO)". We defined cardiac mortality as 
death from myocardial infarction (ICD-IO: 121-24), chronic ischemic heart disease 
(ICD-IO: 125), pulmonary embolism or other pulmonary heart disease (ICD-l 0: 126-
28), cardiomyopathy (ICD-IO: 142-43), cardiac arrest (ICD-IO: 146), arrhythmias 
(ICD-IO: 147-49), heart failure (ICD-IO: 150), or sudden cardiac death. Sudden car-
diac death was defined as death occurring within one hour after onset of symptoms 
or unwitnessed death, in which a cardiac cause could not be excluded24. 25. 
All events were classified independently by two research physicians. If there was 
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disagreement, a consenSllS was reached in a separate session. Finally, all events 
were verified by a medical expert in the field of cardiovascular disease. In case of 
discrepancies, the judgment of this expert was considered definite. 
ECG intelpretatioll alld measurements 
A 12-lead resting ECG was recorded with an ACTA cardiograph (EsaOte, Florence) 
with a sampling frequency of 500 Hz, and stored digitally. All ECGs were pro-
cessed by the Modular ECG Analysis System (MEANS) to obtain ECG measure-
ments and diagnostic interpretations. The MEANS program has been evaluated 
cxtcnsively26-29. 
Only RR intervals between two adjacent normal dominant beats were used to 
compute mean heart rate (HR) and HRV, taken as the standard deviation of normal 
RR intervals (SDNN). Both premature ventricular and supraventricular complexes 
were considered abnormal. The overall QT interval was determined on a repre-
sentative beat for all twelve leads together. To adjust QT for heart rate, we calcu-
lated QT, according to Bazett's formula)o. Left ventricular hypertrophy (LVH) was 
determined using voltage as well as repolarization criteria. Negative T -waves were 
defined as negative T-wave deflections of at least 1.0 lllll1 in any of the leads I-ill, 
aYR, aVF, and V2-V6. 
Data analysis 
SDNN was categorized into quartiles, with 25-, 50- and 75-percentile values of 9.6, 
15.2, and 25.9 ms. 
To evaluate the association between HRV and potentially confounding factors and 
other ECG characteristics, differences in the distribution of selected baseline cha-
racteristics between subjects in quartiles of SDNN were examined by one-way 
analysis of covariance, adjusting for age and gender when appropriate. As a U-sha-
ped relationship was apparent between several determinants and SDNN in which the 
lowest risk was present in the third quartile, separate analyses were pelformed for 
decreased HRV (comparing the lowest three quartiles) and increased HRV 
(comparing the highest two quartiles). All determinants that showed a statistically 
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significant (p<0.05) association with SDNN in one of these analyses, was 
considered a possible confounder. 
Cox' proportional hazards model was used to examine the risk for cardiac, n011-
cardiac and total mortality in relation to quartiles of SDNN, adjusted for two sets of 
confounders: (I) age and sex, and (2) all possible confounders resulting from the 
analysis of covariance. The third quartile of SDNN was taken as the reference 
categOlY. In order to minimize the effect of missing data in the multivariate analysis, 
missing values of categorical variables were replaced by dummies3l • Missing values 
of continuous variables were replaced by the average value and a dUlmny variable to 
indicate whether an imputed value was added to the model. 
Subgroup analyses were performed to examine whether age (below or over 75 
years), sex, history of MI, and presence of ectopic beats influenced the association 
between SDNN and cardiac mortality. 
Results 
Baseline characteristics of participants in quartiles of SDNN are shown in Table 1. 
In the analysis of determinants of decreased HRV, statistically significant diffe-
rences existed between the three comparison groups with regard to age, sex, body 
mass index, and diabetes mellitus. The ECG characteristics associated with de-
creascd SDNN were mean RR interval and overall QTc interval. Increased HRV, 
comparing the highest two quartiles, was associated with age, sex, mean RR, 
presence of negative T-waves, and premature ventricular and supraventricular 
complexes. 
During follow-up, 222 (10.6%) men and 238 (7.5%) women died; 69 (3.4%) men 
and 63 (2.1 %) women died from a cardiac cause. Subjects in the lowest quartile 
relative to those in the third quartile of SDNN, had an 80 percent age- and sex-
adjusted increased risk for cardiac mortality (hazard ratio (HR) 1.8; 95%CI:1.0-3.2) 
(Table 2). 
The corresponding hazard ratios for non-cardiac mortality and all-cause mortality 
were 1.3 (95%CI:0.9-1.8) and 1.4 (95%CI:1.0-1.8), respectively. Interestingly, for 
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subjects in the highest quartile of SDNN compared to those in the third quartile we 
found an even more pronounced increased risk for cardiac mortality (HR 2.3; 
95%CI: 1.3-4.0). 
The risk for cardiac mOltality associated with both decreased and increased SDNN 
were more pronounced in women than in men, in subjects with a history of MI and 
in subjects younger than 75 years (Table 2). Both decreased and increased HRV 
seemed to be associated with non-cardiac mortality in women only. 
Table 1. Baseline characteristics, values are means (standard deviation) or percentages. P-values are 
indicated for equality of quartile-specific values in quartiles of SDNN, adjusted for age and gender. 
Characteristic 
Age (years) 
Women(%) 
Systolic blood pressure (mmHg) 
Diastolic blood pressure (nunHg) 
Body mass index (kg/m') 
Semm Cholesterol (nunolll) 
Cigarette smoking (%) 
Coffee intake (mg/day) 
Alcohol intake (mg/day) 
Hypertension (%) 
Diabetes (%) 
Angina pectoris (%) 
Myocardial infarction (%) 
Cardiovascular drug use (%) 
All 
(n~5272) 
68.7 (8.8) 
60.4 
139.4 (22.3) 
73.6 (11.5) 
26.4 (3.7) 
6.6 (1.2) 
21.4 
482 (238) 
10.3 (15.3) 
29.3 
12.3 
6.7 
12.1 
33.9 
QI 
<9.6 
70.6** 
59.9* 
140.7 
74.2 
26.7* 
6.7 
21.4 
483 
10.7 
31.5 
14.8* 
6.9 
13.3 
34.6 
Q2 
9.6-15.2 
69.1 
64.4 
\39.7 
73.7 
26.4 
6.6 
20.8 
481 
9.9 
30.1 
12.0 
7.0 
11.4 
34.2 
Q3 
15.2-25.9 
67.4 
62.1 
139.5 
73.5 
26.3 
6.6 
20.7 
474 
10.0 
29.4 
11.3 
7.0 
11.3 
34.5 
Negative T-wave (%) 6.8 7.5** 8.4 5.2 
LVH on ECG (%) 4.4 4.0 4.9 4.3 
Mean RR interval (ms) 867 (140) 801 ** 858 898 
Overall QTc (ms) 430.9 (26.2) 438** 432 428 
Presence of PVC (%) 2.8 2.9 2.2 2.6 
Presence ofPSVC (%) 2.7 0.6 0.2 0.2 
L VH=left ventricular hypertrophy; PVC= premature ventricular 
PSVC=premature supraventricular complex.; *: p<0.05; **: p<O.Ol 
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Q4 
>25.9 
68.0* 
54.9** 
137.2 
73.0 
26.1 
6.7 
22.7 
490 
10.9 
26.0 
10.9 
5.7 
12.0 
32.2 
7.4»:* 
4.3 
911* 
426 
3.9* 
10.3* 
complex; 
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Table 2. Age-adjusted hazards ratios for cardiac, non-cardiac, and all-cause mortality of subjects in 
quartiles of heart rate variability (SDNN in m5), relative to those in the third quartile. 
Outcome 
Cardiac 
mortality 
Non-cardiac 
mortality 
All-cause 
mortality 
Group 
All 
Men 
Women 
NoM! 
MI 
<=75 
>75 
All 
Men 
\Vomen 
All 
Men 
\Vornen 
Hazard ratio (95% el) 
QI Q2 
<9.6 9.6-15.2 
1.8 (1.0-3.2) 1.7 (1.0-3.1) 
1.3 (0.6-2.8) 1.6 (0.7-3.4) 
2.5 (1.1-5.8) 2.0 (0.8-4.8) 
1.6 (0.8-3.0) 
2.4 (0.8-7.2) 
2.0 (0.8-5.4) 
1.6 (0.8-3.2) 
1.3 (0.9-1.8) 
1.1 (0.7-1.7) 
1.5 (0.9-2.5) 
1.4 (1.0-1.8) 
1.1 (0.8-1.7) 
1.7 (1.1-2.6) 
1.3 (0.6-2.5) 
3.2 (1.0-9.6) 
2.8 (1.1-7.2) 
1.2 (0.6-2.5) 
1.2 (0.9-1.7) 
0.8 (0.5-1.3) 
1.7 (1.1-2.8) 
1.3 (1.0-1.8) 
1.0 (0.7-1.5) 
1.8 (1.2-2.7) 
Q I, Q2 , Q3, Q4 = first to fourth quartile 
*: reference category 
Q3* Q4 
15.2-25.9 >25.9 
2.3 (1.3-4.0) 
1 2.0 (1.0-4.2) 
1 2.7 (1.1-6.4) 
2.0 (1.0-3.9) 
3.2 (1.1-9.8) 
3.8 (1.6-9.5) 
1.6 (0.8-3.2) 
1.1 (0.8-1.6) 
0.9 (0.5-1.4) 
1.6 (1.0-2.7) 
1.4 (1.0-1.9) 
1.1 (0.7-1.6) 
1.9 (1.2-2.9) 
As premature ventricular or supraventricular complexes occurred more frequently in 
those with increased SDNN, a separate analysis was performed, excluding subjects 
with premature complexes on their ECG. However, this did not change the results 
(data not shown). 
Additional adjustment for body mass index, diabetes mellitus, overall QTc interval, 
mean RR interval, and presence of negative T-waves, did not substantially change 
the hazards ratios for all cndpoints. 
Discussion 
Results of this study show that both decreased and increased HRV, measured in the 
standard lO-second ECG, are associated with cardiac mortality in the elderly. These 
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risks were more pronounced in women, those younger than 75, and subjects with a 
history of Ml. In addition, the results indicate that both decreased and increased 
HRV are associated with death from non-cardiac causes in women, but not in men. 
Sex differences in the risk associated with dccreased and increased HRV for 
mortality in the elderly may partly be explained by selective survival. Men with 
heart disease die at an earlier age than women, and men who live until older age 
may be healthier than women of the same age. Moreover, the risks associated with 
decreased and increased HRV were more pronounced in those under age 75, sug-
gesting that those who survive until older ages are less susceptible to disturbances of 
HRV, possibly due to other unknown characteristics. The risk of both decreased and 
increased HRV for cardiac mortality was more clear in subjects with a history of 
Ml. This suggests that ischemic heart disease is involved in the mechanism control-
ling HRV. However, HRV was also associated with cardiac death in subjects with-
out a history of MI, which may indicate that HRV is also a marker for subclinical 
disease. 
Prior studies assessing the risk associated with HRV in the general population, 
consistently show an association of decreased HRV with cardiac and all-cause mor-
tality in middle-aged populationsl7, 18.'0. An association of increased HRV with 
mortality has never been reported in middle-agcd subjects. Tn elderly populations 
however, contradictory results have been reported on the risk associated with both 
decreased and increased HRV. In the Framingham Heart Studyl6, a linear associa-
tion between decreased SDNN and all-cause mortality was present in men and wo-
men aged 63 years or older, suggesting the absence of an association of increased 
HRV with mortality. In the Zutphen Studyl7, the risk associated with reduced HRV 
was less pronounced in men aged 65 years or older than in middle-aged men, and an 
association of increased HRV with aU-cause mortality was present only in elderly 
men. Finally, in the Bronx Aging Study'l, in men and women aged 75 to 85 years 
no association was present between decreased HRV and cardiac and all-cause 
mortality, but an association of increased HRV with cardiac events was present in 
women. 
The absence of an association of increased HRV with mortality in some of these 
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studies may partly be explained by exclusion criteria and procedUl'es to measure 
HRV. On visual inspection, one can clearly see that increased HRV is accompanied 
by irregular sinus arrhythmias. However, using the conventional editing IUles and 
meaSUl'es for HRV, this irregular HRV cannot be distinguished from normal sinus 
anhythmia. When these irregular sinus beats are considered abnormal, estimated 
risks associated with increased HRV might be reduced. However, proper definitions 
for abnormal sinus beats are lacking. Also age-differences between study popula-
tions are likely to account for part of the discrepancies. 
Presumably, increased HRV, unlike decreased HRV, is hardly influenced by the 
autonomic nervous system but may rather be due to sinus node dysfullction32, 33. 
With increasing age, pathological changes occur in the sinoatrial node, including an 
increase in collagen and elastic fibers34• Pathological studies pClformed in patients 
with sick sinus syndrome showed that an increased amount of fibrous tissue was 
present in the sinus node, apart from defects due to coronary arteriosclerosis35• It 
has been shown that intrinsic sinus node function, which is measured after 
autonomic blockade, deteriorates with age, resulting in prolonged RR intervals and 
increased, irregular HRV36• 37. In the present study, those with increased HRV had 
on average longer RR intervals. The finding that the risk associated with increased 
HRV was more pronounced for cardiac mortality than for non-cardiac and all-cause 
mortality, indicates that increased HRV is influenced by ischemic heart disease. 
Decreased HRV is probably largely due to changes in autonomic balance38• 39. 
Autonomic dysfunction, i.e. sympathetic overactivity and a decrease in vagal 
activity, results in increased heart rates and, consequently, decreased HRV. Changes 
in autonomic balance result from coronary heart disease, but can also be due to 
other disease processes" 3. 3042, as is suggested by the increased risk of decreased 
HRV with non-cardiac mortality observed in our study. 
In conclusion, HRV measUl'ed in the standard lO-second ECG can be used to 
identify older men and women with an increased risk for cardiac mortality. In 
elderly men and women increased HRV is an even stronger indicator for cardiac 
mortality than decreased HRV. 
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CHAPTER 3.5 
THE CARDIOVASCULAR RISK PROFILE IN THE ELDERLY: 
ADDITIONAL VALUE OF THE RESTING ELECTROCARDIOGRAM 
Abstract 
Coronary heart disease is a common disease that frequently occurs without warning 
symptoms and may even present itself with sudden death as the first symptom. The 
electrocardiogram (ECG) is an inexpensive and noninvasive instrument to determine 
the presence of coronary heart disease as well as other abnormalities, known to be 
associated with future cardiovascular events. We examined the predictive value of 
conventional and new ECG abnormalities for future coronary heart disease in older 
men and women participating in the Rotterdam Study. In particular, we assessed 
whether ECG abnormalities arc of additional prognostic value compared to the 
conventional cardiovascular risk indicators that are commonly available in general 
practice. ECG abnormalities were assessed by the Modular ECG Analysis System 
(MEANS). After exclusion of those without a digitally stored ECG the population 
consisted of 2352 men and 3429 women. To develop a risk function for cardiac 
mortality, based on ECG abnormalities and established cardiovascular risk 
indicators, we used logistic regression analysis. First, for each ECG abnormality a 
bivariate analysis was performed, taking age differences into account. Second, a 
multivariate model was applied, simultaneously including the established cardiovas-
cular risk indicators and all ECG abnormalities that showed an association in the 
bivariate analysis. In addition, we estimated a "standard risk function" for cardiac 
mortality, based on only established cardiovascular risk indicators. The "ECG risk 
function", including both ECG abnormalities and conventional cardiovascular risk 
indicators. compared to the "standard risk function". improved predictive power for 
cardiac death. This finding was more pronounced in women than in men. In 
conclusion, both classical and new ECG abnormalities have independent predictive 
value for future coronary heart disease in older men and women. Using the ECG in 
addition to the standard cardiovascular risk profile may improve the identification of 
men and women at risk for cardiac mortality. 
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Introduction 
Coronary heart disease is a common disease that frequently occurs without warning 
symptoms'''; and may even present itself with sudden death as the first symptom7.9• 
Since in most developed countries the proportion of elderly people in the population 
is expected to increase in the next decades, prevention of coronmy events in older 
men and women is of growing importance. However, most studies on coronary heart 
disease involved middle-aged populations and therefore the applicability of their re-
sults to the elderly may be limited. Early identification of persons at risk for coro-
nmy heart disease is an important first step in designing appropriate preventive 
measures. In many countries, including the UK and the Netherlands, identification 
of subjects prone to develop cardiovasculm· disease is primarily the task of the 
general practitioner. 
Current risk profiling in general practice is primarily based on assessment of 
hypertension, diabetes, hypercholesteremia, obesity, and cigm·ette smokinglO • The 
electrocardiogram (EeG) is an inexpensive and noninvasive instrument to determine 
the presence of coronary heart disease as well as other abnormalities, such as pro-
longed QTc interval or atrial fibrillation, known to be associated with future cm·dio-
vascular events. Since computer programs for ECG interpretation with good petfor-
mance have become availablell , 12, the use of EeGs in primary care becomes morc 
feasible. Especially in the elderly, in whom medical histories may be troubled by 
concomitant diseases, the ECG could serve as a useful diagnostic and prognostic 
instrument. 
Recently, new ECG characteristics, including increased QTc dispersion, abnormal T 
axis, and decreased or increased heart rate variability (HRV), have been identified 
as important risk indicators for fatal and nonfatal cardiac events (unpublished data, 
1997). The predictive value of the new ECG characteristics, in addition to conven-
tional ECG abnormalities is largely unknown. 
The value of the ECG in risk profiling in the elderly should be viewed from a 
clinical perspective. Even if ECG abnormalities are strong predictors for future co-
ronary heart disease, it is only valuable to clinical practice if it adds important 
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prognostic information to conventional cardiovascular risk profiling, in terms of im-
proving the detection of subjects at increased, absolute risk for future heart disease. 
The added value of the ECG to cardiovascular risk profiling in the elderly has not 
been determined fully. 
We examined the predictive value of conventional and new ECG abnormalities for 
future coronary heart disease in older men and women. In particular, we assessed 
whether ECG abnormalities are of additional prognostic value compared to the con-
ventional cardiovascular risk indicators that arc commonly available in general 
practice. 
Methods 
Study popularion alld baseline data collection 
This study is part of the Rotterdam Study, a population-based cohort study aimed at 
assessing the occurrence and risk factors for chronic diseases in the elderly. Objec-
tives and methods of the Rotterdam Study are described in detail elsewhere13 • 
Briefly, in the Rotterdam Study all men and women aged 55 years or older, living in 
the Rotterdam district of Ommoord, were invited to participate (response rate 78%). 
Of 7,129 participants, the baseline data, collected from 1990 to 1993, included an 
ECG, information on history of cardiovascular disease, establishcd cardiovascular 
risk factors, and use of medications. 
A digitally stored ECG was available in 6,160 (86%) participants. An ECG was 
missing in 14% of the participants, mainly due to tempormy technical problems of 
the ECG recorder. Blood pressure was calculated as the average of two consecutive 
measurements with a random zero mercury manometer. Body mass index was 
calculated as weight/length' in kg/m'. Hypertension was defined as systolic blood 
prcssure above 160 mmHg or diastolic blood pressure above 95 mmHg or use of 
antihypertensive medication for the indication hypertension. Diabetes mellitus was 
defined as a non-fasting blood glucose above Il.l nnnoVI or use of antidiabetic 
medication. Histmy of symptomatic coronmy heart disease (CHD) was defined as a 
self-reported myocardial infarction or the presence of angina pectoris established 
through the Rose questionnaire!4. 
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After exclusion of 345 subjects without follow-up data, mainly because they moved 
to unknown addresses, and 34 subjects with ECGs that could not be processed by 
the computer program, the study population consisted of 2,352 men and 3,429 
women. 
Follow-up procedures 
The follow-up period, starting at the baseline examination and in the present 
analysis lasting until April 1996, was 3 to 6 (mean 4) years. With respect to the vital 
status of participants, information was obtained at regular intervals from the 
municipal health service in Rotterdam. Information on fatal and non-fatal endpoints 
was obtained from the general practitioners (GPs) working in the study district of 
Ommoord. These GPs, covering around 85% of the cohort, all have their practice 
computerized and report possible fatal and non-fatal events of participants on 
computer file to the Rotterdam Study data center on a regular basis. All possible 
events reported by the GP were verified by research physicians from the Rotterdam 
Study through patient records of the participating GPs and medical specialists. In 
April 1996, the medical records of participants with GPs from outside the Ommoord 
area, around 15% of the cohort, were checked by research physicians and of all 
possible events additional information for coding was collccted. 
Shortly after reporting of death by the municipal health service or the GP, cause and 
circumstances of death were established by questionnaire from the GP and by 
scrutinizing information from hospital discharge records in case of admittance or 
referral. 
Overall, complete follow-up information was available for 94% of the population of 
the Rotterdam study. Differences in baseline characteristics between those with and 
without follow-up data were examined using one-way analysis of covariance, 
adjusting for age and gender when appropriate. Participants in whom no follow-up 
information was available were on average 3.5 years older (73.9 years) than those 
included in the study and had a lower prevalence of hypertension (25% versus 30%) 
and diabetes (10% versus 14%). No other differences in baseline characteristics 
were found. 
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Classification of fatal and non-fatal events was based on the International 
Classification of Diseases, 10th version (ICD-lO)IS. We defined cardiac mortality as 
death from myocardial infarction (ICD-lO: 121-24), chronic ischemic heart disease 
(ICD-lO: 125), pulmonary embolism or other pulmonary heart disease (ICD-lO: 126-
28), cardiomyopathy (ICD-lO: 142-43), cardiac arrest (ICD-lO: 146), arrhythmias 
(ICD-lO: 147-49), heart failure (ICD-lO: 150), or sudden cardiac death. Sudden 
cardiac death was defined as death occurring instantaneously or within one hour 
after onset of symptoms or in case of unwitnessed death, in which a cardiac cause 
could not be excludedl6• 17. 
All events were classified independently by two research physicians. If there was 
disagreement, a consensus was reached in a separate session. Finally, all events 
were verified by a medical expert in the field of cardiovascular disease. In case of 
discrepancies, the judgment reached by this expert was considered definite. 
ECG intelpretalioll and measurements 
A 12-lead resting ECG was recorded with an ACTA cardiograph (ESAOTE, 
Florence) with a sampling frequency of 500 Hz, and stored' digitally. All ECGs were 
processed by the Modular ECG Analysis System (MEANS). MEANS computes a 
representative averaged beat for each of the 12 leads, from which ECG 
measurements and diagnostic interpretations are derived 18. The program is also able 
to perform a classification according to the Milmesota Code l '. The' MEANS 
program has been evaluated extensively!!' 18,20-22. 
T axes were calculated from vectorcardiographic X, Y, Z leads which can, in good 
approximation, be reconstructed from the standard ECG leads23• 24. The mean spatial 
axis is obtained by vcctorially adding instantaneous heart vectors during the T wave. 
The mean frontal axis is then taken to be the angle between the X axis and the 
projection of the mean spatial axis on the XY plane. 
An overall QT interval was determined from the conmlOn QRS onset and T offset 
for all 12 leads together. To adjust for heart rate, Bazetl's formula (QTc = QTI..JRR) 
was used". Taking the location of the overall end of T as a starting point, the 
program determines the end of the T wave in each separate lead. QT dispersion is 
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Table 1. Definition ofECG abnormalities 
ECGfmding 
SILENTMI 
LVH 
IVB 
AVB 
STD 
NEGT 
QTC 
QTCD 
TAX 
HRV 
AFIB 
PVC 
Definition 
Based on presence of pathological Q-waves or loss of R-wave 
potential in the precordial leads, in the absence of symptoms 
Based on combination of voltage and ST-T wave criteria 
Intra-ventricular block: prolonged QRS duration (incomplete or 
complete left or right bundle branch block, or intraventricular con-
duction defect) 
Atrioventricular block (1st, 2nd, or 3rd degree); PR interval >0.20 ms 
ST-T depression: Minnesota Code 4.1 or 4.2 
T wave inversion: Minnesota Code 5.1 or 5.2 
Prolonged QTc 
- Borderline 420 to 460 illS 
- Abnommi >460 ms 
Increased QTc dispersion 
- Borderline 47-66 rus 
- Abnormal >66ms 
Deviation of the frontal Taxis 
- Borderline: _150 < Taxis < ISO or 7S°<Taxis <10So 
- Abnormal: -180° < Taxis < _ISo or 10So < Taxis < 180° 
Decreased HRV 
- Abnormal SDNN <9.6 ms 
- Borderline SDNN 9.6 - IS.2 ms 
Increased HRV: SDNN > 25.9 ms 
Atrial fibri11ation or atrial flutter 
Premature ventricular complexes 
computed as the difference between the maximum and the minimum QT intervals in 
the six precordial leads, the shortest extremity lead and the median of the five other 
extremity leads. 
Definitions of ECG abnormalities used in the present study are shown in Table I. 
Data analysis 
All analyses were performed for men and women separately. To determine the risk 
for cardiac mortality associated with ECG abnormalities we computed age-adjusted 
incidence rates of ali endpoints in those with and without a certain ECG finding, 
using one-way analysis of covariance. 
To develop a risk function for cardiac mortality, based on ECG abnormalities and 
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established cardiovascular risk indicators, we used logistic regression analysis. First, 
for each ECG abnormality a bivariate analysis was performed, taking age diffe-
rences into account. Only ECG abnormalities that showed a clear association with 
cardiac mortality in this bivariate analysis (with p<0.05), were included in the next 
step. Second, a multivariate model was applied, simultaneously including all ECG 
abnormalities that showed an association in the bivariate analysis and the esta-
blished cardiovascular risk indicators (notably body mass index, semm cholesterol, 
hypertension, diabetes mellitus and cigarette smoking, a histOlY of symptomatic MI 
and presence of angina pectoris). The final ''BCG risk function" was determined by 
including all ECG abnormalities which showed an association with cardiac morta-
lity in this multivariate analysis (with p<0.20) and the established cardiovascular 
risk indicators in one logistic model. In addition, we estimated a "standard risk func-
tion" for cardiac mortality, using a multivariate logistic regression model in which 
only the established cardiovascular risk indicators described above were included, 
together with age. 
Using the "ECG risk function" and the "standard risk function", the probability of 
cardiac death was determined for every individual men and women in the study. 
This probability was categorized into deciles of risk.To assess the value of a risk 
function two parameters were calculated. First, for each decile the incidence of 
cardiae death per 1,000 person-years was calculated. In addition, we calculated 
sensitivity for cardiac death of every decile as the proportion of all cases detected 
per decile. To examine whether the "ECG risk function" improves identification of 
those susceptible for cardiac mortality by the "standard risk function", we compared 
the incidence rate and the scnsitivity of cardiac deaths in deciles of risk, estimated 
by both risk functions in the complete popUlation. In addition, we compared 
incidence rates and scnsitivity of cardiac death of the highest deciles of risk in sub-
groups of participants, notably in subjects younger and older than 75 years and in 
those with and without a history of symptomatic cardiovascular disease. For scree-
ning purposes the highest decile of risk will be of most interest. 
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Results 
Table 2. General characteristics of men and women participating in the 
Rotterdam Study. Values are means (standard deviations) or proportions. 
Characteristic Meo \Vomen 
0=2,352 0=3,429 
Age (years) 68.2 (8.1) 69.9 (9.5) 
Systolic blood pressure (mmHg) 138.8 (21.9) 139.8 (22.8) 
Diastolic blood pressure (rrunHg) 74.4 (11.7) 72.9 (11.5) 
Body mass index (kg/m') 25.8 (2.9) 26.8 (4.0) 
Total serum cholesterol (mmalll) 6.3 (1.1) 6.8 (1.2) 
Current cigarette smoking (%) 25.1 18.2 
Hypertension (%) 25.7 32.2 
Diabetes mellitus (%) 12.4 12.8 
History of symptomatic MI (%) 12.7 4.3 
Angina pectoris (%) 6.4 7.0 
General characteristics of men and women parlicipating in the Rotterdam Study are 
presented in Table 2. Women were on average slightly older, had a higher body 
mass index and senun cholesterol, a higher prevalence of hypertension and smoked 
less. A history of symptomatie myocardial infarction was much more frequent in 
men than in women. 
Most ECG abnormalities were more frequent in men than in women (Table 3). 
Repolarlzation abnormalities, including ST -T depression, T -wave inversion, and 
abnormal T axis, had a similar prevalence (about 10 percent) in men and women. 
Prolonged QTc interval, defined as QTe>460 ms, was more frequent in women 
(10.6% versus 5.8%). 
The age-adjusted incidence of all coronary heart disease endpoints was higher in 
men than in women (Table 3). In both men and women, the highest age-adjusted 
incidence of cardiac death was found in subjects with an abnormal Taxis (28.7 and 
27.2 per 1,000 person-years, respectively). In men, a strong association of silent 
myocardial infarction with future coronary heart disease was found. This associa-
tion was absent in women. Apart from silent myocardial infarction, most ECG ab-
normalities showed a stronger association with cardiac death in women than in men. 
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Table 3. Prevalence of EeG abnormalities and age-adjusted incidence rate (per 1,000 person years) 
of cardiac mortality in those with and without specific ECG abnormalities, in 2,352 men and 3,429 
women aged 55 years or older, participating in the Rotterdam Study. 
Men \Vamen 
ECG fInding Prevalence Incidence rate of Prevalence Incidence rate of 
(%) cardiac death (%) cardiac death 
SILENTMI No 92.7 8.1 94.6 6.2 
Yes 7.4 26.2 5.4 8.1 
LVH No 94.3 8.6 95.6 5.7 
Yes 5.7 24.8 4.4 19.8 
IVB No 90.2 8.4 94.7 5.7 
Yes 9.8 18.7 5.3 15.3 
AVB No 93.7 8.9 93.6 5.7 
Yes 6.3 15.1 6.4 17.1 
STO No 90.2 8.4 89.6 5.5 
Yes 9.8 19.0 10.4 13.3 
NEGT No 91.4 8.1 92.2 5.2 
Yes 8.6 24.9 7.8 21.7 
AFIB No 96.6 9.4 97.4 6.0 
Yes 3.4 10.1 2.6 27.2 
PVC No 93.9 9.2 95.9 6.0 
Yes 6.1 11.3 4.1 15.2 
QTC Normal 48.4 7.9 29.6 3.8 
Borderline 45.8 8.2 59.8 4.4 
Abnormal 5.8 13.7 10.6 8.8 
QTCO Nonnal 42.2 5.6 40.4 4.0 
Borderline 27.9 14.6 27.9 5.5 
Abnonnal 29.9 9.6 31.7 9.9 
TAX Normal 78.2 6.5 83.0 4.0 
Borderline 9.9 12.2 7.3 10.7 
Abllomlal 11.8 28.7 9.7 27.2 
HRV Decreased 24.4 6.9 24.9 7.7 
Borderline 22.7 10.0 27.1 5.0 
Normal 24.6 6.4 25.4 2.0 
Increased 28.3 13.0 22.7 6.9 
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Table 4. Coefficients and their standard errors for calculating the absolute four year risk of 
cardiac mortality in men and women. 
Men 
Variable Coef 
Age (years) 0.065 
Body mass index (kglm2) -0.110 
Serum cholesterol (mmollI) -0.031 
Cigarette smoking# -0.288 
Hypertension # 0.572 
Diabetes # 0.704 
Symptomatic MI # 0.987 
Angina pectoris # 0.826 
SILENTMI # 1.440 
LVH# 0.617 
IVB# 0.535 
AVB# 
NEGT# 
QTCD borderline# 0.944 
QTCD abnormal # 0.180 
TAX borderline # 0.335 
TAX abnnormal # 0.699 
HRV decreased # 0.054 
HRV borderline # 0.378 
HR V increased # 0.588 
Intercept -4.237 
*: p<0.05, **: p<O.OI, ***: p<O.OOI 
# Yes::::; I, 00::::;0; for definitions see Table 1. 
Stand. Err. 
0.016*** 
0.043* 
0.111 
0.300 
0.266* 
0.297* 
0.322** 
0.349* 
0.333* 
0.407 
0.312 
0.312** 
0.330 
0.386 
0.325* 
0.430 
0.43 
0.401 
2.376 
\Vomen 
Coef 
0.091 
0.016 
0.120 
0.921 
0.189 
0.561 
0.929 
0.480 
0.711 
0.224 
0.399 
0.940 
0.596 
0.922 
0.782 
0.598 
0.926 
-14.554 
Stand. Err. 
0.015*** 
0.029 
0.095 
0.331** 
0.250 
0.297 
0.349** 
0.373 
0.320* 
0.328 
0.345 
0.309** 
0.379 
0.327** 
0.461 
0.473 
0.473* 
2.102*** 
To obtain the probability that cardiac mortality will occur in 4 years in an individual 
person, multiply the coefficient (PI to J3p) for each variable (zl to zp) by the measured 
value of that variable in a subject, surum these products and add the intercept (a). This 
provides the coefficient C (C:::a+pl*zl+ .... +pp*zp) to calculate the probability of cardiac 
death P=1I1+cxp (-C). 
The components of the "ECG risk function" differed between men and women 
(Table 4). Silent myocardial infarction, left ventricular hypertrophy, and intraven-
tricular block were included only in men, and atrioventricular block and T wave in-
version were included only in women. In both men and women Taxis, QTc disper-
sion, and heart rate variability were important predictors. 
The absolute risk of cardiac mortality was markedly increascd in the upper decile of 
risk of the "ECG risk function" and rates were about 50 pcrcent higher in mcn as 
compared to women (Table 5). The incidence rates reflect the positive predictive 
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value of every decile of risk. For example, of 1,000 men detected in the highest 
decile, on average 66 will die from coronmy heart disease in a period of one yem', 
while 934 will survive. The sensitivity of the upper decile of risk for cardiac death, 
i.e. the percentage of all future cases included in that decile relative to all cases that 
occurred during on average 4 years, was 57.5% in men and 62.2% in women. 
Sensitivity estimates of the upper decile of risk assessed by the "ECG risk function" 
were higher than those assessed by the "standard risk function" in both men and 
women. Analogously, incidence rates for cm'diac death in the upper decile of risk 
were higher using the "ECG risk function", especially in women. 
In men with and without symptomatic CHD, both absolute risk of cardiac death and 
sensitivity of the upper decile of risk increased by using the "ECG risk function" 
instead of the "standard risk function" (Table 6). This increase was most pronoun-
ced for the sensitivity in men without symptomatic CHD (from 23.5% to 41.2%). In 
men younger than 75 years, thc absolute risk for cardiac death and the sensitivity in 
the upper decile of risk were lower than in men older than 75 years. The differences 
between the "ECG risk function" and the "standard risk function" were similar in 
both groups. 
Although absolute risks were smaller, prediction of cardiac death by using the 
"ECG risk function" instead of the standard risk function improved more in women 
than in men. Incidence rates in women with and without symptomatic CHD in the 
highest decile of risk increased with about 10 per 1,000 persons per year. Also 
sensitivity improved considerably (from 39.7% to 55.2% in those without, and from 
66.7% to 79.2% in those with symptomatic CHD). Sensitivity for cardiac death in 
the upper decile of both risk functions was much better in women over age 75 than 
in those younger than 75. However, incidence rates of cardiac death in the upper 
deciles of risk were similar in both groups. Also the difference between both risk 
functions was not modified by age. 
Discussion 
In our population-based study among men and women aged 55 years or older, the 
"ECG risk function", including both ECG abnormalities and conventional cardio-
vascular risk indicators, compared to the "standard risk function", improved predic 
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Table 5. Incidence rate (per 1,000 persons-years) and the sensitivity of cardiac mortality according 
to decile of a risk estimated by the "standard risk function" and the "ECG risk function" in men and 
women. 
Decile Incidence rate (95% CI) Sensitivity (95%CI) 
Standard ECG Standard ECG 
MEN 
I 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-4.5) 0.0 (0.0-4.5) 
2 2.3 (0.0-5.5) 2.3 (0.0-5.5) 2.5 (0.3-8.7) 2.5 (0.3-8.7) 
3 4.6(0.1-9.1) 1.1 (0.0-3.3) 5.0 (1.4-12.3) 1.3 (0.0-6.8) 
4 3.3 (0.0-7.1) 2.30.0-5.6) 3.8 (0.8- 10.6) 2.5 (0.3-8.7) 
5 8.9 (2.7-5.1) 4.4 (0.1-8.7) 10.0 (4.4-18.7) 5.0(1.4-12.3) 
6 2.2 (0.0-5.2) 3.5 (0.0-7.5) 2.5 (0.3-8.7) 3.8 (0.8- 10.6) 
7 7.0 (1.4-12.6) 7.1 (1.4-12.7) 7.5 (2.8-15.6) 7.5-2.8-15.6) 
8 9. I (2.8-15.4) 7.1 (1.4-12.9) 10.0 (4.4 (18.7) 7.5-2.8- 15.6) 
9 14.1 (5.8-22.5) 12.2 (4.6-19.8) 13.8 (7.1-23.3) 10.0 (4.4-18.7) 
10 61.1 (41.1-81.1) 65.9 (46.8-85.0) 45.0 (33.8-56.5) 57.5 (45.9-68.5) 
WOMEN 
0.8 (0.7-2.2) 0.0 (0.0-0.0) 1.2 (0.0-6.6) 0.0 (0.0-4.4) 
2 0.0 (0.0-0.0) 0.7 (0.0-2.2) 0.0 (0.0-4.4) 1.2 (0.0-6.6) 
3 0.7 (0.0-2.2) 0.7 (0.0-2.2) 1.2 (0.0-6.6) 1.2 (0.0-6.6) 
4 1.4 (0.0-3.3) 0.7 (0.0-2.2) 2.4 (0.3-8.5) 1.2 (0.0-6.6) 
5 1.5 (0.0-3.5) 0.7 (0.0-2.2) 2.4 (0.3-8.5) 1.2 (0.0-6.6) 
6 4.2 (0.9-7.6) 3.0 (0.0-5.9) 7.3 (2.7-15.2) 4.9 (1.3-12.0) 
7 3.6 (0.4-6.7) 3.6 (0.4-6.8) 6.1 (2.0-13.7) 6.1 (2.0-13.7) 
8 4.5 (0.9-8.2) 2.2 (0.0-4.8) 7.3 (2.7-15.2) 3.7 (0.8-10.3) 
9 16.9 (9.5-24.3) 12.0 (5.9-18. I) 24.4 (15.6-35.1) 18.3 (10.6-28.4) 
10 35.3 (24.1-46.3) 48.7 (35.3-62.1) 47.6 (36.4-58.9) 62.2 (50.8-72.7) 
CI- confidence interval 
Table 6. Incidence rate per 1,000 person-years and sensitivity for cardiac mortality in the upper 
decile of risk, using the "standard risk function" and the "EeG risk function" in subgroups of age 
and symptomatic coronary heart disease. 
Incidence rate (95%CI) Sensitivity (95%CI) 
Standard ECG Standard ECG 
MEN 
NoCHD 60.4 (26.1-94.5) 63.6 (36.3-90.9) 23.5 (12.8-37.5) 41.2 (27.6-55.8) 
CHD 62.5 (37.4-87.5) 68.1 (41.3-94.8) 82.8 (64.3-94.2) 86.2 (68.4-96.1) 
<= 75 years 57. I (21.6-92.6) 59.2 (31.0-87.4) 25.6 (13.0-42. I) 44.7 (28.6-61.7) 
> 75 years 64.7 (39.7-89.5) 71.1(45. 1-96.9) 63.4 (46.9-77.9) 70.7 (54.5-83.9) 
WOMEN 
NoCHD 34.2 (20.2-48.2) 43.7 (28.5-58.8) 39.7 (27.0-53.4) 55.2 (41.5-68.3) 
CHD 47.5 (24.1-70.8) 58.8 (32.2-85.2) 66.7 (44.7-84.4) 79.2 (57.8-92.9) 
<= 75 years 38.5 (0.0-91.8) 63.5 (12.5-114.3) 9.5 (1.2-30.4) 28.6 (11.3-52.1) 
> 75 ~ears 38.2 (25.8-50.5) 46.9 (33.1-60.6) 60.7 (47.3-72.9) 73.8 (60.9-84.2) 
CI= confidence interval 
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tive power for cardiac death. This finding was more pronounced in women than in 
men. In the upper decile of risk according to the ECG risk function, incidence rates 
of cardiac mortality were almost as high in those without symptomatic CHD as in 
those with symptomatic CHD. Our findings lend support to the view that the ECG 
may aid the physician in cardiovascular risk profiling of individual patients. 
We chose to define only one "ECG risk function", using the "hardest" endpoint, 
cardiac mortality for men and women separately. This improves practical applica-
bility of the risk function. When we examined specific "ECG risk functions" of 
other endpoints, such as sudden cardiac death, non-fatal coronmy heart disease 
events, and total fatal and non-fatal cardiac events, the results were similar as 
compared to the "ECG risk function" for cardiac mortality. 
Comparison with previous studies is limited by our use of new ECG abnormalities, 
such as QTc dispersion, T axis deviation, and increased HRV. These new ECG 
abnormalities were strong predictors of cardiac mortality in men and women. 
Classical repolarization disturbances, notably ST -T depression and negative T-
waves, showed a strong age-adjusted association with cardiac mortality, but lost 
their association when they were entered in a multivariate model together with the 
new ECG abnormalities. In previous studies, ST -T changes, either isolated or in 
combination with other ischemic or hypertrophic changes, have been associated 
. I I d' 26·31 H I I . I I" d' b WIt 1 coronary leart lscase . owever, t Ie c aSSIca repo anzatlon lstur ances 
were highly condated with T -axis abnormalities, which probably attenuated their 
predictive value. 
OUf data showed that silent myocardial infarction was an even stronger predictor for 
cardiac death in men than symptomatic myocardial infarction, but to our surprise we 
could show no association of silent myocardial infarction with cardiac death in 
women. A possible explanation is that the ECG criteria for myocardial infarction 
used by our computer program are less accurate for women than for men. In the 
Rotterdam Study I silent myocardial infarction is relatively Inore common in women 
than in men6 • The relatively high prevalence and the absence of an association with 
cardiac death in women suggest that a large proportion of silent myocardial infarc-
tion in women may be false positive diagnoses. Published reports from the 
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Framingham Study also suggest that the risk associated with silent myocardial 
infarction is more pronounced in men than in women3, 32. 
In a separate analysis we studied the predictive value of the ECG without taking the 
conventional cardiovascular risk indicators into account (data not shown). The 
predictive value of the ECG abnormalities alone was similar to that of the "standard 
risk function". Although in clinical practice the ECG would never be used without 
knowledge on the conventional cardiovascular risk indicators, the ECG might be 
used as a first step in the identifying patients prone to develop cardiovascular 
disease. 
In primary care, early identification of elderly subjects at risk for cardiac mortality 
may be improved by the use of ECGs in addition to established cardiovascular risk 
indicators. The availability of computer programs with good performance, such as 
the MEANS program, has a positive effect on the cost-effectiveness of ECGs in 
general practice. It is not unlikely that conservative strategies, such as reducing 
weight, blood pressure or serum cholesterol, will have a positive effect on the risk 
associated with the ECG risk profile. As the ECG also improved identification of 
women with symptomatic heart disease who are at risk for cardiac death, the ECG 
may also be useful in a hospital setting. 
Ideally, a risk function should be assessed in a "learning population" and be 
validated in a "test population". However, at present we do not have enough follow-
up data to split our study population in subgroups. Whether the associations we 
found hold in other populations of older men and women has to be assessed in 
future studies. 
In conclusion, both classical and new ECG abnormalities have independent 
predictive value for future coronary heart disease in older men and women. Using 
the ECG in addition to the standard cardiovascular risk profile may improve the 
identification of men and women at risk for cardiac mortality. 
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GENERAL DISCUSSION 
The research described in this thesis was initiated with the aim to determine the 
prognostic value of electrocardiographic characteristics for future cardiovascular 
disease in the elderly. More specifically, the objective was to study the electro-
cardiogram (ECG) in non hospitalized elderly subjects as part of the cardiovascular 
risk profile, and use electrocardiographic information over and beyond the tradi-
tional clinical ECG diagnoses, such as Q-wave infarction, left ventricular hyper-
trophy, and arrhythmias. The study of the prognostic value of the ECG encompasses 
two related questions with a different clinical perspective. First, which ECG charac-
teristics reflect myocardial damage or disease, and how should they be assessed? 
This is a diagnostic question. Second: what is the prognostic value of certain ECG 
abnormalities? For both diagnostic and prognostic implications of the ECG, the 
mechanisms underlying the abnormalities is of limited relevance. Still, to under-
stand the etiology of ECG changes may help to reveal the nature of myocardial 
disease, delineate subgroups of patients that share myocardial disorders, and indi-
cate new ways for prevention and treatment. In the work presented in this thesis, 
emphasis was on descriptive, e.g. diagnostic and prognostic, rather than etiologic 
research. The findings, however, point at mechanisms that may be involved and 
require future study. 
To reduce variability in ECG measurements coding schemes have been developed. 
Moreover, computerized ECG analysis has become available and this approach has 
been extensively used in the current studies. This markedly improves the utility and 
generalizability of more subtle or complicated ECG changes in diagnosis and prog-
nosis outside the realm of clinical cardiology. In the following, the information the 
standard 12-lead ECG provides on diagnosis, prognosis and etiology in non hospi-
talized older adults will be discussed. In addition, practical implications are indi-
catcd and suggestions are made for future research. 
147 
Chap/e/' 4 
Diagnosis 
Since the invention of electrocardiography in 1902 by Willem Einthoven, the 
electrocardiogram has gained an important position as a diagnostic tool in clinical 
cardiology!. Today, medical students and residents are taught how to interpret an 
ECG to diagnose myocardial infarction, ventricular hypertrophy, conduction dis-
orders and arrhythmias. Although, intuitively, diagnostic ECG interpretation seems 
rather straightforward, in practice it proves to be a complex process, based on pat-
tern recognition and experience. Thus, standardization of ECG diagnoses by well-
defined and unambiguous criteria is important. Standardization became of special 
importance in the fifties, when large population-based studies were started to assess 
the prevalence and prognosis of ECG abnormalities. This led to the introduction in 
1960 of the Minnesota Code as a standardized coding system for the ECG2• How-
ever, the Minnesota Code is a descriptive rather than a diagnostic system for ECG 
characteristics. This is probably the most important reason that it has never become 
a standard for ECG interpretation in clinical settings, even though it proved useful 
in epidemiologic studies. 
Apart from conventional ECG diagnoses, such as myocardial infarction and left 
ventricular hypertrophy, new ECG characteristics, such as prolonged QTc interval, 
are increasingly being recognized to be of prognostic and, thus also, of diagnostic 
importance. Most of the new EeG abnormalities are based on just a few measure-
ments of interval durations or amplitudes. Again, this seems to be rather uncom-
plicated, but, as for diagnostic ECG interpretation, proves to be rather difficult. For 
instance, the end of the T wave is hard to detect. Differences in measurement tech-
niques are an important source of variation of absolute values of EeG measure-
ments and consequently of prevalence estimates of ECG abnormalities (chapter 
3.4). Therefore, standardization of measurement teclmiques is of utmost importance, 
with important consequences for ECG diagnoses. 
In the last decade, computer programs for diagnostic ECG interpretation with good 
performance have become available'. In the CSE study, the diagnostic performance 
in patient populations of 15 computer programs for ECG interpretation has been 
evaluated against clinical evidence and experienced cardiologists. In the present 
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study, we evaluated the diagnostic performance of our computer program MEANS 
against three cardiologists, in a sample of the general population (chapter 3.1). The 
program was at least at good as trained research physicians using a standardized 
form for clinical ECG intelpretation. Compared to human observers, the computer 
has many advantages. First, it offers a standardized way to interpret ECGs, circum-
venting inter-and intra-observer variability among different human observers. 
Second, computerized ECG interpretation is cfficient and inexpensive. Moreover, 
digital ECGs can be stored more efficiently than hard copy ECGs. Finally, some 
ECG measurements, such as QRS or T axis, can only indirectly be estimated from 
the 12-lcad ECG and are much better assessed from a computer reconstructed vec-
torcardiogram. However, variation between the individual computer programs for 
ECG interpretation is considerable. Standardization of ECG measurements and 
diagnostic intelpretations in the population at large is urgently needed, especially 
for new ECG abnormalities, such as QT dispersion, heart rate variability, and Taxis 
deviation. Similar to what was done in the CSE study in a clinical setting, a refe-
rence database could be used for this purpose. Enormous amounts of digital ECGs 
and follow-up data are available from population-based studies all over the world. 
These data could be used to construct such a reference database. 
The diagnostic value of ECG abnormalities, regardless of the measurement tech-
nique used, depends on their reproducibility over time. Variation in serial ECG in-
telpretation may result from random physiologic fluctuations, such as respiration 
movements or autonomic balance, and from intra- and inter-observer variability, 
which is obviously larger for more complex measurements and diagnoses. ECG 
diagnoses or codes based on a single threshold level, such as many Minnesota 
Codes, show large variability (chapter 2.2): a few microvolts or milliseconds 
diffcrence may markedly affect the coding. The use of more than two diagnostic 
categories or even continuous values may this problem. In addition, when a 
diagnostic measurement or interpretation has a poor reproducibility, multiple 
measurements will in general improve diagnostic accuracy. 
In evaluation or development of diagnostic EeG criteria, the prognostic value of 
each ECG diagnosis should playa decisive role. In this thesis, this was illustrated' in 
our studies on diagnosis and prognosis of prolonged QTc interval (chapter 2.4 and 
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3.1). Our findings concerning diagnosis of silent myocardial infarction in women 
(chapter 2.3 and 3.5), notably the relatively high prevalence of silent myocardial 
infarction and the absence of a clear association of silent myocardial infarction with 
future heart disease in women, suggests that diagnostic criteria for silent myocardial 
infarction in women can be improved with regard to associated risk for future heart 
disease. In general, ECG criteria in women need to be evaluated and improved. 
Nowadays, the ECG is often used as a diagnostic instrument in clinical practice as 
well as epidemiologic studies. However, conllllonly ECG interpretation still is 
pelformed by physicians only. Regrettably, most physicians are not familiar with 
computerized ECG interpretation. As reliable computer programs are available, their 
use in both medical practice and epidemiologic research should be expanded. 
Although computer interpretation may be used on its own, the quality of ECG inter-
pretation particularly improves by combining the interpretation of more observers. 
A computer program may have difficulties with signal problems, whereas a human 
observer may have difficulties with complex diagnostic rules. Thus, ideally compu-
ter ECG interpretation is complementary to the interpretation by the physician. 
Etiology 
For most conventional EeG abnormalities, such as infarction patterns or ventricular 
hypertrophy, the underlying disease process is clear. However, in many of the re-
cently defined ECG abnormalities, such as QTc dispersion and other parameters of 
myocardial repolarization, the underlying mcchanism remains illusive. While their 
prognostic implications are becoming more clear with new research findings, their 
pathophysiologic relation to ischelnic or other myocardial disease has not yet becn 
disclosed. 
With increasing age, physiological and pathological processes change the clectrical 
properties of thc cardiac muscle'" 5. These processes are mutually dependent and 
therefore hard to disentangle. Changes occurring at a cellular level includc fatty 
degeneration, fibrosis, hypertrophy and hypotrophy of myocardial cells and conduc-
tion tissue'" 6.9. Apart from aging itself, ischemia or hypertrophy of the myocardium 
may accelerate these degcnerative processes. Autonomic changes include increasing 
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sympathetic tone with older age 10, increase in sympathetic response to mental and 
physical stress, and an increased response to negative chronotropic dmgs 11 • How-
ever, autonomic balance is not only associated with aging, but also with many other 
processes, stIch as respiration, diabetic neuropathy, left ventricular dysfunction and 
coronary heart disease. Thus, the mechanism underlying ECG findings associated 
with subclinical disease and autonomic balance, such as decreased and increased 
heart rate variability, prolonged QTc interval, QTc dispersion, ST-T abnormalities 
and T axis deviation, is complex and requires further attention. In epidemiologic 
studies the ECG may be used for etiologic purposes, as was demonstrated in studies 
investigating determinants and outcome of autonomic dysfunctionI2-14 . However, in 
interpreting the results of such etiologic studies, the limitations described above 
should be kept in mind. 
Particular problems arise in etiologic analyses in epidemiologic studies. Since for 
many ECG abnormalities the mechanism is unknown, it is hard to judge whether 
non electrocardiographic risk indicators for cardiac disease, such as blood pressure, 
body mass index and serum cholesterol level, should be treated as confounders in a 
multivariate analysis. Many non-electrocardiographic cardiovascular risk indicators 
are associated with the same mechanisms as electrocardiographic risk indicators. 
For instance, body mass index and blood pressure are associated with autonomic 
balance. Although these variables are con11l1Only treated as possible confounders of 
the association between ECG abnormalities and heart disease, they may in fact be 
intermediates or otherwise be part of the causal pathway, and consequently they 
should be left out· of the multivariate model. In most analyses we performed, the risk 
estimates were not materially influenced by additional adjustment for non-electro-
cardiographic risk indicators. This suggests that these non-electrocardiographic risk 
indicators were neither confounders nor intermediates in the association of ECG 
abnormalities with future heart disease. 
The etiology underlying a disease or diagnosis may form the basis of treatment 
policies, which may improve the prognosis of a disease. In a clinical setting, the use 
of ECG abnormalities with an unknown etiology, has little direct therapeutic 
meaning. 
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To further elucidate the mechanism underlying ECG abnormalities, especially ECG 
parameters of repolarization, experimental studies could be pelformed. In a control-
led setting, different mechanism simultaneously playing a role may be explored. 
This is important to establish a basis for clinical understanding of ECG abnonna-
lities. However, practical diagnostic implications of such controlled electrocardio-
graphic investigations may be limited. The strength of the ECG in clinical practice 
lies in its simplicity. The standard 12-lead ECG is fast and non-invasive. In the cli-
nical situation, electrocardiographic tests under controlled situations, taking much 
more of time, will have to compete with many other diagnostic imaging techniques. 
Prognosis 
Prognosis is concerned with clinical outcome, regardless of the underlying 
mechanism, and is often described by the term "predictive value". In the assessment 
of predictive value of ECG abnormalities for groups of subjects, absolute rather than 
relative risks are of interest. 
In many population-based studies (chapter I), as well as in our own studies (chapter 
3), it has been shown that the ECG can be used to identify men and women at 
increased risk for future heart disease and mortality. However, even if ECG abnor-
malities are strong predictors for future coronary heart disease, a risk indicator is 
only valuable to medical practice if it adds something to other commonly available 
elements of the cardiovascular risk profile, by further improving the detection of 
subjects at increased, absolute risk for future heart disease. Indeed, we found that 
the ECG may improve cardiovascular risk profiling in the elderly, especially in 
women (chapter 3.5). In older men and women, in whom the absolute risk for 
coronary heart disease is relatively high, the ECG may serve as a useful tool for risk 
stratification, to be used in addition to or even as a substitute for other well-known 
cardiovascular risk-indicators 
New ECG risk indicators, in particular T axis _deviation and QTc dispersion, are 
strong predictors of cardiac outcome. The risk for cardiac death associated with 
these new ECG abnormalities was at least as high as or even higher than the risk 
associated with conventional ECG abnormalities, such a myocardial infarction or 
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left bundle branch block. 
In the prediction of cardiac mortality in the elderly, in men other ECG abnormalities 
appeared to be important than in women. ECG abnOlmalities which played a role in 
both men and women, often showed stronger associations in women. These findings 
may partly be explained by selective survival I'. As in men the disease starts at an 
earlier age, many of those susceptible to the disease may have died already and the 
survivors may be less susceptible to the disease or express different disease mani-
festations. 
Should the ECG be used to identify elderly persons at increased risk in medical 
practice or in cardiovascular screening? Even though the predictive value of ECGs 
in the elderly is clear, the answer to this question depends on related "costs" and 
"benefits". There are costs in terms of money and time. The ECG should be used in 
addition to and not instead of other preventive strategies, such as detection and 
treatment of high blood pressure and high scnnll cholesterol. There are also costs in 
terms of consequences for patients. For instance, an old men with a silent MI, who 
never knew he was ill, suddenly becollles a patient with heart disease. Especially at 
older age, changes is lifestyle Illay be experienced as a heavy burden. On the other 
hand, benefits it terllls of a longcr healthy life expectancy, may outweigh the costs. 
Reduction of increased risk may be approached in a specific or general way. When 
the underlying disease is known, for instance a diagnosis of myocardial infarction or 
left ventricular hypertrophy, specific treatment Illay be installed. Recent studies 
have indicated that treatment of left ventricular hypertrophy reduces the incidence 
of coronary heart disease l6 . Subjects with silent myocardial infarction may benefit 
from the same treatment as patients with symptomatic myocardial infarction, 
particularly men. 
If the underlying disease is largely unknown, subjects at high risk for cardiac 
disease will profit most from general cardiovascular preventive measures17 . An 
improvcment of the cardiovascular risk profile, for instance by treatment of hyper-
tension or high cholesterol, will probably improve outcome in those with ECG ab-
normalities, with probably larger absolute yields. 
Further research is needed to develop and evaluate preventive strategies for subjects 
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with ECG abnormalities. This may be assessed in clinical trials as well as in studies 
of determinants and outcome of serial changes in ECG abnormalities. 
Conclusions 
The results of our own studies and and of work by others, have expanded the poten-
tial for the ECG in the diagnosis of cardiac disease, and prognostic evaluation in 
cardiovascular risk assessment. While their mechanisms remain to be determined, 
several "new" ECG abnormalities may be detected using standardized or 
computerized measurement techniques. Further knowledge of the pathophysio-
logical basis of ECG changes, such as T axis deviation and QTc dispersion, may 
help to further understand the nature and sequence of myocardial changes in 
coronary artery disease. Today, there is a range of powelful imaging techniques 
available for diagnosis of cardiovascular disease and the practice of risk profiling is 
constantly being defined. However, the ECG is inexpensive and non invasive, and 
new information remains to be disclosed as shown by our results. With the 
availability of sensitive and reproducible computerized ECG analysis, the prospect 
is offered of serial assessment of ECG abnormalities and direct monitoring of ECG 
changes in patients over time. For these reasons, the ECG will maintain its central 
position in cardiovascular diagnosis and prognosis, and has not lost any of its value 
about 100 years after discovery. Electrocardiography deserves further, preferably 
multidisciplinary, attention to further improve its value. 
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CHAPTERS 
SUMMARY 
In most developed countries, the proportion of elderly people in the population is 
expected to increase further in the next decades. Cardiovascular disease is a leading 
cause of death and disability in the elderly and the incidence rates of cardiac 
diseases in older adults are predicted to increase significantly in the years to come. 
Since the invention of electrocardiography in 1902 by Willem Einthoven, the 
electrocardiogram (ECG) has gained an important position in clinical cardiology. In 
the last decade, computer programs for ECG interpretation with good performance 
have become available, improving the applicability of ECGs in medical practice and 
epidemiologic research. The ECG offers an inexpensive, noninvasive means to 
determine the presence of coronary heart disease as well as other cardiac 
abnormalities, such as ventricular hypertrophy and atrial fibrillation, known to be 
associated with the risk of future cardiovascular events. This suggests a potential for 
ECG analysis in cardiovascular screening. Especially in the elderly, in whom 
medical histories may be troubled by concomitant diseases and of which 
documentation is not always as reliable as one would like, the ECG could serve as a 
useful diagnostic and prognostic instrument, also outside the hospital. 
The research described in tltis thesis was initiated with the aim to deterntine the 
prognostic value of electrocardiographic parameters for future cardiovascular 
disease in the elderly. The study of the prognostic value of the ECG encompasses 
two related questions with a different clinical perspective. First, which ECG 
parameters reflect myocardial damage or disease, and how should they be assessed? 
This is a diagnostic question. Second: what is the prognostic value of certain ECG 
abnormalities? 
In chapter 1, a review of the literature on the prevalence and prognosis of ECG 
abnormalities in the elderly is given. To improve the comparability between studies, 
prevalence data are presented for all studies using the Milmesota Code for 
classification of ECG abnormalities. The prevalence of most Minnesota Codes 
showed wide variation across individual studies. Part of this variation may be due to 
a lack of standardization of coding procedures, for which computer programs may 
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offer a solution. The prevalence of abnormal EeG findings is relatively high in the 
elderly. The prevalence of most EeG abnormalities increases with age and is higher 
in men than in women. Most BeG abnormalities are associated with an increased 
risk of future coronary heart disease. 
All diagnostic and prognostic studies described in chapters 2 and 3 are part of the 
Rotterdam Study, a population-based study among 7,983 men and women aged 55 
years or older, aimed at assessing the occurrence and risk factors for chronic 
diseases in the elderly. 
To establish an efficient and standardized way for interpreting large numbers of 
EeGs in populatioll-based studies, we assessed the performance of diagnostic EeG 
interpretation by both the EeG computer program MEANS (Modular EeG Analysis 
System) and research physicians, and compared it with the interpretation of 
cardiologists (chapter 2.1). We studied the diagnostic performance of tln'ee scenatios: 
use of the computer program alone (A), computer program and cat'diologist combined 
(B), atld computer progratn, research physician and cardiologist combined (C). To 
diagnose left ventricular hyperlrophy and left and right bundle branch block the 
computer program alone gave satisfactOlY results. Preferably, however, findings of 
anterior and inferior MI by the progratn, need to be veIified by a cardiologist. 
Diagnostic EeG intelpretation by computer can be very helpful in population-based 
research, is at least as good as EeG interpretation by a trained research physician. but is 
much more efficient and, therefore, less expensive. 
In clinical practice, the relevance of diagnostic or prognostic determinants heavily 
depends on its reproducibility in an individual. In view of this, knowledge about the 
reproducibility of EeG measurements and coding is essential. We assessed minute-
to-minute, day-to-day, and yeat·-to-yeat· variability of computerized EeG 
measurements, composite scores, and Minnesota Code classification, in 101 11011-
hospitalized elderly men and women (chapter 2.2). Overall, variability between 
EeG measurements tended to increase with time. In a routine setting, electrode 
positioning had a relatively small effect on the total variability. EeG interval 
measurements were more reproducible than amplitude measurements. The best 
reproducibility was found for the overall QTc interval and the poorest 
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reproducibility for the Cardiac Infarction InjlllY Score. Minnesota Code 
discrepancies occurrcd frequently; 16%, 19% and 22% in the minute-to-minute, 
day-to-day, and year-to-year group, respectively. Part of this variability may be 
explained by the fact that most codes use a single threshold. For borderline 
measurements, a few milliseconds difference may dramatically change the coding. 
A way to deal with poor reproducibility of measurements in clinical practice is the 
use of repeated measurements to establish the presence or absence of an ECG 
diagnosis. 
The estimated prevalence of ECG abnormalities is directly based on diagnostic 
criteria and measurement techniques. In chapter 2.3, we assessed the prevalence of 
different types of myocardial infarction (MI), notably "typical MI" (MI with 
symptoms and matching ECG abnormalities), "silent MI" (asymptomatic MI, 
diagnosed by ECG abnormalities only), and "non-Q-wavc MI" (symptomatic MI, 
clinically diagnosed by raised cardiac enzyme levels, but without matching ECG 
abnormalities). Overall, the prevalence of "typical MI" was 4.1 % (95%CI 3.5-4.9), 
of "non-Q-wave MI" 2.8% (95%CI 2.2-3.4), and of "silent MI" 3.9% (95%CI 3.2-
4.5). Thus, in the elderly, MIs frequently occur without typical symptoms or ECG 
changes. Misclassification due to incomplete sources of information can be 
considerable and should be taken into account in the design and interpretation of 
epidemiologic studies. As all these silent manifestations of MI also convey an 
increased risk of symptomatic heart disease or death, they require further attention. 
In chapter 2.4, we studied variation in the prevalence of prolonged QT in the 
Rotterdam Study, based on several accepted definitions, and compared our results 
with those from other studies applying the same definitions. Prolonged QT is 
frequent both in men and women, and its prevalence increases with age. Women 
have longer heart-rate adjusted QT intervals than men. Depending on the formula 
used to adjust QT for heart rate and the threshold used to define prolonged QT, the 
prevalence of prolonged heart-rate adjusted QT varies from 6% in men and 9% in 
women using QT index, to 31 % in men and 26% in women using a linear regression 
equation. In comparisons with other studies applying the same correction formulas 
and adjusting for age showed large discrepancies in prevalence estimates of 
prolonged heart-rate adjusted QT remain, probably largely attributable to 
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differences in measurement technique. 
In chapter 3, the prognostic value of several relatively "new" ECG abnormalities, 
measured by the ECG computer program MEANS, for future cardiovascular disease 
and mortality is described, All studies in chapter 3 are restricted to 2,358 men and 
3,454 women, participating in the Rotterdam Study, for whom a digital ECG and 
follow-up information was available, During the 3 to 6 (mean 4) years of follow-up, 
568 (9.8%) subjects died. 
Prolonged heart-rate adjusted QT interval has been associated with an increased risk 
for ventriculm' arrhythmias, sudden death, and coronary hem·t disease in patient 
populations, but studies in the population at large have shown controversial results. 
We examined the association between heart-rate adjusted QT interval, using 
different formulas to correct for heart rate, and cardiac and all-cause mortality 
(Chapter 3.1). Participants in the highest qum·tiIe of heart-rate adjusted QT 
intervals had about a 70% age- and sex-adjusted increased risk for both all-cause 
mortality (hazard ratio (HR) 1.8; 95%CI:1.3-2.4) and cardiac mortality (HR 1.7; 
95%CI: 1.0-2.7) compared to those in the lowest quartile. These risk estimates do 
not change after adjustment for potential confounders. In women, increased risk 
associated with prolonged QT for cardiac death is more pronounced than in men. 
The risk associated with prolonged QT is hm'dly affected by the heart-rate 
correction formula used. 
Increased QTc dispersion has been associated with an increased risk for ventricular 
arrhythmias and cardiac death in selected patient populations, using manual 
measurements. QTc dispersion has been hypothesized to reflect local differences in 
ventricular repolarization, resulting from myocardial ischemia and patchy 
myocardial fibrosis. QTc dispersion was computed by MEANS as the difference 
between the maximum and minimum QTc interval in 12 leads and 8 leads. For QTc 
dispersion in 8 leads, those in the highest tertile relative to the lowest tertile, had 
about a twofold risk for cardiac death (HR 2.5; 95%CI 1.6-4.0) and sudden cm'diac 
death (HR 1.9; 95%CI 1.0-3.7), and a 40% increased risk for total mortality (HR 
1.4; 95%CI 1.2-1.8) (chapter 3.2). Additional adjustment for potential confounders 
does not materially change the risk estimates. Hazard ratios for QTc dispersion in 
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12 leads are comparable to those found for QTc dispersion in 8 leads. QTc 
dispersion is an important predictor of cardiac mortality in older men and women. 
In chapter 3.3 we studied a new ECG characteristic, the electrical T axis, which we 
hypothesized to be a general marker of repolarization abnormality, indicative of 
subclinical myocardial damage. Subjects with an abnormal T axis have increased 
risks for cardiac death (HR 3.9; 95%CI 2.8-5.6), sudden cardiac death (HR 4.4; 
95%CI 2.6-7.4), non-fatal cardiac events (HR 2.7; 95%CI 1.9-3.9), and combined 
fatal or non-fatal cardiac events (HR 3.2; 95%CI 2.5-4.1). Additional adjustment for 
established cardiovascular risk indicators results in lower, but still highly significant 
risks for all endpoints. The risks associated with an abnormal T axis are higher than 
those of any other cardiovascular risk indicator. The T axis is a new, strong, and 
independent risk indicator of fatal and non-fatal cardiac events in the elderly. 
In chapter 3.4 we examined the association between heart rate variability (HRV) on 
a standard 10-second ECG, and cardiac and all-cause mortality. HRV, calculated as 
the standard deviation of normal RR intervals (SDNN), was categorized into 
quartiles. The third quartile of SDNN was used as the reference category. Subjects 
in the lowest quartile compared to those in the third quartile of SDNN, have an 80% 
age- and sex-adjusted increased risk for cardiac mortality (HR 1.8; 95%CI:1.0-3.2). 
Interestingly, for subjects in the highest quartile of SDNN compared to those in the 
third quartile, an even more pronounced risk for cardiac mortality is present (HR 
2.3; 95%CI: 1.3-4.0). As has been suggested by many other studies, decreased HRV 
is probably largely due to changes in autonomic balance. Presumably, increased 
HRV is hardly influenced by the autonomic nervous system, but may rather be due 
to sinus node dysfunction. 
Clinical relevance of electrocardiographic risk indicators largely depends on the 
added prognostic value of ECG abnormalities in addition to other cardiovascular 
risk indicators, in identifying subjects at increased risk for future heart disease. In 
chapter 3.5 we studied the predictive value of conventional and "new" ECG 
abnormalities for cardiac mortality, when used in addition to the cardiovascular risk 
profile commonly available in general practice. In both men and women, the highest 
age-adjusted incidence of cardiac death was found in subjects with an abnormal T 
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axis (28.7 and 27.2 per 1,000 person-years, respectively). In men, a strong 
association of silent myocardial infarction with future coronary heart disease was 
found. This association was absent in women. Apart from silent myocardial 
infarction, most ECG abnormalities showed a stronger association with cardiac 
death in women than in men. The "EeG risk function" including both EeG 
abnormalities and conventional cardiovascular risk indicators, compared to the 
"standard risk function", improves the predictive power for cardiac death. This 
finding is more pronounced in women than in men. In the upper decile of risk 
according to the EeG risk function, incidence rates of cardiac mortality are almost 
as high in those without symptomatic coronary heart disease as in those with 
symptomatic coronary heart disease. Our findings lend support to the view that the 
EeG may aid the physician in cardiovascular risk profiling of individual patients. 
In conclusion, in chapter 4 the implications of the studies presented in this thesis 
are discussed and recommendations for future research are given. The EeG is an 
inexpensive and noninvasive diagnostic test with important prognostic properties, 
notably in non-hospitalized subjects. Development of EeG computer programs, that 
have been shown to pelform well has certainly increased its applicability. As shown 
by our results, new information from the EeG remains to be disclosed. In addition, 
sensitive and reproducible EeG analysis by computer offers possibilities for serial 
EeG analysis. Even today, when powerful imaging techniques are available, the 
ECG maintains a central position in the diagnosis and prognosis of cardiovascular 
disease. Electrocardiography clearly deserves, preferably multidisciplinary, 
attention to further improve its value in epidemiologic research and cardiovascular 
risk profiling. 
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SAMENVATTING 
In veel westerse landen zal naar verwachting in de komende jaren het percentage 
ouderen in de bevolking verder toenemen. Hart-en vaatziekten vormen een belang-
rijke oorzaak van ziekte en stelfte bij ouderen en het valt dam'om te verwachten dat 
de totale incidentie van hart-en vaatziekten de komende jaren eveneens sterk zal 
toenemen. 
Sinds de llitvinding van electrocardiografie in 1902 door Willem Einthoven lleeft 
het electrocardioam (ECG) een belangrijke plaats in de klinische cardiologie 
verworven. In de jaren '90 zijn goede computer progrmmna's voor ECG interpre-
tatie beschikbaar gekomen, die het gebl1lik van ECG's in de medische praktijk en in 
epidemiologisch onderzoek hebben bevorderd. Het maken van een ECG is goed-
koop en niet erg belastend voor de patient en geschikt voor het vaststellen van 
coronaire hartziekten en andere afwijkingen, die samenhangen met de kans op het 
optreden van toekomstige cardiovasculaire ziekten. Het ECG kan aldus worden 
bellUt voor screening op toekomstig risico voor hart-en vaatziekten. Vooral bij 
ouderen, bij wie de anamnese bemoeilijkt kan worden door de aanwezigheid van 
meerdere ziekten, zou het ECG als een zinvol diagnostisch en prognostisch 
instrument kUllllen dienen, ook buiten de kliniek. 
Het onderzoek dat in dit proefscl11'ift bescln'even wordt, heeft tot doel de prognos-
tische waarde van ECG kenmerken voor toekomstige hart- en vaatziekten bij oude-
ren te bepalen. Bij het bestuderen van de prognostische waarde van het ECG zijn 
twee verschillende vraagstellingen van belang. Ten eerste, welke ECG kenmerken 
reflecteren reeds aanwezige hartschade of hartziekte, en hoe moeten deze 
kenmerken worden bepaald? Dit is een diagnostische vraag. Ten tweede, wat is de 
prognostische waarde van bepaalde ECG afwijkingen? 
In hoofdsluk 1 wordt een overzicht gegeven van de IiteratllUl' over de prevalentie en 
de prognose van ECG afwijkingen bij ouderen. Om de verschillende onderzoeken 
zo vergelijkbaar mogelijk te maken, wordt de Minnesota Code gebrllikt voor 
klassificering van ECG afwijkingen. Toch blijken grote verschillen te bestaan tussen 
studies onderling. Dit kan voor een deel verkiaard worden door een gebrek aan 
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standaardisering van codeerprocedures, hetgeen opgelost zau kunnen worden met de 
tegenwoordig beschikbare computer progranuna's, De prevalentie van ECG afwij-
kingen bij ouderen is relatief hoog. Veel ECG afwijkingen komen vaker voor op 
hogerc leeftijd en vaker bij mannen dan bij vrouwen. De meeste ECG afwijkingen 
zijn gerelateerd aan het optreden van toekomstige hartziekten. 
In het onderzoek dat wordt beschreven in hoofdstuk 2 ell 3 is gebruik gemaakt van 
gegevens die verzameld zijn in het Erasmus Gezondheid Ouderen (ERGO) 
onderzoek, in het Engels 'Rotterdam Study' genoemd. Het ERGO onderzock is een 
bevolkingsonderzoek bij 7983 mannen en vrouwen van 55 jaar en ouder, dat tot doer 
heeft het optreden van chronische ziekten bij ouderen te onderzoeken en de 
risicofactoren die daarbij een rol klllmen spelen. 
Met als doel om te komen tot een efficiente en gestandaardiseerde methode voor de 
interpretatie van grote hoeveelheden ECG's in bevolkingsonderzoeken, hebben we 
de diagnostische prestaties van het computer programma MEANS en onderzoeks-
artsen vergeleken met die van cardiologen, bimlen ons bevolkingsonderzoek 
(hoofdstttk 2,1). We vergeleken de diagnostische prestaties van drie verschillende 
scenario's waarin: (A) ECG's aileen door het computer programma worden 
beoordeeld, (B) de door de computer gevonden afwijkingen worden geverifieerd 
door een cardioloog, of (C) aile ECG's zowel door de computer als de onder-
zoeksarts worden beoordeeld en de ECG's waarover zij van mening verschillen door 
de cardioloog worden beoordeeld. Het blijkt dat voor diagnostiek van linker ventri-
kel hypertrofie en linker- en rechter bundeltakblok het computerprogramllla bevre-
digende resultaten geeft. Het verdient echtcr aanbeveling om aile VOO1'- en achter-
wandinfarcten die door de computer worden gediagnostiseerd worden te laten veri-
fieren door een cardioloog. De computer presteert minstens zo goed als speciaal 
opgeleide onderzoeksartsen en computer interpretatie is bovendien cfficienter en 
dus een stuk goedkoper. 
In de klinische praktijk wordt de relevantie van een diagnostische of prognostische 
bepaling in belangrijke mate bepaald door de reproduceerbaarheid van de meting in 
de individuele patient. Wij bestudeerden de reproduceerbaarheid binnen minuten, 
dagen en jaren van computermatige EeG metingen, samengestelde scores en 
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Minnesota Codes, in een steekproef van 101 deelnemers aan het ERGO onderzoek 
(hoofdstnk 2.2). De variabiliteit nam toe met de tijd die lag tussen de ECG's. De 
plaatsing van eleetroden heeft weinig invloed op de totale variabiliteit. Metingen 
van ECG intervallen zijn beter reproduceerbaar dan metingen van ECG amplitudes. 
Wij vinden de beste reproduceerbaarheid v~~r het QTc interval en de nunst goede 
voor de Cardiac Infarction InjUly Score. Discrepanties in Minnesota Codes komen 
veel voor: in 16% van de ECGs voor de vergelijking bimlen minuten, in 19% van de 
ECGs voor de vergelijking bhmen dagen en in 22% van de ECGs voor de 
vergelijking binnen jaren. Dit zou gedeeltelijk verklaard kUllllen worden doordat de 
meeste codes een enkelvoudige drempelwaarde gebruiken. Voor metingen die dicht 
bij de drempelwaarde liggen kan een verschil van enkele nulliseconden codering 
drastisch veranderen. In de medische praktijk kan slechte reproduceerbaarheid van 
metingen ondervangen worden door herhaalde metingen toe te passen am de aan- of 
afwezigheid van een ECG diagnose vast te stellen. 
De geschatte prevalentie van ECG afwijkingen is gebaseerd op diagnostische 
criteria en meettechnieken. In hoofdstnk 2,3 bepaalden we de prevalentie van ver-
schillende typen myocardinfarct (MI), namelijk het 'typische MI' (MI met bijpas-
sende symptomen en ECG afwijkingen), het 'stille MI' (MI zander symptomen 
maar met karakteristieke ECG afwijkingen) en het 'Iuide MI' (MI met bijpassende 
symptomen maar zonder karakteristieke ECG afwijkingen, gediagnostiseerd met 
behulp van enzymbepalingen). De prevalentie van het 'typische MI' was 4, I % , van 
het 'stille MI' 3,9% , en van het 'Iuide MI' 2,8%. Bij ouderen komen hartinfarcten 
dus relatief vaak voor zander symptomen of zander ECG afwijkingen. Misc1as-
sificatic van MI door het gebruik van beperkte infonnatiebronnen kan aanzienlijk 
zijn en daar moet rekening mee worden gehouden bij de opzet en interpretatie van 
epidemiologische studies. AI deze manifestaties van MI geven een verhoogd risico 
op symplomatische hartzieklen of sterfte en verdienen meer aandacht. Hoofdstnk 
2.4 geeft de resultaten van onderzoek naar de variatie in de prevalentie van verlengd 
QT gecorrigeerd voor hartfrequentie, gebaseerd op verschillende beschikbare 
dcfinitics, en onze resultaten worden vergeleken met die van andere studies die 
dezelfdc defilulies gebruikten. Een verlengd QT interval komI vaak voor bij zowel 
mannen als vrouwen en de prevalenlie neemt toe met de leeflijd. Bij vrouwen is het 
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voor hartfrequentie gecorrigeerde QT interval langer dan bij mannen. Afhankelijk 
van de formule die gebl1likt wordt am QT te corrigeren voor hartfrequentie en van 
de drempelwaarde voor verlengd QT. varieert de prevalentie van 6% bij mannen en 
9% bij vrouwen voor QT index tot 31 % bij mannen en 26% bij vrouwen voor de 
lineaire regressie-correetie. Vergelijking met andere studies die dezelfde eorreetie 
formule gebl1likten lict na correctie voor leeftijdsverschillen grate verschillen zien 
in prevalentieschattingen van gecorrigeerd QT interval, beide worden waarschijnlijk 
vooral veroorzaakt door verschillen in meetteehnieken. 
In hoofdstuk 3 wordt de prognostisehe waarde van enkele 'nieuwe' ECG afwij-
kingen, bepaald met het computer programma MEANS, voor het optreden van toe-
komstige hartziekten beselu·even. AIle studies in dit hoofdstuk werden verricht bij 
de 2358 mmmen en 3454 vrouwen in het ERGO onderzoek, van wie zowel een 
digitaal ECG als follow-up informatie over het optreden van hart- en vaatziekten 
beschikbaar was. Gedurende de 3 tot 6 (gemiddeld 4) jaar follow-up zijn 568 (9,8%) 
deelnemers overleden. 
Verlengd QT, geeorrigeerd voor hartfrequentie, is in verband gebracht met 
ventriculaire ritmestoornissen, plotselinge dood en coronaire hartziekten in 
onderzoek bij geseleeteerde patientgroepen, maar studies in de algemene bevolking 
laten tegenstrijdige resu!taten zien. Wij onderzochten de relatie tussen QT interval, 
gecorrigeerd voor hartfrcquentie middels verschillende formules (QTc), en het risico 
op totale en em'diale sterfte (hoofdstuk 3.1). Oeelnemers met QTe intervallen in 
hoogste 25% van de QTc verdeling hebben, na correetie voor leeftijd en geslacht, 
een 70% grotere kans om te sterven en am te sterven aan cardiale oorzakcll, dan 
deelnemers met QTc intervallen in de laagste 25% van de verdeling. Oit risico 
wordt niet verklaard door andere risico factoren. Het risico bij een verlengd QT is 
grater voor vrouwen dan voor mannen, Het gebruik van verschillende correctie-
formules had weinig effect op de risicoschattingen. 
Een toegenomen dispersie van het QTc interval is in voorgaand onderzoek in 
verband gebracht met cen verhoogd fisico op vcntriculairc ritmestoornissen en 
hartsterfte onder geselecteerde paticntgroepen. Hierbij waren de metingen met de 
hand werden uitgevoerd. QTc dispersie zou het gevolg kmmen zijn van lokale 
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verschillen in repolarisatiesnelheid van de hartspier, die veroorzaakt worden door 
ischaemie en vOrIning vanlittekenweefsel in de hartspier. Wat betreft QTc dispersie 
in 8 afleidingen hebben mensen in het hoogste tertiel ten opzichte van mensen in het 
laagste tertiel een tweemaal zo hoog risico op cardiale dood en plotselinge hartdood 
en een 40% hoger risico op totale sterfte (hoofdstuk 3.2). Correctie voor andere 
samenhangende varia belen heeft weinig invloed op deze risicoschattingen. De 
risico's voor cardiale sterfte geassocieerd met QTc dispersie in 12 afleidingen waren 
vergelijkbaar met die voor QTc dispersie in 8 afleidingen. QTc dispersie is een 
belangrijke voorspeller voor cardiale stelfte onder oudere mannen en vrouwen. 
In hoofdstuk 3.3 introduceren we een nienw ECG kenmerk, de electrische T as. We 
stelden dat de T -as een algemene maat vaar repalarisatiestaarnissen zau kumlen 
zijn, die samenhangt met schade aan de hartspier. We onderzochten de prognos-
tische waarde van de T-as voor fatale en niet-fatale cardiale problemen. In vergelij-
king tot mensen met een nonnale T -as hebben mensen met cen abnonnale T -as een 
vier maal zo hoog risico op cardiale dood en plotse hartdood en een bijna drie maal 
zo hoog risico op niet-fatale coronaire hartziekte. Correctie voor bekende risico-
factoren voar hart- en vaatziekten resulteert in lagere, maar nog steeds statistisch 
significant verhoogde risico's vaar aIle eindpunten. De risico's die samenhangen 
met een abnarmalc T -as zijn hoger dan die van de andere cardiovasculaire risico-
indicatoren. De T-as is een nienwe, sterke risicoindicator voor fatale en niet-fatale 
hart- en vaatziekten bij ouderen. 
In hoofdstuk 3.4 onderzochten we de relatie tnssen hartritmevariabiliteit (HRV) in 
het standaard lO-seconden ECG en cardiale sterfte. HRV werd bepaald als de 
standaard deviatie van aile normale RR intervallen (SDNN) en werd vervolgens 
verdeeld in kwartielen. Het derde kwartiel van SDNN werd gebruikt als referentie. 
Mensen in het laagste kwartiel vergeleken met die in het derde kwartiel hadden na 
correctie voor leeftijd en geslacht een 80% hoger risico op cardiale stelfte. Een 
interessante bevinding was dat mensen in het hoogste kwartiel SDNN vergeleken 
met die in het derde kwartiel zelfs een meer dan twee maal zo hoog risico hebben op 
cardiale stcrfte. Zoals reeds in eerder onderzoek is gesuggereerd, wordt het risico 
gerelatcerd aan verminderde HRV waarschijnlijk voornamelijk veroorzaakt door een 
slcchte autonome balans. Verhoogde HRV daarentegen wordt waarschijnlijk 
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nauwelijks bei'nvloed door auto nome functie, maar is eerder het gevolg van een 
verminderde funetie van de sinusknoop. 
De klinisehe relevantie van eleetroeardiografisehe risieoindicatoren in sterk afhan-
kelijk van de toegevoegde waarde van ECG afwijkingen aan het conventionele car-
diovasculaire risieoprofiel, voar het identificeren van mensen met een verhoogd 
absoluut risico op hart- en vaatziekten. In hoofdslnk 3.5 bestudeerden we de 
voorspeIlende waarde van ECG afwijkingen voor cardiale sterfte, wanneer het ECG 
geblllikt wordt als aanvulling op het gewone cardiovasculaire risicoprofiel, zoals dat 
bijvoarbeeld in de huisartsenpraktijk geblllikt wordt. Bij zowel maJmen als vrouwen 
is na correctie voar leeftijd de hoogste incidentie van hartsterfte aanwezig bij 
mensen met een abnormale T-as (respectievelijk 28.7 en 27.2 per 1000 persoons-
jaren). Bij mannen is er een sterk verband van 'stil myoeardinfarct' met toekomstige 
haJt-en vaatziekten, terwijl dit verband met voor vrouwen geldt. Voor de meeste 
ECG afwijkingen, behalve het stille hartinfaJ'ct, is het risico voor cardiale sterfte 
hoger voor vrouwen dan voor mmmen. De 'ECG risieofunctie', opgebouwd uit ECG 
afwijkingen en conventionele cardiovasculaire risicoindicatoren, geeft cen betem 
voorspeIlende waarde voor cardiale sterfte dan de 'standaard risicofunetie', die 
aIleen uit niet-electrocardiografisehe risicoindicatoren was opgebouwd. Dit verschil 
is groter bij vrouwen dan bij mannen. Onze resultaten steunen het idee dat het ECG 
de arts kan helpen bij risicoprofilering van individuele patienten. 
Tenslotte besehouwen we in hoofdstuk 4 de implicaties van de studies die in dit 
proefschrift worden beschreven en doen we aanbevelingen voor verder ondcrzoek. 
Het ECG is een goedkope, niet-invasieve diagnostische test met belangrijke 
prognostisehe eigenschappen. De ontwikkeling van goed presterende ECG computer 
programma's hebben de toepasbaarheid van het ECG vergroot, met name voar 
bevolkingsonderzoeken. Onze resultaten laten zien dat er nog steeds nieuwe 
informatie in het ECG ontdekt kan worden. Tegenwoordig zijn krachtige beeld-
varmende teehnieken beschikbaar, mam' desondanks behoudt het ECG zijn centrale 
rol in diagnose en prognose van hart- en vaatziekten. Electrocardiografie verdient 
meer, liefst multidisciplinaire aandacht, om zijn waarde verder te kunnen benutten. 
168 
Dankwoord 
Dit proefschrift is het resultaat van een bijzondere en vruchtbare samenwerking 
tussen vijf mensen werkzaam op het Instituut Epidemiologie & Biostatistiek en de 
afdeling Medische Informatica van de Erasmus Universiteit. Het feit dat ik deel 
mocht uitmaken van deze inspirerende samenwerking, is waarschijnlijk de meest 
waardevolle les die ik de afgelopen vier jaar heb geleerd. Ik hoop dat in de toekomst 
deze samenwerking zal voortleven, zowel binnen als buiten Rotterdam. 
Dr. A.W. Hoes en dr. ir. J.A. Kors, beste Arno en Jan, ik ben jullie oprecht dank-
baar voor alles wat jullie mij hebben geleerd. Met groot geduld en tact hebben jullie 
vier jaar lang de dagelijkse begeleiding van het onderzoek op je genomen. Tijdens 
het hele project heb ik genoten van de open sfeer, waarbij alles wat niet duidelijk 
was hardop werd uitgesproken en besproken. Arno, jouw sehrijftalent is overal in 
dit boek terug te vinden en ik zal je lessen in de klinische epidemiologie niet snel 
yergeten. Jan, jouw eindeloze nieuwsgierigheid om alles zelf te begrijpen en jouw 
nauwkeurige manier van werken waren een prettig tegenwicht voal' mijn onge-
duldige honger naar resultaten. Jullie waren tot grote steun in minder gemakkelijke 
tijden. Ik hoop dat onze wegen in de toekomst nog vaak zullen kruisen. 
Mijn promotores, prof. dr. D.E. Grobbee en prof.dr.ir. J.H. van Bennnel, wil ik be-
danken voor de grote vrijheid die ik kreeg bij uitvoer van dit onderzoek, gecom-
bineerd met onvoorwaardelijke steun op de momenten dat het nodig was. Rick, ik 
waardeer je leidinggevende en inhoudelijke kwaliteiten zeer. Jan, het enthousiasme, 
de gastvrijheid en de energie waarmee je werkt zijn heel stimulerend. 
Behalve mijn (CO)prolllotores hebben vele anderen bijgedragen aan het onderzoek. 
Zonder volledig te kunnen zijn wil ik een aantal mensen noemen. Jacqueline Dekker 
droeg lllij tijdens en na het afronden van haar promotieonderzoek met aanstekelijk 
enthousiasme veel bruikbare kennis over. Gerard van Herpen heef! lllij geleerd met 
andere ogen naar het ECG te kijken. Arend Mosterd heef! de basis gelegd yoor mijn 
onderzoek in de tijd dat ERGO nog met smart wachtte op 'de ECG-AIO'. 
Zonder de hulp van cardiologen was een deel van ons onderzoek onmogelijk 
geweest. Dick Kruijssen heeft bij de start van ERGO de artsen opgeleid om ECGs te 
beoordelen. J aap Deckers en Marcel Grosfeld waren bereid stapels ECGs te beoor-
169 
delen, in de wetenschap dat ze daarna zelf ook beoordeeld zouden worden. Peter 
Klootwijk stelde zijn gloednieuwe apparatuur beschikbaar voor analyse van hartrit-
mevariabiliteil. Ik heb er met plezier mee gewerkt, in goed gezelschap van Angela 
en Marianne, die mij veel hebben geleerd over de analyse van hartritme. 
Zonder de oprichters en medewerkers van het ERGO onderzoek, was dit proef-
schrift er nooit gekomen. Ook de deelnemers van het ERGO-onderzoek, de Om-
moordse huisartsen, en vooral Elly, die zorgde voor het verzamelen en netjes 
bewaren van veel infonnatie, ben ik dank verschuldigd. Voor de ondergewaardeerde 
taken van datamanagement waren Hanneke en later Caroline van Rossum, Saskia en 
Peggy van onschatbal'e waarde. Het secretariaat en de beheerders van beide afde-
lingen hebben me vaak geholpen. Bob, Mees en Albert stonden altijd klaar om 
computerproblemen te verhelpen. 
Op de 21e is een AIO gelukkig nooit echt aileen. In vier jaur heb ik drie kamel's 
bewoond, elk met hun eigen goede sfeer. Marieke, Arend, Erik, en Dianne wijdden 
mij in in de 'geheimen' van de afdeling en het AIO-bestaan. Aleks en Paul zorgden 
voor gezelligheid op de volgende kamer. Met Manon en Anke heb ik de laatste jaren 
lief en leed, en vele cafe latte's gedeeld. Behalve mijn kamergenoten zijn andere 
collega's veel voor me gaan beteken. Sandra en Iris, het carpoolen en vooral de 
gezellige conversaties maakte het reizen tussen Amsterdam en Rotterdam een stuk 
plezieriger. Anske, Sesmu, Marianne, Caroline van ROSSUffi, Ber, Carl, Caroline 
Klaver, en Jifke ook jullie zal ik missen en ik hoop jullie nog wei eens te zien. 
Zonder de relativerende invloed van vrienden en familie had ik het nooit vol-
gehouden. Jacqueline, Elles, Beatrice, Anne Mara, Eisbeth, Joanne en Gerdien 
zonder jullie zou het leven maar saai zijn. Ik heb jullie trouwe vriendschap in deze 
drukke zomer weer zeer gewaardeerd. Tijdens de vele zonnige schaats- en 
fietsuurtjes in het weekend kon ik het werk lekker verge ten en kreeg ik soms goede 
adviezen. Met onze toerskivrienden hoop ik deze kerstvakantie goed te beginnen 
met een feesl. Beatrice en Anita, ik vind het heel fijn dat jullie straks naast me wil-
len staan als paranimf. Lies en Len, ook al zien we elkaar nu minder dan vroeger, 
als zussen zijn jullie steeds belangrijker voor me geworden. Pappa en mamma, dank 
voor aile goede zorgen, belangstelling, vertrouwen en warmte voor jullie zo 
'zelfstandige' dochter. Bart, je bent de dierbaarste in mijn leven. Je helpt me altijd 
onthouden dat het leven er is om van te genieten en zorgt er ook VOOl' dat dat kan. 
170 
Curriculum vitae 
Margaretha Christine (Martine) de Bmyne was born on January 4, 1967 in Utrecht, 
the Netherlands. From 1979 to 1985 she attended Gymnasium-ll at the Gymnasium 
Celeanum in Zwolle. 
In 1985 she started her medical studies at the University of Amsterdam and she 
obtained her medical degree in 1993. Starting in 1987, she also studied Medical 
Informatics at the University of Amsterdam. In 1988 and 1989 she was a student 
member of the faculty board of Medical Informatics. In April 1991 she graduated on 
the project 'Decision support in general practice based on the NHG standards'. In 
the same year she worked four months in the Advanced Computing Laboratory of 
the Imperial Cancer Research Fund in London, where she performed studies on the 
development and implementation of a protocol for treatment of hyperlipidaemia in 
the Oxford System of Medicine. In 1991 and 1992 she worked part-time for VV AA 
as an advisor for the development of MicroHIS, an information system for general 
practice. 
In 1993 she started the work described in this thesis at the department of 
Epidemiology and Biostatistics and the Department of Medical Informatics, 
Erasmus University Medical School in Rotterdam (promotores Prof. dr. D.E. 
Grobbee and Prof. dr. ir. J.H. van Bemmel). She was managing editor of the 
'Yearbook of Medical Informatics' published by the International Medical 
Informatics Association, from 1995 to 1997. 
In 1996 she achieved the Master of Science in Clinical Epidemiology at the 
Netherlands Institute for Health Sciences in Rotterdam. 
From November 1997 she will probably be working at the Julius Centre for Patient-
Oriented Research, where she will be involved with quality of care research in 
general practice. 
171 
172 


